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Abstract 
Calcium phosphate cements are in-vivo setting, injectable calcium phosphate 
based biomaterials. They are made of calcium phosphate salts which when 
mixed with water react to form apatite, the mineral phase of bones and teeth. 
This study investigates a novel way of forming calcium phosphate cements 
using bioactive glasses. The aim of the work was to discover a novel route of 
synthesis using a silicate bioactive glass. 
Fifteen glass compositions were produced designed to investigate P2O5 
content, CaF2 content and calcium to sodium ratio within the glass. Glasses 
were produced via a melt-quench route before being milled and sieved to 
below 38 μm. The bioactive glass and Ca(H2PO4)2 powders were mixed in an 
overall calcium to phosphate ratio of 1.67. The cement powder was then 
reacted with a 2.5 % solution of Na2HPO4. The paste was then mixed and 
then placed into cylindrical moulds. Eight samples were immersed into Tris 
buffer solution for 1 hour, 1 day, 7 days or 28 days. The compressive 
strength was measured for each specimen as well as SEM performed and 
the setting times for each composition was studied using the Gilmore needle 
test. The cement phase was analysed using 31P & 19F MAS-NMR, FTIR and 
XRD.  
The results showed that both compressive strength and setting time was 
dependent upon glass composition. As sodium content was increased both 
the initial and final setting times decreased. Increased fluoride addition 
caused a decrease in the setting time. In the fluoride free compositions 
octacalcium phosphate was identified in all compositions. The cement setting 
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reaction for these compositions followed a similar reaction of first forming 
dicalcium phosphate dihydrate which transformed to octacalcium phosphate 
then eventually hydrolysing to hydroxyapatite. When fluoride was 
incorporated into the cement the phases formed were fluoridated-apatite and 
DCPD. In conclusion a novel method of producing calcium phosphate 
cements was discovered using a bioactive glass as a reactive precursor. It 
was shown that the cement phase, setting time and compressive strength 
could all be altered by changing the glass composition. 
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Foreword 
This thesis contains the discovery of and subsequent in-vitro characterisation 
of a novel calcium phosphate cement formed through the reaction where at 
least one of the reactive precursors is a bioactive glass. Each glass 
composition was used to produce a cement which was then characterised for 
compressive strength and cement phase after immersion for various time 
points in Tris buffer solution. The effect of glass composition on the cement 
properties and cement phase is then discussed. This novel method was 
patented, a copy of which is included in the appendix. A six and twelve week 
in-vivo ovine animal study was subsequently performed on this material a 
report of which is also included in the appendix of this thesis. 
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Chapter 1: Introduction 
The aim of this project is to develop novel calcium phosphate cements 
(CPCs) setting in vivo which are produced through reaction where at least 
one of the precursors is a bioactive glass. 
CPCs are calcium phosphate based synthetic bone graft materials which 
form conventionally as a result of the reactions between calcium phosphate 
salts. On mixing with water the salts react to form apatite, the mineral phase 
of bones and teeth. CPCs have uses in both orthopaedics and dentistry 
where they are used as bone substitute materials to replace missing or 
diseased bone. They are advantageous because of their injectability which 
allows the surgeon to inject the setting cement paste into the implantation 
site minimally invasively. These materials are also in vivo setting which 
allows them to mould to the shape of the implantation site once implanted 
which ensures complete void filling. Unlike CPCs, pre-set bone substitutes 
do not have this advantage and cannot set in vivo. 
The disadvantages of currently used CPCs are that firstly the calcium 
phosphate salts used lack sufficient solubility which leads to poorly 
controllable setting times. Salts are also fixed in their stoichiometry meaning 
they are restrictive when alteration of composition is desired to improve the 
properties of these materials. CPCs also suffer from low early water stability 
caused by their poor setting characteristics. On incomplete setting the 
cement mixed with body fluid can be dislodged from the implantation site. 
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This has the potential for large surgical complications and even mortality for 
the patient if untreated. 
Bioactive glass has also been used as bone-substitute materials. They are 
amorphous materials and are produced from SiO2-P2O5-CaO-Na2O where 
the SiO2 is the glass network forming oxide. They are defined a class A 
bioactive materials as they are osteoinductive (Hench, 2006). The initial 
commercial examples were based on the glass composition 45S5 (46.1 
mol% SiO2, 26.9 mol% CaO 24.4 mol% Na2O and 2.5 mol% P2O5) 
developed by Hench et al. in the late 1960’s. Later examples has been 
developed notably StronBone, a strontium containing bioactive glass 
indicated for bone substitution (O'Donnell et al., 2010). The material is 
implanted as granules where the granular mixture is mixed with the patients’ 
blood and then impacted into the implantation site.  
The advantages of bioactive glasses are that they show good 
biocompatibility, forming a strong interfacial bond with host bone. This 
intimate bone is caused by apatite formation on the surface of the glass and 
in-growth of host bone in the material (Hench et al., 1971). By definition glass 
allows significant variation in compositions which enables alteration of the 
properties in order to optimise notably solubility and biocompatibility. The 
disadvantages of bioactive glass as a bone-substitute materials are that they 
are non-injectable. Bioactive glasses are implanted during the surgery which 
is considerably more invasive method than injection of CPCs. Bioactive 
glasses also have no inherent strength once implanted. Whilst neither CPCs 
nor bioactive glasses can be used for load-bearing application, CPCs do set 
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during their implantation forming a uniform material which is resistant to 
forces applied to it preventing material migration from the implantation site. 
Bioactive glasses however remain particulate until either material induced 
apatite formation or host bone formation which can take at least a few 
weeks. Meaning the glass granules are susceptible to deformation or 
migration from the implantation site which is undesirable. 
The intention of this project is to combine the advantages of both a bioactive 
glass and calcium phosphate cements and produce a novel biomaterial 
which is superior in its properties to both CPCs and bioactive glasses. This 
will widen both the applications and effectiveness of current bone grafting 
materials available to surgeons. The advantages of using this approach are 
outlined below. 
Glasses exist in a higher energy state than their crystalline counterparts. As 
a result of this the glasses are more soluble than the equivalent crystal 
structure. The solubility of a glass can also be manipulated at will through 
alterations in the design of the composition. This gives a wider control of 
setting times through changes in glass composition when glasses are used 
to produce in vivo setting synthetic bone graft. Thus the setting times of 
these materials can be more readily controlled through glass composition 
and particle size distribution rather than just particle size as with CPCs. 
Glass compositions can also accommodate substantial incorporation of 
therapeutically useful ions. It is desirable in certain applications to produce 
substituted apatites (fluoride & strontium) during the setting reaction of 
CPCs. This has been attempted by introducing additional salts that contain 
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the desirable ion to the salt powders. However, this has been shown to have 
deleterious effect on the setting reaction of CPCs (Bohner et al., 2005). It is 
hypothesised that introducing these ions from the glass structure would avoid 
these complications enabling the beneficial effect of the ions without affecting 
the cement properties. 
Using bioactive glass also introduces the silicate phase which is a potential 
site for heterogeneous nucleation and has been proposed as such by Hench 
et al (Hench, 2006) in the bioactivity mechanism of bioactive glasses. In 
conventional CPCs (without hydroxyapatite seed crystals added to the 
formulation) the nucleation is likely to occur via homogenous nucleation. 
Heterogeneous nucleation has a lower energy barrier than homogeneous 
nucleation meaning it occurs more commonly in a system. This means that 
potentially cement developed using glasses would nucleate more rapidly and 
thus set more rapidly than conventional CPCs. 
Another advantage of using the glass is that it has been identified that the 
release of silicon and calcium ions into the site of implantation improves the 
biocompatibility of the material. 17 – 20 ppm soluble Si species and 88 – 100 
ppm soluble Ca ions release from bioactive glasses increases the rate of 
osteoblast proliferation and differentiation (Sun et al., 2009) (Xynos et al., 
2000, Xynos et al., 2001, Hench et al., 2002). Bioactive glasses are 
examples of class A bioactive materials, only class A bioactive materials 
induce rapid new bone formation in vivo (osteoproduction). Comparing Class 
A bioactive materials with Class B, like dense HA substrates, or inert 
materials shows that class A materials are the only examples capable of 
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forming new mineralised bone. This will result in a new glass-based in vivo 
setting bone graft substitute being more biocompatible and osteoinductive 
compared to a conventional CPC. 
Therefore the resulting material will be an in vivo setting bone-substitute with 
a range of potential advantages over both bioactive glasses and CPCs. The 
new CPCs made from bioactive glasses will have improved setting time and 
be injectable which makes them considerably easier and less invasive than 
all non-injectable bone substitutes like bioactive glasses, porous bone 
scaffolds, or HA granules. In conclusion these novel materials will be far 
superior to current orthopaedic materials available to surgeons. 
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Chapter 2: Literature Review 
2.1 Calcium Phosphates 
2.1.1 Hydroxyapatite 
Hydroxyapatite is a common mineral which is the major inorganic phase of 
bone and teeth. It is a type of calcium phosphate with the chemical formula 
Ca10(PO4)6(OH)2. It has extensive use in biomaterials, especially for bone 
substitution, given its affinity with bone. 
 
 
Figure 1 Crystal structure of monoclinic hydroxyapatite (Cazalbou et al., 2004) 
2.1.1.1 Structure 
Pure hydroxyapatite (s-HAP) is monoclinic with space group P21/b and lattice 
parameters a = 9.4214(8), b = 2a, c = 6.8814(7) Å,  ≠ 120 (White and 
Dong, 2003) (See Figure 1). Ns-HAP (non-stoichiometric) has a slightly 
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different crystal structure to s-HAP (stoichiometric), it is in an hexagonal form 
with space group P63/m a = 9.4240, b = 9.4240, c = 6.8790 Å (Kay et al., 
1964). Hydroxyapatite has a similar structure to octacalcium phosphate 
(OCP) (Ca8(HPO4)2(PO4)4) and there is a strong relationship between these 
two compounds. Hydroxyapatite has an OH- column running vertically down 
its structure (White et al., 2005). This column is easily substituted and 
common substitutions for the hydroxyl groups include F-, Cl- and CO3
2-. 
These hydroxyl ions are aligned in one orientation along the column OH-OH-
OH-OH this induces hydrogen bonding down the structure and provides 
stability. Slight impurities of fluoride ions can cause ‘flipping’ of the alignment 
of the hydroxyl ions OH-OH-F-HO-HO (Elliott, 1994). 
2.1.1.2 Nucleation and Crystal Growth 
The nucleation of hydroxyapatite is a complicated process and depends 
upon reaction conditions. In highly supersaturated solutions at neutral or 
alkali pH conditions it was shown that amorphous calcium phosphate first 
forms which then transforms to OCP which then hydrolyses to hydroxyapatite 
(Elliott, 1994). Studies where seeded crystals were added to calcium 
phosphate solutions with altering conditions showed that the rate of crystal 
growth is largely determined by the degree of the supersaturation of the 
surrounding solution (Moreno et al., 1977, Moreno and Varughese, 1981). 
Kinetic analysis showed that linear growth rate was dependant on the square 
of the degree of supersaturation of the solution (Moreno and Varughese, 
1981, Moreno et al., 1977). 
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2.1.1.3 Substitution in Hydroxyapatite 
Substitution in apatites is very common and indeed it is actually incredibly 
difficult to synthesise pure stoichiometric, monoclinic, s-hydroxyapatite. 
Virtually all naturally occurring apatites have some degree of substitution 
within their structure. Substitution for the hydroxyl ions in apatite is common 
and it is known that F-, Cl-, CO3
2-, O2
2-, and SO4
2- can all substitute at this site 
in various degrees. The structure of apatites is not generally known and it 
should be noted that sizes of different anions should be taken into account 
as this can distort the apatite crystal structure. Another factor with this type of 
substitution is that it can alter the substitution in other sites of the apatite 
structure, particularly at the Ca sites (Elliott, 1994). As substitution of OH- 
ions for larger or smaller ions will alter the sizes of ions that can substitutes 
for Ca2+ or PO4
3- ions. The most common substitution for OH- is F-, and 
fluorapatite is more stable than hydroxyapatite (Elliott, 1994). There are two 
routes by which this substitution can occur. The first is through ion exchange 
where already formed apatite crystals undergo ion exchange where OH- ions 
are replaced without dissolution of the apatite crystal. It should be noted that 
the degree of substitution will depend on the concentration of the ion to be 
substituted also this method will not give 100% substitution (Braun et al., 
1995). The second route is incorporation of these ions during formation 
through precipitation from solution where fluoride ions or chloride ions are 
added to the reaction solution and they enter the apatite structure during 
apatite formation. Addition of fluoride ions to the apatite formation reaction 
will cause the substituted apatite to form directly without going via an OCP 
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intermediate (Muragalelli et al., 1992, Shiwaku et al., 2010a, Shiwaku et al., 
2010b). 
There is much substitution in apatites at the calcium sites which are 
numerous and complex. Two calcium sites exist within the apatite structure 
Ca(I) and Ca(II), the distribution of substitution is often different between the 
two sites. There are four Calcium occupying site I and six Calcium occupying 
site II within one hydroxyapatite unit cell (LeGeros, 1991). The distribution 
between the two sites will be affected by charge as if the charge of the ion 
substituting the calcium ion is different from 2+ (as in calcium ions) then the 
charge compensation mechanism will affect distribution and the size of the 
substituting cation in relation to the two sites. Other factors affecting 
distribution include polarisability, ability to form partial covalent bonds, extent 
of substitution, temperature, thermal treatment and method of preparation 
(Elliott, 1994). The coordination number of the Ca(I) site is nine, whereas for 
Ca(II), it is seven. Based on this it has been suggested that the Ca(I) site 
should be preferentially occupied by larger cations than the Ca(II) site. The 
most common and most relevant substitution occurring at the calcium sites 
are Sr2+ and Na+, a full list of possible substitutions can be found in the 
literature (Elliott, 1994). 
2.1.1.4 Carbonated Apatite 
Understanding the structure and chemistry of carbonated-apatite is 
important, as it is the main form of apatite found in bones and teeth and it is 
also a very common substitution in apatites. There are two distinct types of 
carbonate substitution, type A and type B. Type A substitution occurs when 
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the CO3
2- ion is substituted at the position of the hydroxyl groups to give a 
formula of Ca10(PO4)6CO3. Type B substitution is for a PO4
3- ion in the apatite 
lattice, this further induces substitution of a Ca2+ ion for a Na+ ion to provide 
charge balance in the resulting structure, Ca9Na(PO4)5CO3(OH)2. Type A 
substituted carbonated-hydroxyapatite is produced through solid-state 
reactions at 1000C, only a small fraction of biological apatite is believed to 
be type A. Whilst the solubility effects of type A substitution have not been 
measured, it is hypothesized that this substitution will cause higher solubility 
of the apatite due to weaker bonds introduced by the carbonate substitution 
(LeGeros, 1991). 
Type B substituted carbonated-hydroxyapatite can be prepared through 
direct precipitation or hydrolysis of OCP or dicalcium phosphate dihydrate 
(DCPD). The degree of substitution is dependent upon the amount of CO3
2- 
in solution. A maximum substitution level of 22 wt% exists as carbonate can 
only replace a maximum of three PO4
3- ions in the apatite lattice. Type B 
substitution has a number of effects on the apatite these being (I) decrease 
in a-axis and an increase in c-axis dimensions compared to carbonate-free 
apatites; (II) decrease in crystal size; (III) increase in crystal strain; (IV) 
change in crystal morphology; (V) increase in solubility. The increase in 
solubility is caused by the decrease in crystal size that increases the total 
surface area. Additionally, the Ca-CO3 bond is weaker than the Ca-PO4 
bond, making the apatite more susceptible to acid dissolution (LeGeros, 
1991). 
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FTIR is a good method of both identifying carbonate substitution and 
confirming which type is present. Bands present give bands at 1474 and 
1406 cm−1 for type B, 1541 and 1449 cm−1, for type A 1563, 1506, 1541 and 
1453 cm−1 (Fleet and Liu, 2004).  
It is also possible to obtain apatites with mixed type A and B incorporated 
into the apatite structure (Gibson and Bonfield, 2002). Samples have been 
synthesised in-vitro using Ca(OH)2 and H3PO4 with CO2 gas bubbled through 
the reaction solution, the powder was then synthesised calcined at 
temperatures between 500° and 1100°C for 2 h, with a heating rate of 
2.5°/min. (Gibson and Bonfield, 2002). FTIR was used to identify 
incorporation of carbonate into the apatite structure. Bands at 1570, 1545, 
1504, 1498, 1466, 1455, 1410 (all CO3 v3), 880, 873 (CO3 v2) and 755 cm
-1 
(CO3 v4) all show carbonate substitution. 
2.1.1.5 Identification 
Infrared and Raman Spectroscopy 
Table 1 IR and Raman Peak Positions of Hydroxyapatite (Elliott, 1994) 
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vs, very sharp; vw, very weak; w, weak; m, medium; s, strong; vs, very strong; sh, 
shoulder (Elliott, 1994). 
 
IR performed on apatite and calcium phosphates in general can be a useful 
and fast technique used for their identification. Additional bands to those 
listed above have been used as methods of determining common 
substitutions in apatite structures, peaks of note include, 3545 & 3572 cm-1 
which are assigned to fluorohydroxyapatite; 3498 & 3570 cm-1 which are 
assigned to chlorohydroxyapatite; and 872, 879, 1410, 1450, and 1541 cm-1 
indicating presence of carbonate (CO3
2-) substitution in the apatite structure 
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NMR spectroscopy 
In 1H MAS-NMR of hydroxyapatite at 500.13 MHz and a spinning speed of 
7.3 kHz a sharp resonance was present at 0.2 ppm relative to trimethyl 
silane which was attributed to the proton in the OH- group, a second 
resonance at 5.6 ppm as identified which was attributed to surface adsorbed 
water (Yesinowski and Eckert, 1987). Additionally 43Ca MAS-NMR has been 
performed on hydroxyapatite) samples attempting to distinguish between the 
two calcium sites present in the crystal structure (53.784 MHz, spinning 
speed 4 kHz). The authors were able to distinguish between the two sites 
with the Ca(I) site being located at -1.8±0.8 ppm and the Ca(II) site at 
11.2±0.8  ppm (Laurencin et al., 2008). 31P MAS-NMR studies performed on 
hydroxyapatite (68.42 MHz, spinning speed 2.5 kHz) gave a resonance at 
2.8 ppm relative to 85% H3PO4. The authors also produced a number of 
calcium-deficient apatites with Ca/P = 1.46 & 1.58 these also gave 
resonances at 2.8 ppm indicating no difference in peak position with 
changing stoichiometry (Rothwell et al., 1980). 
X-ray Diffraction 
The XRD pattern below is of hydroxyapatite. A characteristic diffraction line 
to look for is a triplet of peaks around 32 degrees 2 theta (31.7 (211), 32.1 
(112) and 32.8 (300) degrees 2 theta). There is also a characteristic 
diffraction line at 25.8 (002) degrees 2theta. These characteristic diffraction 
lines are especially useful when identifying small apatite crystals. 
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Figure 2 X-ray Diffraction Pattern and relative intensities of Hydroxyapatite ICSD 
reference code 01-074-0565 from (Sudarsan.K and Young, 1969). 
 
2.1.2 Fluorapatite 
Due to Fluorapatite (FAP) being the least soluble of the apatite mineral 
series it is found in nature, a notable example is in marine organisms (Puura 
and Nemliher, 2001). Fluorapatite has been found in many types of marine 
invertebrates, notable examples are in brachiopods, crustacean 
exoskeletons, coral, and sharks teeth (MacFadden et al., 2004). Sharks teeth 
are examples of placoid scales and are made of apatite. Apatite in shark 
teeth resembles FAP with OH- ions hydrogen bonded to nearby F- ions in a 
linear fashion along the c-axis (Ogaard et al., 1991). 
2.1.2.1 Structure 
FAP is hexagonal with space group P63/m and lattice parameters, a   b   
9.36  , c  6.88 A. The fluoride ions occupy the centre of calcium (  ) 
‘triangles’ found at    1 4 and    3 4.  luoride ions (1.36  ) are smaller in 
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comparison to hydroxyl ions (1.40 A) fitting into the calcium ‘triangles’ (Elliott, 
1994). The substitution of F- for OH- ions causes a reduction in the volume 
unit cell, which causes the lattice to become denser.  This increase in density 
causes enhanced stability because of electrostatic bonds formed between F- 
and adjacent ions. 
2.1.2.2 Effect of Fluoride Substitution 
The incorporation of fluoride ions into the apatite structure to form either 
fluorohydroxyapatite (Ca10(PO4)6(OH)2-xFx) or pure fluorapatite 
(Ca10(PO4)6F2) has a number of effects upon the properties of the apatite 
which includes (I) an increase in structural stability due to a better fit of 
fluoride in the Ca ‘triangles’; (  ) contraction of the a-axis but no change in the 
c-axis dimensions; (III) increase in crystallinity which induces increased 
crystallite size and a decrease in crystal strain; (IV) a stoichiometry of apatite 
closer to that of pure apatite (Ca/P = 1.67); (V) decrease in solubility 
(LeGeros, 1991). 
2.1.2.3 Identification 
By far the best way of identifying the presence of pure fluorapatite is by 19F 
Magic Angle Spinning Nuclear Magnetic Resonance (MAS-NMR) a 
technique that can be run on solid samples and will show the individual 
presence of any fluoride environments within a specimen. On an 19F MAS-
NMR spectra FAP will appear at -101 ppm (relative to CFCl3) (Brauer et al., 
2010c) or 64 ppm (relative to C6F6) (Braun et al., 1995). Mixed substituted-
fluorapatite with either OH- or Cl- groups will be distinguished from pure 
stoichiometric FAP, as will possible fluoride containing impurities (for 
instance CaF2). Unpublished work has been completed where 
19F MAS-NMR 
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has been used to confirm sharks teeth are made of fluorapatite and that 
fluoride containing bioactive glasses form fluorapatite on immersion (Brauer 
et al., 2010a).  
FTIR has been used to identify the formation of FAP by the absence of a 
band at 3572 cm-1 which is the OH peak in hydroxyapatite, the logic being 
that if it is absent then pure FAP must be present. This is however a flawed 
method, a paper which used a solution route to synthesize various degrees 
of substituted fluorohydroxyapatite shows that this peak is not present after 
Ca5(PO4)3OH0.8F0.2 degree of substitution meaning it cannot be used as a 
reliable method to assess the formation of pure FAP (Wei et al., 2011). 
X-ray Diffraction has been used to identify the formation of apatite in 
circumstances where fluorapatite or mixed fluorohydroxyapatites have been 
synthesized (Azami et al., 2011). XRD will tell the investigator if the reaction 
has reached completion to confirm that apatite has been produced without 
impurities and starting materials are no longer present. XRD cannot however 
distinguish easily between hydroxyapatite and fluorapatite and thus cannot 
be used on its own to show FAP formation. The reason for this is that while 
there are some slight differences between degrees 2 theta positions these 
differences are minor and cannot be, with confidence, used to confirm the 
presence of fluorapatite. In addition to this if substitution is not 100% fluoride 
for hydroxide ions then this difference between lines decreases further. 
A number of studies have used F-electrode analysis to show the presence of 
fluoride in an apatite sample (Takagi et al., 2010, Azami et al., 2011). The 
suspected FAP should first be dissolved in an acidic solution, perchloric acid 
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(HClO4) has been used for this purpose. Then an F-electrode can be used to 
assess concentration of fluoride present in the sample. This can then be 
compared against Ca and P concentrations to assess whether the sample 
has the correct Ca/F ratio (0.200) for stoichiometric fluorapatite. SEM-EDX 
has also been used to measure fluoride concentration in synthesized FAP 
samples (Azami et al., 2011), however this is an inaccurate method due to 
fluoride being a relatively light element. Both of these two methods are 
inaccurate methods for measuring fluoride concentrations and while they will 
indicate the presence of FAP when used in conjunction with XRD analysis it 
will not be possible for the investigator to confirm with complete certainty as 
to whether a sample is pure FAP. 
2.1.3 Octacalcium Phosphate 
Octacalcium phosphate (OCP) has the chemical formula 
Ca8(HPO4)2(PO4)4.5H2O, the composition of OCP was first described by 
Berzelium in 1836. OCP is an important calcium phosphate phase as it is 
regarded as a transient intermediate in the formation of the 
thermodynamically more stable hydroxyapatite (Elliott, 1994). Its ability to act 
as an intermediate to hydroxyapatite formation is due to the fact that it 
nucleates and grows more readily than hydroxyapatite. This intermediary 
however is thought to be pH dependent. At reaction conditions with a pH 
between 5.0-9.0 OCP will be an intermediate phase before hydroxyapatite 
formation whereas if reaction conditions are above pH 9.0 then 
hydroxyapatite will precipitate directly (Chow, 2000). This is most likely due 
to the relative lack and abundance of OH- or H+ ions at the different pHs. As 
hydroxyapatite synthesis requires the presence of sufficient OH- ions 
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whereas OCP incorporates two acidic protonated phosphates (HPO4
2-) in its 
structure. 
Understanding the formation and hydrolysis of OCP is then important in the 
mineralization of bones and teeth, remineralisation of carious lesion, and 
formation of hydroxyapatite-based biomaterials. OCP has been found as a 
component of dental calculus and other calcifications (Kakei and Yoshikawa, 
2003). It is also thought that OCP is an intermediate mineral phase in bone 
formation with X-ray diffraction studies showing the presence of OCP in bone 
of metaphysis of a two day old rabbit (Elliott, 1994). 
 
Figure 3 Crystal structure of octacalcium phosphate (Cazalbou et al., 2004) 
2.1.3.1 Structure 
OCP has a triclinic lattice, space group P1 and unit cell a = 19.692(4), b = 
9.523(2), c = 6.835(2) Å and  = 90.15(2),  = 92.54(2) and  = 108.25(1) 
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(Mathew et al., 1988). The asymmetric unit (the largest structural unit in 
where none of the atoms are related through symmetry) is 
Ca8H2(PO4)6.5H2O, there are two asymmetric units per unit cell. The OCP 
structure consists of two ‘layers’ being the ‘apatite’ layer and ‘water’ layer. 
The ‘apatite’ layer is approximately 1.1 nm thick and is alternating with the 
‘water’ layers (sometimes referred to as ‘hydrated’ layer) which are 
approximately 0.8 nm thick parallel to (100) and are a clear feature of the 
OCP structure (Elliott, 1994). 
The ‘apatite’ like layer provides an explanation for the similarities seen in the 
lattice parameters of OCP and hydroxyapatite (a = 9.4176, and c = 6.8814 
 ). This ‘apatite’ layer is made of alternating sheets of phosphate ions with 
Ca2+ ions. The water layer consists of phosphate ions more widely spaced 
than the apatite layer and Ca2+ ions with a slightly variable amount of water 
molecules between them. The constituent ions in the OCP structure are 
distributed between these two layers differently. Six Ca2+ ions and two of the 
six phosphates are located in the apatite layer. The ‘water’ layer is made of 
two Ca2+ ions and a single phosphate ion. This leaves three phosphate ions 
which are located in the junction between the apatite’ and water layers. Two 
of the phosphate ions are protonated, the phosphate ion in the water layer 
and one of the phosphate ions located at the inter layer junction (Elliott, 
1994). 
2.1.3.2 Hydrolysis and Role in Calcium Phosphate Chemistry 
There are two reactions that contribute to the hydrolysis transformation of 
OCP to hydroxyapatite: 
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Ca8(HPO4)2(PO4)4.5H2O + 2Ca
2+  Ca10(PO4)6(OH)2 + 3H2O + 4H
+ 
1.25Ca8(HPO4)2(PO4)4.5H2O  Ca10(PO4)6(OH)2 + 1.5H3PO4 +4.25H2O 
The reaction of hydroxyapatite formation from OCP has been studied using a 
number of techniques. Single crystal X-ray diffraction and polarized light 
microscopy showed that during the phase transformation of OCP to 
hydroxyapatite, pseudomorphs of OCP were produced (Elliott, 1994). The 
pseudomorphs properties approached those of hydroxyapatite as the 
reaction progressed. It is believed that the reaction from OCP to 
hydroxyapatite occurs through crystal transition rather than dissolution and 
reprecipitation. This idea is supported by a number of studies showing 
intercrystalline mixtures of OCP and hydroxyapatite. A crystal of partly 
hydrolysed OCP when studied on XRD gave the pattern of OCP and 
hydroxyapatite with the b- and c- axis collinear (Elliott, 1994). This suggests 
an intercrystalline mixture of the two crystals given the similarity in their 
crystal structure. High-resolution electron microscopy studies were 
performed on partially and fully hydrolysed OCP crystals (Nelson and 
Mclean, 1984). Partially hydrolysed OCP crystals showed periodic contrast 
variations that had a periodicity of 16.5 Å. This was interpreted as regions of 
OCP that had lost water causing a 2.4 Å contraction of the a-axis parameter. 
The fully hydrolysed OCP crystals contained similar contrast variations 
surrounded by apatite. This evidence supports the idea the calcium-deficient 
hydroxyapatite is a mixture of OCP and hydroxyapatite, rather than a 
separate crystal phase itself. This is again supported by 1H MAS-NMR 
performed on a calcium-deficient hydroxyapatite with a Ca/P = 1.50 which 
showed equal amounts of HPO4
2- and OH- present the sample (Elliott, 1994). 
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Orientation growth of OCP on an ion selective membrane was performed. 
The system used consisted of three chambers, the central chamber was 
formed by a cation and anion selective membrane 2 mm apart. The central 
chamber was kept at a constant by pH-stat controlled addition of acid or 
base. Various concentrations of calcium and phosphate solutions were 
pumped through the outer chambers.  When the pH of the central chamber 
was 7.4 and calcium and phosphate concentrations of 12 and 7.2 mmol l-1 
respectively were used then well crystalline ribbons of OCP grew. These 
ribbons grew along their c-axis and were perpendicular to the membrane 
inner surface. Identification was performed using XRD and SEM. It was 
shown that addition of Ca2+ ions caused these ribbons to transform over 7 
days to well-orientated hydroxyapatite (Moriwaki Y, 1983). This supports the 
idea that OCP is the intermediate in biological apatite formation as it shows 
that OCP formed in an ordered structure would remain in this orientation 
during transformation to apatite. This fits with the strong and defined 
orientation seen in biological apatite making up bones and teeth. 
The effect of other ions on the hydrolysis of OCP to hydroxyapatite has been 
studied also. Carbonate ions have been shown to decrease the rate of 
transformation, these are also retained into the final apatite structure giving a 
carbonated apatite. The amount of carbonate incorporated has been shown 
to depend upon which alkali carbonate is used to donate the carbonate to the 
reaction (Elliott, 1994). Another study measuring the transformation of OCP 
using SEM and IR spectroscopy showed that Mg2+, citrate and 
pyrophosphate ions inhibit the transition (Sharma et al., 1992). The same 
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study also showed that F-, CO3
2-, HPO4
2-, and Ca2+ ions facilitated OCP to 
apatite transformation. Other factors shown to influence this reaction are 
solution pH, ionic concentrations and OCP crystal size (Elliott, 1994). 
The effect of fluoride is believed to be due to the fluoride inducing the 
formation of fluorapatite which has greater stability than hydroxyapatite which 
creates a larger driving force for the formation of fluorapatite over 
hydroxyapatite and at a faster rate (Elliott, 1994). Heat and fluoride ions were 
shown to accelerate the transformation of OCP to hydroxyapatite at 40C 
and 0.01% NaF respectively, these conditions increased the rate 
considerably (Elliott, 1994). Very interestingly addition of fluoride to reaction 
conditions which have been shown to form OCP showed formation of 
fluorapatite directly (Shiwaku et al., 2010a, Shiwaku et al., 2010b, Muragalelli 
et al., 1992). 
2.1.3.3 Identification 
Infrared and Raman Spectroscopy 
A study synthesized OCP using a method originally produced by LeGeros et 
al (Legeros, 1985), with modification to the method by Tomazic et al 
(Tomazic et al., 1989). The authors produced two forms of OCP which they 
refer to as polymorphs. Form A is the directly synthesized OCP whereas 
form B is a version of form A that has been exposed to water. This is 
probably not two polymorphs of OCP and is perhaps rather a calcium-
deficient apatite consisting of intercrystalline mixtures of OCP and 
hydroxyapatite. As is shown above OCP is easily hydrolysed to 
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hydroxyapatite in the presence of water and the difference in the specimen 
could be explained by this (Fowler et al., 1993). 
Table 2 IR and Raman Peak Positions of Octacalcium Phosphate. 
a 
Infrared band positions for A 
form and B form OCP at 48 C and wavenumber differences between forms (A-B). 
b 
Raman band 
positions for excitation with 488.0-nm radiation a t low (L), medium (M), and high (H) power 
levels (L = 50-85 mW; M = 175-200 mW, H = 350-400 mW) and wavenumber differences between 
excitation at high and low powers (H - L) where discernible. The spectrum has a broad 
unresolved water band that extends from about 3700 to about 2000 cm
-1
. 
d
 Very broad weak 
band. 
e
 Center of 1048 and 1052cm
-1
 doublet. 
f
 From average of 360 and 345 cm
-1
 bands. NM = 
not measured, w = weak, mw = medium to weak, m = medium, s = strong, v = very, sh = 
shoulder, b = broad. (Fowler et al., 1993) 
 
 
In infrared experiments on the OCP there are a number of bands that allow 
the differentiation of OCP from apatite. The peaks that refer to HPO4 groups 
can be used to distinguish between OCP and apatite. The bands at 3300, 
2950, 1298, 1207, 1138, 1207, 1138, 1118, 1109, 1086, 913, and 873 cm-1 
can be used to identify OCP in IR measurements. For Raman spectroscopy 
bands at 1112, 1079, 1052, 1011, 1005, 916, and 874 cm-1 can be used. 
NMR spectroscopy 
46 
 
 
1H MAS-NMR performed at 500 MHz and a spinning speed of 7.8 kHz 
showed the presence of a chemical shift at 13 ppm referenced to trimethyl 
silane and this was assigned to an acidic proton of a HPO4
2- ion located in 
the junction between the apatite and ‘water’ layers. The other HPO4
2- located 
in the water layer was not found, the failure to find a clearly resolved 
resonance was attributed to positional disorder of this ion and overlap with 
resonances with the structural water found in OCP. Chemical shift at 1.1 and 
1.5 ppm were detected and were assigned to protons on an isolated water 
molecule found in the OCP water layer. At 5.5 ppm there was an intense 
spinning sideband pattern that was assigned to relatively immobile structural 
water groups. The intensity of this resonance was attributed to a more mobile 
water species either in the OCP water layer or on the OCP surface. 1H MAS-
NMR studies performed on thermally dehydrated OCP (a process known to 
induce OCP to hydroxyapatite transformation) gave a resonance at 0.2 ppm 
which was attribute to the OH- found in hydroxyapatite. This was attributed to 
as evidence of the theory that the structural water in OCP can relocated 
themselves to a nearby PO4
3- ion to form HPO4
2- and OH- in a dehydration 
reaction of OCP to form hydroxyapatite (Elliott, 1994). 
A 31P MAS-NMR study performed on OCP (121.5 MHz, spinning speed 6 
kHz) prepared through a reaction of sodium phosphate monobasic dihydrate 
(H2NaPO4.2H2O) and calcium nitrate tetrahydrate Ca(NO3)2.4H2O. The OCP 
sample gave four resonances relative to 85% H3PO4 at -0.2, 2.0, 3.3 and 3.7 
ppm with an approximate intensity ratio of 3:1:1:1 respectively. The authors 
were able to distinguish where the different phosphate groups appeared on 
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the MAS-NMR spectra. The resonance at -0.2 ppm was assigned to P5 and 
P6; the resonance at 2.0 ppm was P3; 3.3 ppm was P2 and P4; lastly 3.7 
ppm was attributed to P1. Phosphates labelled P1-4 are the PO4
3- ions in the 
OCP structure and P5 & P6 are the HPO4
2- ions (Tsai et al., 2010, Tseng et 
al., 2004, Davies et al., 2012). 
X-ray Diffraction 
 
Figure 4 XRD Reference Pattern and Relative Intensities of Octacalcium Phosphate 
ICSD reference code 00-044-0778 
The above figure 2 shows the reference XRD pattern of OCP. Given the 
similarities between the pattern for OCP and apatite the only diffraction line 
where OCP can be distinguished from apatite is the diffraction line at 4.7˚ 2, 
which in highly crystalline OCP will give an intense diffraction line. 
2.1.4 Brushite 
Brushite or dicalcium phosphate dihydrate (DCPD) has a formula of 
CaHPO4.2H2O. Brushite was discovered in 1865 in phosphatic guano in the 
Caribbean. Brushite typically occurs in rock formations and encrusted on 
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ancient bones, dental calculus and pathological calcifications (Walther et al., 
1996). It is proposed that Brushite is an intermediate for apatite formation 
indeed if Brushite is placed into a pH solution outside of its solubility range 
then apatite will form (Elliott, 1994).  
 
Figure 5 Crystal structure of DCPD; Black sphere = calcium, light grey sphere = 
phosphorus, dark grey sphere = oxygen, white sphere = hydrogen (Sainz-Diaz et al., 
2004) 
2.1.4.1 Structure 
DCPD is monoclinic, space group Ia with lattice parameters a = 5.8120.002, 
b = 15.1800.003, c = 6.2390.002 Å and  = 116 252’.  our formula units 
are present per unit cell with an asymmetric unit CaHPO4.2H2O, none of the 
5 hydrogen atoms are related by symmetry (Curry and Jones, 1971). The 
structure of DCPD consists of columns that are parallel to the short diagonal 
of the (010) face of the unit cell, of alternating Ca2+ and PO4
3- ions. The 
columns are joined together to form corrugated sheets, a conspicuous 
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feature of the structure. The sheets have the composition of CaHPO4 and 
are linked together by water molecules (Gashti et al., 2013). Similarly 
structured sheets are also notably found in the structure of Ca(H2PO4)2.H2O 
(Elliott, 1994). 
2.1.4.2 Hydrolysis and Role in Calcium Phosphate Chemistry 
Hydrolysis of DCPD will ultimately lead to formation of hydroxyapatite, 
however, unlike the structural relationship between OCP and hydroxyapatite, 
DCPD is not a pseudomorph of apatite (Elliott, 1994). Where the 
transformation from OCP to hydroxyapatite goes via a phase transition the 
single crystal unit is altered chemically to give the formula of hydroxyapatite. 
In DCPD to apatite transformation the route of formation is through 
dissolution of DCPD then precipitation of hydroxyapatite which can go via 
OCP as an intermediate depending upon reaction conditions. 
DCPD will transform to OCP if in a solution with a pH range 6.2 – 7.4 and at 
a temperature within 25 – 37 C (Tung et al., 1985). If reaction conditions 
have a higher pH or temperature than this then it is believed the apatite will 
precipitate directly. The reason for this is that the precipitation and growth 
rate of hydroxyapatite is slow if the pH or temperature is not high; this is in 
contrast to OCP which has a lower solubility than DCPD and will form readily 
in mild conditions. The formation of apatite from DCPD has been shown to 
be inhibited by addition of Mg2+ and pyrophosphate ion (Rowles, 1968). 
Addition of F- ions during hydrolysis will cause the direct precipitation of 
either pure fluorapatite or fluorohydroxyapatite even at conditions where 
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without fluoride OCP would form as an intermediary for hydroxyapatite 
formation (Tung et al., 1985, Chow and Brown, 1973) (White et al., 1988). 
2.1.4.3 Identification 
IR and Raman 
Below are the IR and Raman frequencies for DCPD. DCPD can be 
distinguished from its bands at 875 cm-1 (IR) and 880 cm-1 (Raman), which 
are P-O(H) stretching. 
Table 3 IR and Raman Peak Positions of DCPD (Elliott, 1994). a vw, very weak; w, 
weak; m, medium; s, strong; vs, very strong; br, broad; sh, shoulder 
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NMR spectroscopy 
31P MAS-NMR (2 kHz, spinning speed) 1H decoupled at 68 MHz studies 
performed on DCPD samples have shown a resonance at 1.7 ppm relative to 
85% H3PO4. 
1H MAS-NMR studies have shown resonances at 6.4 and 10.4 
ppm referenced to trimethyl silane which were attributed to structural water 
and acidic protons respectively. This was performed at both 200 and 500 
MHz with a spinning speed up to 8 kHz (Miquel et al., 1990). 
X-ray Diffraction 
 
Figure 6 XRD pattern and Relative Intensities of DCPD 
In order to distinguish DCPD from apatite and OCP the peak at 11.607˚ 2 
can be used to distinguish, as apatite does not possess a diffraction line at 
this angle. 
2.2 Nucleation Theory 
Nucleation is the localized formation of a thermodynamic system. In this 
project nucleation theory is specifically applied to the nucleation of crystalline 
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phases. There exist two mechanisms of nucleation, homogeneous and 
heterogeneous nucleation. This is an important process involved in the 
setting of calcium phosphate cements. Traditionally calcium phosphate 
cements form their cement phases (apatite or DCPD) via homogeneous 
nucleation. However examples exist where cement systems have been 
seeded with hydroxyapatite crystals in order to facilitate heterogeneous 
nucleation and shorten setting times. 
Nucleation theory has also been applied to explaining fracture mechanics of 
ceramic systems. Griffith suggested that the thermodynamics associated 
with nucleation could also be applied in the formation of cracks from defects 
in ceramics (Griffith, 1921). The formation of the crack (or surface) requires 
energy to form the new surface (interfacial energy). Another application of 
nucleation theory is in formation of glass-ceramics where crystalline phases 
can form within an amorphous glass phases. Understanding nucleation 
theory is essentially important in understanding the reaction mechanism for 
many cement systems as it can play a large role in understanding the 
reaction mechanism. It can also aid in the tailoring of setting times and 
compressive strengths, important factors when developing a cement for 
commercial use. 
2.2.1 Homogeneous Nucleation 
Homogeneous nucleation is the spontaneous formation of a new 
thermodynamic system within the interior of a uniform system. This 
nucleation is then the formation of an interface at the boundaries of a new 
phase. Supersaturation is the driving force for nucleation (Abraham, 1968). 
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Supersaturation occurs when the pressure in the newly formed solid is less 
than the liquid pressure, and brings about a change in free energy per unit 
volume, Gv , between the liquid and newly created solid phase. The change 
in free energy is balanced by the energy released through the creation of the 
new phase (volume free energy), and the energy required to form a new 
interface (interfacial energy). If the overall change in free energy, G, is 
negative, nucleation is favoured. 
 
Figure 7 the change in free energy resulting from the formation of a spherical nuclei 
of solid in a liquid. (Hacker) 
Energy is consumed to form an interface; the exact energy required depends 
upon the surface energy of each phase. Nuclei are measured in terms of 
their radius. It is only when nuclei are larger than the critical radius (r*) that 
they are stable and nucleation and potential growth proceed. If hypothetical 
nuclei form that are smaller than the critical radius then the energy released 
by forming its volume is less than the energy required to form its surface. If 
this occurs then nucleation will not proceed. If the radius of the nuclei is 
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larger than the r* then nucleation proceeds because the net G is negative 
meaning the nucleation is thermodynamically favoured (Oxtoby, 1998). 
If a spherical nuclei of particles is forming then –Gv Joules cm
-3 of energy is 
liberated during formation, energy is required to form the surface interface, 
which is Gs Joules cm
-2. The energy to form a spherical cluster of a new 
phase of a specific radius r is equal to: 
(1) 
 
 
 
Where 
Gv = Energy of formation 
Gs = Interfacial energy 
G = Net free energy 
If the radius of the nuclei is <r* then the overall G increases when adding 
molecules or atoms to the nuclei until the r* is reached at which point the 
G<G*. The addition of further atoms or molecules to the nuclei gives an 
overall release of energy, favouring the growth of the nuclei. 
(2) 
 
 
 
To equate the maximum free energy change for the formation of a nuclei at 
the critical radius (Gr
*), the expression below defines the relationship of the 
interfacial energy and free energy per unit volume. 
(3) 
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2
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The formation of nuclei involves the addition of atoms or molecules and if this 
process involves energy then the likelihood of this occurring is low. 
Considering the entropy of the solid-liquid interface, the following expression 
can be formed on the basis of the rate of nuclei formed by recognizing this 
event as an activated process: 
(4) 
 
 
 
Where: 
nr
* = number of nuclei per unit volume 
n = number of atoms or molecules per unit cell 
k   Bolt mann’s constant 
T = Absolute temperature 
When the nuclei radius is r* then addition of further molecules or atoms to 
the nuclei means energy available for work (G) is released, rather than is 
used. At this point the rate of growth is not limited by nucleation but instead 
limited by diffusion of particles to the nuclei. An additional element to 
nucleation is then the rate at which atoms are attached to the nucleus. An 
atom or molecule at the liquid-solution interface must acquire an activation 
energy (Ga) in order to join the nuclei. The probability of this occurring is 
defined by the expression: 
(5) 
 
 
 
Where:  
P = Probability 
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n
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Vo  = Vibrational frequency of an atom attempting to cross nuclei-liquid 
boundary 
Combining the previous two equations the rate of homogeneous nucleation 
is expressed as:  
(6) 
 
 
 
Where: 
N = Avogadro’s number 
R = Universal gas constant 
The equation presented above calculates the rate of nucleation at differing 
temperatures. The nucleation rate describes a nucleus being formed (Gr*) 
and its rate of growth determined by the rate of atom attachment (Ga) at the 
nuclei-liquid interface (Abraham, 1968). 
2.2.2 Heterogeneous Nucleation 
Heterogeneous nucleation is nucleation that occurs at phase boundaries or 
on impurities with the system. It requires less energy to occur than 
homogeneous nucleation due to the Ga being lower because the surface 
energy barrier is lower. Heterogeneous nucleation may be either intrinsic 
(occurring within the liquid, for instance on nucleating agent) or extrinsic 
(liquid surface). Heterogeneous nucleation has a lower free energy barrier 
than homogeneous nucleation; this then makes it more likely to occur. A 
heterogeneous nucleus is a spherical cap which has a lower free energy 
barrier to formation than a nucleus formed through homogeneous nucleation 
with equivalent volume (Gao, 2004). 

I  nvo exp 
NGr *Ga
RT

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Figure 8 Wetting angle determination of nuclei on a substrate facilitating 
heterogeneous nucleation. (Chung et al., 2010) 
A nuclei forming on a substrate generates two interfacial surface energies. 
These being substrate-nuclei interfacial energy (Gs
b) and liquid-nuclei 
interfacial energy (Gs
c). The total surface energy is then expressed as: 
(7)   
 
Where: 
 = Contact angle 
Gs = Total interfacial energy 
As the contact angle decreases towards zero, the surface energy also 
decreases. Consequently the barrier to nucleation is reduced (Gr* 
decreases). For a contact angle greater than zero, the free energy barrier for 
nucleation is expressed as: 
(8) 
 
 
 
Heterogeneous nucleation will only be favourable if 
Gr*heterogeneous<Gr*homogeneous. 

f   Is a term which represents the strength 
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Gs  Gs
bCos Gs
c
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of the inter-atomic attraction between the nucleus and the substrate and is 
measured from the contact angle,. 
(9) 
 
 
 
The total free energy for the formation of a nucleus with the critical radius in 
a heterogeneous nucleated system is expressed as: 
(10) 
 
 
 
Regarding the contact angle, (), there are four incidences which determine 
how the substrate-nuclei interaction will determine how the nucleation 
occurs. 
If  180, then no wetting of the substrate will occur. In this instance only 
homogeneous will occur as the spherical cap is now a sphere and not 
associated with the substrate. 
If  90 to <180, the contact angle approaches 180 and approaches the 
Cos approaches -1. A reduction in the wetting of the substrate by the 
nucleus will result in an increase likelihood of homogeneous nucleation. 
If  = 0 to <90, the contact angle approaches 90 then Cos approaches 
0.the energy barrier of heterogeneous nucleation can be reduced to half that 
of homogeneous nucleation. 

f   
2  cos  1 cos 
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If  = 0, then Cos = 1. This means the substrate is completely wetted by 
the nuclei. There is no barrier to nucleation (Gr* = 0). 
2.3 Solubility of Calcium Phosphates in Calcium Phosphate 
Cements 
Phase transition based on dissolution-precipitation reactions are well 
documented for the setting and hardening of calcium phosphate cements. A 
requirement for this process to occur is moderate instability i.e. the precursor 
for the reaction to proceed should be more soluble than the product phase. 
The monophasic system of the production of calcium deficient hydroxyapatite 
(CDHA) from -tricalcium phosphate (-TCP) is an example of this.  
3-Ca3(PO4)2  9Ca
2+ + 6PO4
3- 
Ca9(HPO4)(PO4)5(OH)  9Ca
2+ + 6PO4
3- + H2O 
3-Ca3(PO4)2  Ca9(HPO4)(PO4)5(OH) 
Since at physiological pH CDHA is the less soluble than -TCP (Ishikawa, 
2010), CDHA is the more thermodynamically stable phase and thus its 
formation is favoured. When -TCP is placed into solution it will partly 
dissolve in order to reach equilibrium. Ca2+ and PO4
3- will be released into 
solution from dissolution of -TCP. These ions will precipitate to CDHA as it 
is the most thermodynamically stable phase. This then encourages continual 
dissolution of the -TCP and precipitation of CDHA. The dissolution-
precipitation then continues until the -TCP has completely dissolved and 
the CDHA has formed completely. The crystals are interlocked forming a 
hard, set cement.  
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Figure 6 (below) shows solubility of a range of calcium phosphates at a 
range of pH’s at ambient temperature. The diagram indicates that 
hydroxyapatite is the least soluble phase in the wide pH range so generally 
its formation is favoured thermodynamically. The diagram indicates the role 
the pH plays in determining which phases form. Other factors will also play a 
role in determining the phases that form namely stoichiometry and 
temperature of formation. 
 
 
Figure 9 Solubility phase diagram of various calcium phosphate phases at pH range 
2-14. (Chow, 2009) 
Table 4 Calcium phosphate salts with formulas, calcium to phosphate ratio (Ca/P), and 
respective abbreviations listed. Ksp = Solubility constant (Chow, 2009) 
Compound Abbreviation Formula Ca/P 
Ratio 
Ksp. 
Monocalcium Phosphate 
Monohydrate 
MCPM Ca(H2PO4)2.H2O 0.50 Highly soluble 
Monocalcium Phosphate 
Anhydrous 
MCPA Ca(H2PO4)2 0.50 Highly soluble 
Dicalcium Phosphate Dihydrate / 
DCPD 
DCPD CaHPO4.2H2O 1.0 10
-6.59
 
Dicalcium Phosphate Anhydrous 
/ Monetite 
DCPA CaHPO4 1.0 10
-6.90
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α-Tricalcium Phosphate α-TCP α-Ca3(PO4)2 1.50 10
-25.5
 
β-Tricalcium Phosphate β-TCP β -Ca3(PO4)2 1.50 10
-28.9
 
Amorphous Calcium Phosphate ACP CaxHy(PO4)z.nH2O 1.20-2.20 10
-25.2
 – 10
-24.8
 
Tetracalcium Phosphate TTCP Ca4(PO4)2O 2.00 10
-38
 
Hydroxyapatite HAP Ca10(PO4)6(OH)2 1.67 10
-116.8
 
Octacalcium Phosphate OCP Ca8(HPO4)2(PO4)4 1.33 10
-96.6
 
2.4 Calcium Phosphate Cements 
2.4.1 Calcium Phosphate Cements: History 
The first published data on calcium phosphate biomaterials was in 1920 by 
(Albee, 1920), who first developed the concept of using these materials for 
medicinal applications and provided the basis for what has been developed 
since. The research conducted used what the authors describe as “triple 
calcium phosphate”, using this to promote bone growth at a fracture site 
comparing their results to a control. The authors injected triple calcium 
phosphate into the gap formed in the occurrence of a bone fracturing in 
canine cranial defects. The results showed that addition of triple calcium 
phosphate showed a faster bone growth and union compared to a control 
where no triple calcium phosphate was used. Query remains as to what 
specifically was used in this study as the solution injected was described as 
“5 % triple calcium phosphate suspension in distilled water”. (Chow, 2009) 
points out that it is unclear whether the calcium phosphate used was 
“precipitated or ceramic material and whether it was powder or granular 
form”. Regardless of this criticism of the lack of specificity on the authors’ 
behalf, in its very fundamentals this paper demonstrated that a material 
containing calcium and phosphate will promote and improve the healing of 
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fractures and so must take premier position in the origins of calcium 
phosphate biomaterials in orthopaedic medicine. 
It was not until 1951 when the next noticeable step in this field occurred; Ray 
and Ward (Ray and Ward, 1951) investigated granular synthetic 
hydroxyapatite and its effectiveness at repairing defects in the long bones of 
dogs and the crania of cats. The authors created defects surgically in the 
bones then inserted the granular synthetic hydroxyapatite and compared the 
results to those obtained from autogenous bone grafts. The results from this 
study showed that while the granular synthetic hydroxyapatite was replaced 
by bone it was slower at doing so than autogenous bone grafts. 
Koester et al (1976) produced 7 calcium phosphate ceramic formulations and 
tested their bioresorbability in the fibula of dogs. After 6 months they showed 
that their formulations had been replaced by bone tissue, thus demonstrating 
the ability of these materials to be implanted, integrate and eventually be 
replaced by bone. They also noted that for biocompatibility a Ca/P ratio in the 
material had to be between 2:1 and 4:1, and that the optimum was 3:1. 
The idea for the first calcium phosphate cement was proposed by LeGeros in 
1982. In the first patent on calcium phosphate cements tetracalcium 
phosphate (TTCP) and dicalcium phosphate anhydrous (DCPA) (or 
dicalcium phosphate di-hydrous (DCPD) were used as initial reagents. The 
authors discovered that leaving these mixtures in test tubes led to a ‘hard’ 
deposit after a few hours. These compounds are more soluble at neutral pH 
than hydroxyapatite (Hwang et al., 1986) and when mixed with water 
produce HA. As a consequence of this discovery various animal studies were 
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conducted (Costantino et al., 1992, Friedman et al., 1991, Costantino et al., 
1991) which demonstrated precipitation of nano-crystalline HAP in these 
compositions. On implantation highly biocompatible HA was readily replaced 
by new bone. This cement composition using TTCP and DCPA (or DCPD) 
was approved by the FDA in 1996 and became the first commercial calcium 
phosphate cement. 
2.4.2 Applications and Formulations 
2.4.2.1 Orthopaedic Applications 
These cements have varied medicinal applications and are specifically useful 
in orthopaedic medicine due to the compositional similarity to bone. They are 
implanted into bone in many procedures, they are used in skeletal fractures, 
hip replacements, vertebroplasty, kyphoplasty and in other corrective and 
restorative orthopaedic procedures.  
Vertebroplasty and kyphoplasty were introduced in 1987 and are minimally 
invasive surgical procedures designed to reduced pain of those afflicted 
which is conducted on the vertebrae in the treatment of osteoporosis-induced 
vertebral compression fractures (McGirt et al., 2009). The two procedures 
differ slightly in their methodology, Vertebroplasty involves injecting the 
cement into the compressed vertebrae to stabilise the site and prevent 
further damage and hopefully decrease the pain to the patient. Kyphoplasty 
involves inserting a balloon, inflating this balloon then filling the cavity 
produced with the cement, this is a corrective surgery designed to repair the 
site of vertebral collapse (Lewis, 2006). 
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There is also an application of calcium phosphate cements in treating 
common fractures. While it may not be worthwhile in small fractures because 
of the risks/benefits associated with the surgery, due to their properties these 
cements would be very useful when the fracture site is large or if metallic 
implants are used as the use of cements has been shown to speed up the 
healing process by increasing the rate at which new bone is formed (Aberg 
et al., 2012). This would be hugely popular with patients as it could 
potentially speed up the recovery time from these fractures meaning that the 
patient could be mobile more quickly allowing a faster return to regular 
physical condition. 
2.4.2.2 Dental Applications 
Alveolar ridge preservation is a surgical procedure in which a bone graft 
material is placed in the alveolar socket of tooth at the time of extraction to 
preserve the alveolar ridge from its physiologic resorption. Among the 
numerous available filling materials used to prevent alveolar ridge resorption, 
allografts and xenografts are limited because of problems of supply and risks 
of cross contamination. To overcome these limits, many synthetic bone 
substitutes have been proposed foremost amongst these are calcium 
phosphate materials. 
Calcium phosphate materials offer great potential for bone regeneration 
since they have a chemical composition close to the biological apatite of 
bone tissue. They are biocompatible and the ability to act as a substrate for 
bone growth makes them a favourable material for use in dentistry. The 
rationale behind their use in socket filling procedures is that they will prevent 
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the physiological resorption of the alveolar crest after tooth extraction. 
Because of its osteoconductive properties, a calcium phosphate based 
biomaterial will enhance the growth of blood vessels and proliferation of bone 
cells within the material, thereby promoting biomaterial resorption and 
subsequent replacement by new bone. Their efficiency as bone substitute 
materials has already been proven in different human applications including 
the alveolar ridge preservation and the bone regeneration around defects in 
dental implants usually in combination with barrier membranes (Guided Bone 
Regeneration). 
Guided bone regeneration (GBR) has been combined with dental implants to 
encourage bone regeneration and enhance osseointegration. It is based on 
the concept that by using barrier membranes it is possible to separate the 
bone from the soft tissues and at the same time create the space into which 
new bone can grow. The use of an osteoconductive graft material, such as 
calcium phosphate based material, when combined with GBR at the time of 
implant placement may enhance the potential for complete bone 
regeneration and osseointegration. At present, guided bone regeneration is 
basically applied in the oral cavity to support new bone tissue growth on 
alveolar ridge to allow stable placement of dental implants. 
Currently one option available when filling the alveolar socket or undertaking 
guided bone regeneration for fixation of an implant is granular calcium 
phosphate ceramic materials. These materials are typically hydroxyapatite 
(Ca10(PO4)(OH)2) or tricalcium phosphate (Ca3(PO4)2) or biphasic mixtures of 
both.  These materials have been used successfully offering an 
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osteoconductive and somewhat resorbable bone substitute material. Their 
disadvantages however are: 
1. Deformation of Implantation Site – Granules by their nature have no 
inherent bulk strength until they have been fully osseointegrated, which can 
take weeks to occur. Until this point they can easily be deformed by the 
application of pressure and force upon them. This could cause the formation 
of voids in the material and a modification in shape where the new bone 
forms.  
2. Migration from Implantation Site – Similarly to the potential for 
deformation of the implant site there is also, for the same reason, potential 
for migration of the granules from the implantation site. During healing, 
displacement of graft material can lead to incorrect or incomplete guided 
bone regeneration. 
3. Difficult Preparation – Granular bone substitutes are typically mixed 
with patients’ blood or saline solution prior to implantation. The surgical time 
is lengthened by the need to extract or collect the patients’ blood and this 
method does not give replicable results. 
4.  Low Resorption Rate – In some clinical situations it is desirable that 
after use of a bone substitute material rapid resorption and replacement with 
host bone occur. This facilitates a return to normal bone structure and typical 
load distribution ensuring healthy bone quality and appearance. As 
hydroxyapatite is a stable crystalline phase resorption is strictly cell mediated 
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which can take many years to complete, or in some instances may never 
occur.  
All of these problems lead to unnecessary discomfort for the patient, difficulty 
for the clinician, lengthening of surgical time and compromised in-vivo 
performance. There is a clear need for a novel material to address these 
problems. 
2.4.2.3 Typical Formulations 
The field of calcium phosphate cements (CPC) appears a comprehensively 
studied field with most or all combinations of calcium and phosphate 
containing salt having been prepared and tested, leading to a recent review 
on these materials stating “…every possible combination of the cement 
formulation has already been tested…”. As example of this the interested 
reader is referred to a paper published (Driessens et al., 1993) where the 
authors produced 108 different combinations of numerous calcium 
phosphate salts in order to measure their setting times.  
In the almost three decades since the first calcium phosphate cement was 
developed numerous research groups have produced many different types of 
CaP cement which form a wide range of cement phases. There are two 
classes of CPC’s which exist, Apatite and DCPD cements.  
Table 5 Commercial compositions of calcium phosphate cements (Bohner et al., 2005) 
Company Cement 
/name 
Components End 
Product 
ETEX a-BSM Powder: ACP (50%), DCPD (50%); Solution: H2O (unbuffered 
saline solution) 
Apatite 
Embarc 
Biobon 
Stryker-Leibinger 
Corp 
BoneSourc
e 
Powder: TetCP (73%), DCPD (27%); Solution H2O, Na2HPO4, 
NaH2PO4 
Apatite 
HydroSet 
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Teknimed Cementek Powder: a-TCP, TetCP, Na Glycerophosphate; Solution: H2O, 
Ca(OH)2, H3PO4 
Apatite 
Cementek 
LV 
Powder: a-TCP, TetCP, Na Glycerophosphate, dimethylsiloxane; 
Solution: H2O, Ca(OH)2, H3PO4 
Biomet Calcibon Powder: a-TCP (61%), DCP (26%), CaCO3 (10%), HAP (3%); 
Solution: H2O, Na2HPO4 
Apatite 
Mimix Powder: TetCP, a-TCP, C6H5O7Na.2H2O 
Mitsubishi 
materials 
Biopex Powder: a-TCP, TetCP, DCPD, HAP, Mg3(PO4)2, NaHSO3; 
Solution: H2O, sodium succinate, sodium chondroitin sulphate 
Apatite 
Biopex-R Powder: a-TCP (75%), TetCP (18%), DCPD (5%), HA (2%); 
Solution: H2O, sodium succinate, sodium chondroitin sulphate 
Kyphon KyphOs Powder: a-TCP (77%), Mg3(PO4)2 (14%), MgHPO4 (4.8%), SrCO3 
(3.6%); Solution: H2O (NH4)2HPO4  
Apatite 
Shanghai Rebone 
Biomaterials Co, 
Ltd 
Rebone Powder: TetCP, DCPD; Solution: H2O Apatite 
Synthes-Norian Norian 
SRS 
Powder: a-TCP (85%), CaCO3 (12%), MCPM (3%); Solution: H2O, 
Na2HPO4 
Apatite 
Norian 
CRS 
Kasios Eurobone Powder: b-TCP (98%), Na4P2O7 (2%); Solution: H2O, H3PO4, H2SO4 DCPD 
Synthes ChronOs 
inject 
Powder: b-TCP, MCPM,  MgHPO4.3H2O, Na2H2P2O7; Solution: 
NaH2PO4, H2O, sodium hyaluronate 
DCPD 
 
DCPD and apatite cements both have excellent biocompatibility (Elliott, 
1994) and have excellent potential for their common applications. DCPD 
cements have a higher rate of resorbability, which is believed to be due to 
DCPD being more soluble than CDHA and HA (Dorozhkin, 2008) and in fact 
DCPD cements have been shown to resorb faster than apatite cements 
(Klein et al., 1985, Liu et al., 1999, Apelt et al., 2004), as a consequence of 
this DCPD cements suffer from a rapid decrease in strength, though overall 
strength of implanted bone increases due to bone ingrowth (Nishimura et al., 
1991). 
Apatite cements do have better ‘material’ properties than DCPD cements, for 
instance DCPD cements have considerably short setting times (~30 s) 
(Mirtchi et al., 1991, Mirtchi et al., 1989) compared to apatite cements (10 
min). The extremely short setting times is a considerable disadvantage as in 
order for these materials to be used clinically then the surgeon must be 
allowed sufficient time for the paste to be loaded into the implantation device 
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and implanted before the material sets. Various attempts have be used to 
lengthen the setting times of DCPD cements firstly via using less soluble 
reactants, addition of pyrophosphates which have been shown to inhibit 
setting. An attempt has been tried to where the cement is frozen during 
storage and delivery (Grover et al., 2008).  
Another potential disadvantage of DCPD cements is that inflammation has 
been seen in certain conditions (Tamimi et al., 2012). In some instances 
DCPD cements have been shown to convert to apatite in vivo (Dorozhkin, 
2008). While on the face of it this does not seem a large problem given the 
biocompatibility of apatite, the crystal growth associated with this reaction 
has been shown to cause tissue damage and inflammation, to address this 
issue magnesium is added to some formulations which acts as an inhibitor to 
apatite formation. Another cause of tissue inflammation associated with 
DCPD cements is potentially when too much DCPD is present in the cement 
mixture (Apelt et al., 2004, Grover et al., 2003, Flautre et al., 1999) causing 
inflammation for the initial implantation period, due to the acidity associated 
with DCPD. 
It cannot be ignored that apatite cements have wider clinical use than DCPD 
cements. Currently there are 18 different formulations (Bohner et al., 2005) 
of apatite cements available compared to 3 DCPD cements formulations 
(Tamimi et al., 2012). Given the similar biological properties these cements 
share why are there so many more apatite cements than DCPD cements? 
Especially given the considerable advantage DCPD cements have in being 
resorbed faster than apatite cements. In his review (Dorozhkin, 2008) 
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suggests that ultimately the reason for this imbalance was due to simply that 
apatite cements were developed before DCPD cements. While there 
perhaps is some truth in this it is possibly a little simplistic. This is due to a 
number of reasons including the number of additives required to simply 
match the properties of apatite cements, the poor strength of DCPD 
cements, and the greater amount of research which has gone into apatite 
cement development along with the fact that apatite cements were 
developed first. 
2.4.3 Chemistry of Setting in Calcium Phosphate Cements 
2.4.3.1 Hydroxyapatite Cement 
Hydroxyapatite cements represent the most common and widely used 
commercially group of CPC’s. There are a number of different types within 
this one group but all have their formula based on that of apatite 
Ca10(PO4)6(OH)2.  
Introduction: HAP cements were the first composition developed by Brown 
and Chow in 1986 and the setting reaction is listed below. 
Setting reaction: The very basic setting reaction for the formation of HAP 
cement is listed below: 
10Ca2+ + 6PO4
3- + 2OH- → Ca10(PO4)6(OH)2 
This is a very simplified reaction, but it highlights which ions are required for 
HAP formation. Obviously there must be a source of Ca2+ and PO4
3- ions 
which are traditionally delivered in the form of various calcium phosphate 
salts. This reaction also highlights the requirement for OH- ions which 
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suggests the importance of a high pH (at least above pH 7) to provide a 
source of hydroxyl ions during the setting reaction. 
CaHPO4 + Ca4(PO4)2O → Ca5(PO4)3OH (Fukase et al., 1990) 
The above reaction is a reaction between tetracalcium phosphate (TTCP, 
Ca4(PO4)2O ) and  dicalcium phosphate anhydrous (DCPA, CaHPO4). The 
authors confirmed using XRD that the reaction is 100% complete (i.e. 100% 
apatite formation) after 4 hours. The compressive strength also reached a 
maximum (36 ±0.3 MPa) at 4 hours, demonstrating compressive strength is 
proportionally related to the completion of the reaction. Though the formation 
of poorly crystalline HAP was shown, further studies revealed that this setting 
reaction eventually goes to calcium deficient hydroxyapatite (Ca10-
x(HPO4)x(PO4)6-x(OH)2-x.nH2O,CDHA) (Ishikawa et al., 1999) initially formed 
HAP acts as a nucleus for CDHA. A further study suggests that the HAP 
formed in the initial setting reaction reacts with excess DCPA to form CDHA 
(TenHuisen and Brown, 1994). Because of this it may be the case that in 
actual fact no cement systems exist which actually form stoichiometrically 
pure Hydroxyapatite free from substitutions at all, it appears after conducting 
a literature review no hydroxyapatite forming cements have been found. 
2.4.3.2 Calcium-deficient Hydroxyapatite Cement 
CDHA cements are perhaps the most common form of apatite cements. It is 
believed the CDHA is formed via the intermediate phase of OCP meaning 
OCP forms first and then rapidly transforms to CDHA. Bones and teeth 
mostly consist of CDHA which is what contributes to the excellent osteo- and 
bio- compatibility. 
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Given the vast amount of publications where the cement phase is CDHA 
there is an equally large range of reactions where it is formed. 
3Ca3(PO4)2 + H2O → Ca9(HPO4)(PO4)5OH (Monma and Kanazawa, 2000, 
Fernandez et al., 1996, Gbureck et al., 2004b, Bohner et al., 2006, Brunner 
et al., 2007, Alves et al., 2008, Jack et al., 2008, Gbureck et al., 2004a, 
Gbureck et al., 2003) 
CaxHy(PO4)z.nH2O + H2O → Ca10-x(HPO4)x(PO4)6-x(OH)2-x + nH2O (Knaack et 
al., 1998, Tofighi et al., 2000) 
3Ca4(PO4)2O + 3H2O → Ca9(HPO4)(PO4)5OH (TenHuisen and Brown, 1998) 
The reactions stated above also require a phosphate solution to react or to 
speed up their reaction; because of this many formulations require either 
NaH2PO4, Na2HPO4 or H3PO4 as part of the liquid phase used to initiate the 
setting reaction. Most reactions have been shown to happen in one step (see 
reactions listed above) though it should also be mentioned that CDHA has 
been found to form via an intermediary phase of DCPD in the cement system 
involving a reaction between MCPM and CaO. 
CaO + Ca(H2PO4)2H2O → 2CaHPO4.2H2O 
6CaHPO4.2H2O + 3CaO → Ca9(HPO4)(PO4)5OH  + 2H2O 
The first step involves rapid precipitation of DCPD following by further 
reaction of CaO with the DCPD to form the CDHA. 
2.4.3.3 Carbonated Apatite Cements 
Carbonatapatite (Ca8.8(HPO4)0.7(PO4)4.5(CO3)0.7(OH)1.3) is a form of apatite 
which is substituted by carbonate groups. 
Setting reaction: 
5.2CaHPO4.2H2O + 3.6CaCO3 → Ca8.8(HPO4)0.7(PO4)4.5(CO3)0.7(OH)1.3 
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Two commercial cement samples are examples of these types of cements 
Biocement D® and Norian SRS® (Fernandez et al., 1999b, Constantz et al., 
1995) (see table 5) it has been shown that these two commercial samples 
are formed via a two-step process. The first step involves precipitation of 
DCPD which then further reacts to form carbonated apatite (Boudeville et al., 
1999). 
α-Ca3(PO4)2 + Ca(H2PO4)2.H2O +7H2O → 4CaHPO4.2H2O 
5.2CaHPO4.2H2O + 3.6CaCO3 → Ca8.8(HPO4)0.7(PO4)4.5(CO3)0.7(OH)1.3 + 
2.9CO2 + 12H2O 
In the first reaction DCPD forms rapidly. Subsequent the pH drop increases 
the CaCO3 dissolution which then initiates the second reaction to form the 
carbonated apatite. The second reaction is slower than the first. 
2.4.3.4 Brushite (DCPD) Cements 
DCPD cements were discovered and developed after the discovery of apatite 
cements in 1987 by two independent research groups Mirtchi and Lemaitre 
(Mirtchi et al., 1990) and also Bajpai et al. (1991). The first DCPD cements 
were prepared by mixing together MCPM and β-TCP, then adding water. The 
resulting paste was shown to set in an exothermic reaction over time to give 
a hard cement material consisting of DCPD, known as the mineral Brushite.  
Setting reaction: There are a number of different reactions to form DCPD 
cements, listed below is a selection of these. 
Ca4(PO4)2O + 2H3PO4 + 7H2O → 4 CaHPO4.2H2O 
β-Ca3(PO4)2 + H3PO4 + 6H2O → 3 CaHPO4.2H2O 
β-Ca3(PO4)2 + Ca(H2PO4)2 → 4CaHPO4.2H2O 
β-Ca3(PO4)2 + Ca(H2PO4)2.H2O → 4CaHPO4.2H2O 
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The setting mechanism for DCPD cements involves 4 steps: (1) the 
constituents of the cement starting material powder dissolve in water; (2) the 
dissolved ions form a super-saturated gel; (3) nucleation of DCPD crystals 
occurs within the gel phase; (4) crystal growth from the nucleated small 
crystals, these crystals interlock giving a hard set cement (Tamimi et al., 
2012). DCPD can only precipitate at a pH <6 due to its solubility at higher 
pH. DCPD cement pastes must be acidic during setting therefore an acidic 
component must be incorporated into the starting materials for DCPD 
cements. The DCPD cement system using the reactants β-TCP and MCPM 
has had the pH studied over the course of setting, initially the MCPM starts 
to dissolve which causes a rapid decrease in pH to 2.5 (Bohner and 
Gbureck, 2008, Bohner et al., 1997) and then pH increases during the setting 
reaction to pH 5. The pH in the cement system can be altered (pH 2.5-6) by 
using different ratios of each of the starting materials; if more MCPM is used 
the pH will remain low even after setting has completed whereas if excessive 
β-TCP is used the pH can be almost neutral at pH 6 (Bohner et al., 1997). 
In another DCPD cement reaction MPCM was replaced with orthophosphoric 
acid. The advantages of this system over the β-TCP/MCPM system are (1) 
good control over reactivity and composition; (2) Faster preparation; (3) 
longer setting times and higher tensile strengths; it should be pointed out 
however that because orthophosphoric acid is more acidic than the MCPM it 
replaces, the pH of the cement drops dramatically to 2.5 and stays at this 
level even after setting and therefore there are concerns that the lower pH 
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may give problems relating to the biocompatibility (i.e. inflammation) (Bohner 
et al., 1997). 
Thermochemical studies have been performed on the setting reaction of 
DCPD cements. In the MCPM cement system, after mixing with water the 
MCPM hydrolysis is an endothermic reaction (ΔH  23.0 kJ mol-1) to form 
phosphate and calcium ions (Bohner and Gbureck, 2008). 
Ca(H2PO4)2.H2O → Ca
2+ + 2H2PO4
- + H2O 
At the same time as the previous reaction is taking place the β-TCP 
dissolves after exposure to protons in an exothermic reaction (ΔH  -66.0 kJ 
mol-1) to also produce form dihydrogen phosphate and calcium ions (Bohner 
and Gbureck, 2008). 
β-Ca3(PO4)2 + 4H
+ → 3Ca2+ + 2H2PO4
- 
The exothermic (ΔH  -10.0 kJ mol-1) precipitation of DCPD then occurs 
which causes a jump in pH (Bohner and Gbureck, 2008, Nurit et al., 2002). 
Ca2+ +  2H2PO4
- + 2H2O → CaHPO4.H2O + H
+ 
The overall reaction is thus exothermic (ΔH  -83kJ mol-1) which is why these 
cements warm up when setting. 
β-Ca3(PO4)2 + Ca(H2PO4)2.H2O + 3H2O → 4CaHPO4.H2O 
DCPD or Brushite has been found to transform into CDHA (Xie et al., 2001), 
about which it has been hypothesised that this can cause tissue inflammation 
potentially caused by either crystal growth or orthophosphoric acid release 
caused by the transformation reaction. The reaction is caused by dissolution 
of the DCPD which the precipitates to CDHA (Xie et al., 2001). 
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(10-x)CaHPO4.2H2O → Ca10-x(HPO4)x(PO4)6-x(OH)2-x + (4-x)H3PO4 + (18-
x)H2O 
To avoid the aforementioned side effects two available solutions were 
suggested. (1) To introduce excess β-Ca3(PO4)2 which could react with the 
orthophosphoric acid released thus limiting damage to tissue (Grover et al., 
2003); and (2) to add magnesium ions to the formulation which have been 
shown to inhibit apatite precipitation (Bohner, 2000, Bohner, 2001). 
At of the time of writing there are currently 3 different commercial DCPD 
cements which are listed in table 5. From looking at the commercial 
examples of DCPD cements it can be seen that all three have an acidic 
phase (PA or MCPM) and all use β-TCP in their preparation. The addition of 
the acidic phase is explained by the need for an acidic environment for 
DCPD to precipitate. The addition of these acidic starting materials provides 
the acidic setting medium which causes DCPD to be the most favourable 
product to precipitate. The use of β-TCP in all three commercial samples 
appears less clear as it has be shown that β-TCP is not essential for the 
formation of DCPD and there are many examples of DCPD cement reactions 
which do not involve β-TCP, so why is β-TCP used in all the preparations? 
The explanation of this is simply the production of β-TCP is the cheapest out 
of all the possible alternatives (TTCP, ACP and α-TCP) to manufacture, 
TTCP has a highly energy demanding route of synthesis (Moseke and 
Gbureck, 2010) and α-TCP can be produced in a similar method to β-TCP 
the only difference being α-TCP requires a higher temperature for synthesis 
(Cicek et al., 2011). 
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2.4.4 Effects of particle size upon calcium phosphate cement 
setting 
Monophasic systems are relatively simple systems to document and study. 
Apatite cements involving the reactions of two or more calcium phosphate 
salts in the setting reaction is a more complicated system. The relative 
solubility’s of the different salts used as well as their respective particle sizes 
will affect both the dissolution and precipitation of the cement phase. The first 
calcium phosphate cement was prepared via a reaction between Monetite 
(CaHPO4, DCPA) and tetracalcium phosphate (Ca4(PO4)2O, TTCP). In 
essence the dissolution-precipitation method for cement formation is the 
same as with the setting reaction of -TCP. The TTCP and DCPA both 
dissolve releasing Ca2+ and PO4
3- ions, which then precipitate to CDHA, the 
most thermodynamically favourable phase in this system at physiological pH. 
For optimal cement properties (compressive strength and setting times) the 
particle sizes of the two salts in this instance must be carefully considered. 
TTCP is more soluble than DCPA and thus will release its ions in their 
respective ratios in a different rate than DCPA. The results of alterations in 
particle size are listed in table 6. For optimal results the TTCP must have a 
larger particle size than the DCPD, then complete dissolution of both 
precursors will take place and the CDHA will precipitate. 
Table 6 Effects of particle size upon compressive strength of calcium phosphate cement 
formed through the reaction of tetracalcium phosphate and dicalcium phosphate anhydrous 
(Ishikawa, 2008) 
Average particle diameter (m) Ratio of the 
average particle 
diameter of 
TTCP/DCP 
Compressive Strength 
(MPa) 
TTCP DCPA 
1.6 11.9 0.13 0 (no setting) 
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12.4 11.9 1.04 7.1  1.0 
1.6 0.9 1.78 21.8  4.4 
12.4 0.9 13.78 51.0  4.5  
 
Table 6 above demonstrates the importance of particle size in biphasic 
system. TTCP is a more soluble salt at physiological pH than DCPA, 
therefore when the particles are small for TTCP and large for DCPA no 
setting was achieved because of an imbalance of the dissolution of the two 
phases. Optimal compressive strength was observed when the particle size 
of the TTCP was large and DCPA was small. In this case the two phases 
dissolved at similar rates allowing similar dissolution profiles for both salts 
meaning they dissolved and apatite precipitated at a constant rate. 
2.4.5 Substitution in Calcium Phosphate Cements 
2.4.5.1 Fluoride 
Fluoride-substituted apatite cements form fluorapatite, which has novel 
advantages and applications. Hydroxyapatite cements resorb gradually 
under cell-mediated acidic conditions and are replaced by host bone. This 
ability has been seen as a key attribute contributing to their use as bone 
filling materials. However, there are applications where materials which are 
biocompatible and osteoconductive but not bioresorbable would be 
advantageous. This could potentially be accomplished by producing apatite 
cements with a range of resorption rates. Apatite cements which are more 
stable under acidic conditions would be capable of achieving this given the 
mechanism of cement resorption. It should be noted DCPD cements are 
more stable than apatite cements under acid pH but they are converted to 
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apatite under physiological conditions in situ. Therefore, CPC’s which have 
little or no solubility under acidic conditions would be ideal. Partially or fully 
fluoride substituted apatites have been demonstrated to have considerably 
lower solubility in acids than hydroxyapatite (Takagi et al., 1998). So 
fluorapatite forming cements would be anticipated to show decreased 
resorption rates compared to apatite (HA, CDHA) cements. 
As of the time of writing two fluorapatite cements systems have been 
described in the literature (Wei et al., 2011, Takagi et al., 2010), The first 
system was a reaction between TTCP and DCPA with a solution of 2 M 
H3PO4 also containing 3 concentrations of HF as a source of fluoride with a 
L/P = 0.5 (ml/g). The cement mixtures with the three fluoride concentrations 
0.2%, 2.0% and 4% were prepared. A control with no fluoride was also 
produced. The method used to identify fluorapatite was by dissolving 
prepared samples in HClO4 and then analysing for fluoride ions using a 
fluoride-ion selective electrode. The study confirmed fluoride was present 
and the amounts were proportional to the percentage substitutions (0.2, 2 
and 4%). This study also performed in vivo rat studies using these cements, 
the results were very encouraging. The control cement was found to have 
‘significantly resorbed’; the 0.2% sample was shown to have considerably 
less resorption than the control; the 2% cement only showed ‘slight 
resorption’; and the 4% cement showed ‘no resorption’. This study then 
demonstrated the hypothesis of decreased resorption of FAP cement to be 
correct. 
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A second study on fluorapatite cement involved a reaction between TTCP 
and NaF powders with a liquid phase of 17% (v/v) H3PO4.  
5Ca5(PO4)2O + 2H3PO4 + 4Na  → 2Ca10(PO4)6F2 
The authors (Takagi et al., 2010, Wei et al., 2011)  used the cement to fill 
carious cavities. The method the authors used to determine that they had 
formed fluorapatite was by performing FTIR and looking for an absence of 
OH bands at 3571cm-1 and 632cm-1 (OH Stretch). The authors performed 
cytotoxicity studies on the produced cements and found no significant 
difference between the FAP cement and the non-fluoride containing control 
on the cell density which allowed them to conclude that these cements are 
not cytotoxic. 
A big criticism of these studies is in the methods they use to identify the 
formation of fluorapatite, it is very difficult to confirm the presence of 
fluorapatite as XRD and FTIR which are the most common techniques used 
to identify phases in CPC’s will not differentiate between HAP and  AP. The 
method of identification used in the second study mentioned give extremely 
uncertain results, the OH band in the apatite that appear on the FTIR spectra 
is not a sharp band and so using this data to conclude that FAP had formed 
is not done with a high degree of confidence. A considerably better way of 
showing fluorapatite formation would be using 19F MAS-NMR, which would 
indicate the various fluoride containing phases within the cement sample and 
is perhaps the only method FAP can be identified with a high degree of 
confidence. 
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2.4.5.2 Strontium 
Addition of strontium can be very beneficial for calcium phosphate cements 
and could potentially allow CPC’s to be used to treat osteoporosis. 
Osteoporosis is a metabolic disease which causes decreased bone mass 
resulting in decreased bone strength and increased risk of fracture (Mallette 
et al., 1989, Sandhu and Hampson, 2011). The consequences of this for an 
individual suffering from osteoporosis is an increase in disability and mortality 
and generally causes a difficulty in performing normal daily duties. Current 
treatments for osteoporosis included selective oestrogen receptor 
modulators and strontium ranelate (Burlet and Reginster, 2006). Strontium 
ions have been shown to stimulate the cell replication of preosteoblasts 
which ultimately increase the rate of new bone formation, it has also been 
shown to decrease bone resorption by inhibiting osteoclast differentiation 
and activity (Marie et al., 2001, Grynpas et al., 1996, Canalis et al., 1996). 
Strontium has also been shown to be radio-opaque, a study conducted in 
2010 (Romieu et al., 2010) attempted to establish whether strontium-
substituted cement would produce radio-opaque cements. The authors 
produced a strontium-substituted cement from 6DCPD + 2.5CaO + 
1.5SrCO3, the resulting cement was then assessed for radiopacity and it was 
concluded that strontium addition improved the visibility of the cement in X-
rays. This would be highly beneficial as currently CPC’s are difficult to see in 
X-rays. Cements which are more radiopaque would be more easily tracked 
for their resorption and replacement by bone. 
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To date a number of attempts at strontium substitution have been done. 
Addition of strontium has been achieved via three routes (i) addition of 
soluble strontium salts to the liquid phase used to begin the cement reaction; 
(ii) producing strontium substituted salts as the powder starting materials; (iii) 
strontium is added as a separate powder phase (e.g. SrCO3 or SrHPO4).  
Two routes used where strontium salts were introduced into the powder 
mixtures used strontium hydrogen phosphate (Guo et al., 2008, Guo et al., 
2005) and strontium carbonate (Boudeville et al., 2010). Both systems were 
designed to produce strontium-substituted apatite (Sr-HA). The study using 
strontium carbonate found addition of strontium caused a decrease in the 
reaction rate, as without strontium X-ray diffraction showed the starting 
materials (DCPD + CaO) disappeared after 2 hours whereas with the 
introduction of strontium carbonate the SrCO3 was still present after 4 weeks 
and not found after 3 months. The authors did however conclude that the 
developed cement does have potential for clinical use as they produced a 
cement with an optimal setting time of 15 min, a compressive strength of ~20 
MPa after 1 day, and confirmed that the strontium did become part of the 
apatite structure. When SrHPO4 was used as the powder phase the authors 
used DCPA and TTCP with 0.5M PA (phosphoric acid) as the liquid phase 
and then added various amounts of SrHPO4 to give 0%, 5%, and 10% 
substitution. The authors found strontium can actually increase the 
compressive strength at an optimum degree of substitution. 5% Sr 
substitution consistently gave higher compressive strengths, at 5 days the 
0% Substitution had a compressive strength ~50 MPa whereas the 5% had 
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an compressive strength of ~63 MPa. It should also be noted that 10% 
substitution had a negative effect on compressive strengths when compared 
with the 0% substitution. The production of a Strontium-substituted DCPD 
cement was attempted (Alkhraisat et al., 2008) where strontium chloride was 
added in different amounts to a cement system consisting of β-TCP and 
DCPD. The authors found using XRD that strontium ions did substitute into 
the DCPD crystal lattice which caused the lattice to expand. The effect of the 
strontium on the final setting time is interesting, the authors found that 10% 
Sr substitution increased the setting time to 8.3 min from 1.3 min in 5% 
substitution (the authors did not determine setting time of 0%). In apatite 
cements increased setting time is usually detrimental to the clinical 
applications of these cements. In DCPD cements a major criticism of them is 
their very short setting times (30 s). Strontium addition could actually be 
beneficial in DCPD cements not only for their biological effect of strontium 
but also for the use in being able to extend the setting times. 
In two studies (Yu et al., 2009, Pina et al., 2010) the authors synthesised 
Strontium-substituted α-TCP, which was used to produce CPC’s, 
interestingly one study produced a DCPD cement and the other an apatite 
cement. The DCPD cement was formed with the Sr-α-TCP and solutions 
containing 10 wt.% PEG (poly(ethylene glycol) and 20% wt.% citric acid sol 
or 0.5 wt.% HMPC (hydroxyl propyl methylcellulose), 10 wt.% PEG and 20 
wt.% citric acid. The results showed the mixtures formed DCPD after the 
initial set which after immersion in SBF for 15 and 30 days formed an apatite 
phase, addition of strontium increased the setting time from 3 ±0.5 min with 
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no substitution to 7 ±0.5 min with strontium substitution. Finally the authors 
also showed that the strontium substitution of 11.74% increased the 
compressive strength compared to the non-substituted samples. The authors 
attribute this to a lower content of DCPD phase present in the Sr containing 
samples, however, this is perhaps inaccurate and an alternative theory is 
presented below. 
A recent study (Boanini et al., 2010) assessed the effect of strontium ions of 
the hydrolysis of α-TCP, by immersing α-TCP powder in solution and then 
introducing strontium via the solution phase by dissolving SrCl2 into the 
solution at various substitutions (0, 5, 10 and 20%), the authors found that in 
the 0% substitution CDHA was detected after 2 days (at 30 °C) and the 
sample was completely CDHA after 3 days, with 5% substitution CDHA was 
only found after 10 days and in the higher substitutions CDHA was not found 
after the longest time point the authors attempted (14 days). 
2.4.6 Criticisms of the Literature on Calcium Phosphate Cements 
2.4.6.1 Immersion media 
In the literature there are considerable differences in protocols when 
producing and analysing calcium phosphate cements. Particularly many 
different solutions have been used to immerse these cements into including, 
physiological-like solution (PLS), simulated body fluid (SBF), Tris buffer, and 
deionised water. The problem with using different solutions is they will have 
different effects upon the immersed cements. PLS contains phosphate and 
calcium ions which if compared to a solution without these ions may give 
different reaction rates for instance addition of these ions may cause the 
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reaction to reach 100% completion before the same cement in a solution 
devoid of these ions. SBF has problems which have been outlined a 
particular problem is presence of Mg2+ and Cl- ions, Mg2+ has been shown to 
inhibit apatite formation (Giocondi et al., 2010). Using deionised water is a 
problem as immersing the cement may alter the pH of the solution which 
may affect the rate of reaction completion and this does not adequately 
match what the cement faces when implanted during use. Ideally a pH 7.2 
buffered solution without other ions present should be used, which is why 
Tris buffer has been used to immerse the cement in these experiments. 
2.4.6.2 Compressive Strength 
Compressive strength is a particularly poor technique to analyse these 
materials, especially for applying the results gained to their application. 
Firstly the compressive strength is not a particularly useful technique as the 
flexural strength is a much more useful technique in imitating the forces 
these materials are under when implanted. Secondly often when making the 
cement cylinders for testing their compressive strengths the cylinders are 
manipulated to give artificially higher compressive strengths. This is achieved 
by loading the cement paste under pressure into the moulds when the 
cylinders are produced. This produces much denser specimens which as a 
result have higher compressive strengths compared to samples which are 
simply pressed into the cylinder by hand. This is not applicable for when they 
are used clinically because when the surgeon implants the material it is 
injected into the site without excessive force. Flexural strength matches the 
real stresses these materials face when they are implanted, though these are 
rarely published due to poor strengths being achieved (Moreau et al., 2009). 
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2.4.6.3 Categorisation 
There is a strong tendency to categorise these cements into the products 
they form during their setting reaction (i.e. apatite, DCPD etc.) a tradition that 
has been carried on in the previous section out of a desire not to stray from 
convention. The problem with this categorisation is that these materials are 
strongly related and will each form into each other depending upon reaction 
conditions.  or instance an ‘OCP cement’ may form OCP initially but will 
convert to apatite over time in a basic of neural pH. Is the OCP merely a 
transition stage to apatite formation and it should be called an apatite 
cement. A ‘DCPD cement’ placed into neutral or basic pH will convert to 
apatite and does so in the body causing negative effects. If Ca2(H2PO4)2 is 
placed into solution it initially dissolves then reprecipitates into 
CaHPO4.2H2O which if with another source of calcium is present will form 
OCP. Should this be called a DCPD cement due to presence of 
CaHPO4.2H2O in its very early setting reaction. 
2.4.6.4 Characterisation 
Analysing the phases present in calcium phosphate cements has been 
typically  poorly conducted and inconsistently studied. Typical methods of 
characterisation of calcium phosphate cements have been done using X-ray 
diffraction and FTIR. A few studies have used 31P MAS-NMR to characterise 
cement phase but these are dramatically in the minority (Legrand et al., 
2009). The problem with relying predominantly of X-ray diffraction as the 
primary method of characterising cement phase is that whilst it is a very 
useful technique it also has several disadvantages. Typically investigators 
perform XRD measurements with a scanning range beginning above 10 °2θ 
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because of this octacalcium phosphate, due to its similar XRD pattern to 
hydroxyapatite is rarely found as a cement phase. In addition to this XRD 
gives very little information regarding substitutions in apatite meaning it 
cannot be used on its own to confirm carbonate of fluoride substitutions for 
instance. 
2.5 Bioactive Glass 
Bioactive glasses are silicate-based glasses that in contact with physiological 
fluids form apatite on their surface. The original compositions of bioactive 
glasses included SiO2, P2O5, CaO, and Na2O although many other species 
have been incorporated since including K2O, SrO, CoO, CaF2,  NaF, ZnO, 
and MgO amongst others. The glasses have a number of medical uses as 
they are biocompatible, resorbable and osteoinductive. The advantages of 
bioactive glasses is their ability to react on their surface rapidly. This enables 
fast bonding to bone and other body tissues making them an excellent bone-
substitute material. The main disadvantages of bioactive glass when used as 
bone-substitute materials is their poor mechanical properties. This means 
they are unable to be used for load bearing applications as the tensile 
bending strength of most compositions range between 40-50 MPa (Hench, 
2006). Also the granular nature means implantation can be very invasive 
compared with an injectable bone substitute. Lastly dissolution of the glass in 
vivo can cause a high pH rise above body pH that causes problems during 
osseointegration and can lead to voids in the centre of the implant site. 
2.5.1 Introduction to Glasses 
The first definition of a glass was by Tammann who defined a glass as a 
vitreous state and regarded it to be an extremely undercooled liquid. Later X-
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ray studies allowed the structure of glasses to be determined (Vogel, 1985). 
Glasses have a random arrangement of atoms lacking in long-range order 
unlike crystalline materials which have a structure consisting of regular 
repeating units. Glasses are amorphous (non-crystalline) materials. 
The conventional method of producing a glass involves rapidly cooling a 
liquid at a rate which prevents crystallization of the material. As the fluid 
material rapidly decreases in temperature the material begins to rapidly 
increase in viscosity this prevents the glass constituents arranging 
themselves into a crystalline arrangement. This continues until solidification 
of the material occurs. Glasses are thermodynamically unstable but are 
kinetically stable due to a high Ea required for molecular rearrangement 
(Kohne et al., 2011). 
 
 
Figure 10 Specific Volume-Temperature graph of glass formation. (Best, 1990) 
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Figure 7 above shows changes of specific volume (volume/unit mass) that 
occurs if a molten liquid is cooled from its liquid state to form either a 
crystalline material or a glass material. In the first instance if the molten liquid 
is cooled at a low rate then when the material reaches its melting point (point 
B) it crystallizes. At the melting point there is an abrupt decrease in the 
specific volume caused by the formation of the crystalline phase.  
If that same molten liquid is now instead cooled at a rapid rate below its Tm 
then there is no abrupt change in the specific volume at any temperature. 
The change in specific volume instead occurs continuously (point A to D) 
over a large temperature range and the result of this is that a glass is formed. 
At the lower temperatures (below Tm) the rate of the change in specific 
volume is similar in both the formation of either crystalline or glass phases. 
Although as is visible the magnitude of the difference in specific volume 
between crystalline and glass is large due to the large decrease in the 
formation of the crystalline form. 
The glass transition temperature (Tg) in silicate glasses is related to the 
energy required to break and re-form covalent bonds in an amorphous (or 
random network) lattice of covalent bonds. The Tg is not fixed for all silicate 
glasses and depends largely upon the composition. A more disrupted glass 
network causes a decrease in Tg due to fewer covalent bonds in the 
structure. Addition of network modifiers will cause a more disrupted structure. 
The charge and size of the network modifying agent will cause different 
effects on the Tg. Rapid cooling a molten glass mixture below its Tg is 
essential in glass formation (Holloway, 1973). 
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2.5.2 Zacharaisen’s Random Network Theory 
Zachariasen proposed a theory of the network structure of glass in the early 
1930’s (Zachariasen, 1932, Vogel, 1985). The model proposes the 
relationship between the structure of the glass and the glass properties. 
Supported by X-ray diffraction studies this theory provides the basis of 
understanding glass structure (Zarzycki, 1991). In this model, the internal 
energy of the amorphous and crystalline phases of the same 
stoichiometry/composition are assumed to be similar and that the inter-
atomic interactions within the amorphous and crystalline are also similar 
(Ray, 1978). 
The polyhedral structure is found in both crystalline and amorphous states of 
the same material. The random network in the glass is facilitated by the 
change in both bond length and dihedral angles in the polyhedral (Zarzycki, 
1991). This then led Zachariasen to suggest that the structure of a glass is 
composed of a three dimensional network made of an irregular arrangement. 
This irregular structure is what differentiates between glass and crystalline 
materials (Holloway, 1973). The two-dimensional structural differences in 
amorphous and crystalline SiO2 based structures are represented below. 
 
91 
 
 
Figure 11 Structural differences of pure SiO2 in its crystalline (left) and amorphous 
configuration (right). (Anac, 1992) 
In this model it is proposed that the ideal condition for glass formation is 
when it is formed of structural components which are capable of forming an 
extended three-dimensional network that does not possess long range order. 
Zachariasen then proposed four basic rules required for glass formation 
(Zachariasen, 1932, Vogel, 1985). 
 The constituent polyhedra should link together to form a three-
dimensional network. 
 A network forming cation must have a low-coordination number 
otherwise there is an increase likelihood of crystallization. 
 An oxygen atom may be bonded to no more than two cations. 
 The oxygen polyhedra share corners and not faces or edges. 
Further to these rules, additional rules were proposed which relate to the 
formation of low-order three-dimensional networks. Typically those glasses 
formed of compounds such as SiO2, P2O5, GeO2 and B2O3 (Vogel, 1985). 
 A compound tends to form a glass if it has the ability to easily form 
polyhedral groups of small building units. 
 No more than one corner of the constituent polyhedra should be 
shared. 
 Anions in the glass such as O2- should not bind to more than two 
central atoms of a polyhedron. Therefore, in simple glass anions will 
form bridges between polyhedra. For example in silicate glasses Si-O-
Si bonds will form between SiO4 tetrahedron. 
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 The number of corners of the polyhedra making up the structure 
should be optimally 4 or less and should not exceed 6. 
 Three of the corners of each polyhedra must be connected to 
neighbouring polyhedra. 
Addition of oxides such as Na2O or CaO will cause bridging oxygen atoms 
between tetrahedra to break to form negatively charge non-bridging oxygen 
atoms. The oxygen associated with the added oxides will become bound to 
one of the tetrahedra lacking an oxygen induced by the severing of the Si-O-
Si bond between the tetrahedra. The cation will then be bound ionically to the 
non-bridging oxygen atom. The cation will sit in the cavity formed by the 
severing of the tetrahedral bond (Vogel, 1985). This is represented in figure 9 
below. 
 
Figure 12 illustration of effect on glass structure of addition of network modifying agents. 
(Coleman, 2013) 
Cations have been classified by the manner in which they affect glass 
formation and the structure of the glass. These have been classified into 
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three types network formers, network modifiers and intermediates (Vogel, 
1985). 
Network Formers, are the backbone of all oxide glasses and are the units 
which build the three-dimensional networks. For instance, in a pure SiO2 
glass the basic unit is a tetrahedron of a silicon atom surrounded by four 
bridging oxygen atoms. Network formers typically have a coordination 
number of 3 or 4, other than Si typical network formers are P, B and Ge. 
Silicate glasses are three-dimensional structures of tetrahedrons consisting 
of silicon and oxygen atoms. In a glass consisting of only silica, this is built of 
SiO4 tetrahedra, in this structure each silicon atom is covalently bonded to 
four oxygen atoms which are each bonded to two silicon atoms. 
 
Figure 13 SiO4 Silica tetrahedron unit. (Grundwald, Publication year not stated) 
Network modifying oxides, do not form a glass network on their own and are 
incapable of doing so. These cations act to disrupt the glass structure by 
creating non-bridging oxygen atoms. The creation of non-bridging oxygen 
atoms causes a weakening of the glass structure as for each network 
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modifying oxide added one bridging oxide is broken to form two non-bridging 
oxygen atoms. Increasing the amount of network modifying oxides causes a 
gradual breakdown of the silica network. This is not necessarily a detrimental 
effect as this has been harnessed to produce disrupted and soluble bioactive 
glasses which are extremely useful. Common network forming oxides include 
CaO, Na2O, K2O, SrO and BaO. 
Intermediates are oxides which alone are not capable of forming glass 
networks. However, they can reinforce the network or disrupt it. They can 
either bond to network forming tetrahedrons via bridging oxygen atoms 
forming a more cross-linked network. Alternatively, they can act to form more 
non-bridging oxygen atoms leading to a more disrupted glass network. 
Examples of intermediates include Ti, Zn, Pb, and Al.  
2.5.3 History of Bioactive Glass 
The concept of bioactive glasses began in 1967 as a result of research to 
find a material that would not be rejected by the body and was bioinert. It 
was discovered by Hench (1972) that certain glass compositions can bond to 
bone in so produced the world’s first bioactive glasses. Orthopaedic 
materials used before had previously been metallic or plastic in nature and 
tended to form scar tissue in the interfacial layer between the material and 
host tissue. What was required was an implant material that would form a 
bond between material and tissue. 
Research began in 1969 and was based on a simple hypothesis that if a 
material formed hydroxyapatite on its surface then it would give an increase 
in bioactivity compared to other metallic or plastic materials used at the time. 
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A hydroxyapatite-forming material was desired because hydroxyapatite is the 
main mineral phase of both bones and teeth (Hench, 2006). 
Initial work done by Hench et al. (1972) discovered that certain composition 
ranges produced glass that would bond to bone. These were termed 
bioactive glasses and were made of SiO2, Na2O, CaO and P2O5. Hench 
investigated changes in these four component systems. The P2O5 content 
was maintained at 6 wt % whilst the amounts of the other three components 
was altered to see the respective bioactivity of the alteration in compositions 
(Hench, 2006). The compositional effects on the bone-bonding ability when 
the composition is shown in figure 14. 
 
Figure 14 Ternary phase diagram of bioactive glass compositions relating to bioactivity. 
(Hench, 2006) 
Areas labelled B and D showed no bone bonding this is caused by problems 
within the glass network. Compositions in section D did not form glasses, 
they likely crystallized during quenching. The cause of this is mostly likely 
because the amount of network modifier was too high and produced a very 
disrupted network which did form glass but converted to a partially crystalline 
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solid which is more thermodynamically stable and less reactive than glass. 
Area B, whilst it did produce a glass, the glass produced was most likely ‘too 
stable’ due to a high amount of bridging oxygen atoms. This prevents 
opening of the structure to release the requisite ions for apatite formation and 
thus increased bioactivity. Section A was an optimal region for bone-bonding 
of the glass compositions, then inside this region glass with a composition 
inside the S section were able to bond to soft tissue. The optimal 
composition was section E and led to the glass 45S5 used for bond-
substitution the composition was 45% SiO2, 24.5 Na2O, 24.5% CaO and 6 % 
P2O5 (these are all weight percent). 
A criticism of this initial work done by Hench et al was their choice to design 
compositions using weight percent of components. This effectively ignores 
Zachariasen random network theory and suggests the researchers were 
simply concerned with discovering an optimal composition by doing an 
exhaustive search, rather than understanding the science of the glass 
structure which would have enabled them to design the glasses based on 
their structure which may have led them to discover more bioactive glasses 
than 45S5. It is also somewhat puzzling that the P2O5 content was not 
altered to investigate its effect on bioactivity. Given that the authors 
themselves state that their aim was to produce apatite, a high phosphate 
containing mineral. It seems logical that increasing the amount of 
phosphorus in the glass would increase bioactivity and this has been since 
shown (O'Donnell et al., 2008b). 
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2.5.4 Structure of Bioactive Glass 
Bioactive glasses consist of two major types of component, network formers 
and network modifiers. 45S5 is perhaps the most widely known bioactive 
glass composition 46.1 mol% SiO2, 26.9 mol% CaO 24.4 mol% Na2O and 
2.6 mol% P2O5. The SiO2 and P2O5 components act as network formers and 
CaO and Na2O components acting as network modifiers. It was initially 
believed that in ‘45S5 bioactive glass’ the SiO2 and P2O5 network forming 
components were bonded together with Si-O-P bonds existing within the 
glass structure. This idea was based upon molecular dynamic (MD) 
computer simulations (Tilocca et al., 2007, Tilocca and Cormack, 2007). 
However, Pedone et al has shown Si-O-P bonds do not exist within the glass 
structure (Pedone et al., 2010). This is consistent with 31P MAS-NMR data 
gained which has shown that the P2O5 exists as orthophosphate (PO4)
3- 
(Q0p) within the glass network (O'Donnell et al., 2008a, Brauer et al., 2009). 
This promotes the idea that the glass is a split network with the phosphate 
component existing within the silica network (Eden, 2011).  
2.5.5 Q Structure and Network Connectivity 
Glass Q structure refers to the structure and quaternary/tetrahedral 
coordination of the network forming units which the glass consists of. 
Q1 has 1 bridging oxygen and 3 non-bridging oxygen’s meaning the network 
former in the glass is structured so the individual units are dimers. 
Q2 structure has 2 bridging oxygen’s and two non-bridging oxygen’s meaning 
the network former forms long chains or possibly rings.  
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Q3 structure has 3 bridging oxygen’s and 1 non-bridging oxygen meaning it 
has a 3D structure, similar to the Q4 structure which has 4 bridging oxygen’s. 
The Q structure has a great deal of influence on the properties of the final 
glass. A trend tends to exist that the lower the Q structure the higher the 
solubility of the resulting glass. Although there is obviously a limit on how low 
a NC (network connectivity) can be as glasses with a NC below 2 tend to 
become hard to produce because they have a high chance of crystallising 
during the quenching process. 
Hill presented a calculation to determine the theoretical network connectivity. 
Network connectivity (NC) is the average number of bridging oxygen atoms 
per network forming unit. The calculation published was (Brauer, 2011): 
(11) 
 
 
 
In this equation MI refers to the molar concentration monovalent cations and 
MII refers to divalent cations. This equation has it flaws as it assumes that 
phosphate exists as part of the glass network and can, depending upon 
composition exist with a range of Qn structures. However, as explained 
previously phosphate in bioactive glass exclusively exists as orthophosphate 
regardless of composition. Therefore this equation has been updated to 
account for the role of phosphate in the glass. 
(12) 
 
 
 

NC  2
[(2  S iO2) (2  P2O5)]  [2(M2
IOM I IO)]
S iO2 (2  P 2O5)

NC 2
[(2SiO2)[2(M2
IOMI IO)(6P2O5)]
SiO2
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This equation gives a strong tool for predicting the average Q structure of a 
bioactive glass. This is excellent when designing novel bioactive glass 
compositions as it allows you to tailor the bioactivity of designed glasses. 
Whilst the network connectivity model has it benefits it should be noted that 
there are drawbacks in following this model exclusively. The NC model does 
not take into account the nature of the modifying cations or the charge to size 
ratio and the influence they have on the glass network. Another caution 
should be noted is that the NC model aims to produce the most soluble 
glasses and whilst the bioactivity of a bioactive glass is directly related to its 
ability to form apatite, its ability to form apatite is not directly related to its 
solubility. 
The Qn structure of the silicate phase depends somewhat on the ratios of the 
network forming and network modifying components. It has been shown that 
replacing the SiO2 for P2O5 will cause an increase in Q
3 and a decrease in Q2 
in the glass network of the silicate phase (O'Donnell et al., 2008a). 
The structure of a bioactive glass directly influences the physical properties 
of the resulting glass including mechanical properties and solubility. The 
structure of the glass can be predicted using its molar composition. 
Zachariasen’s random network model states that bridging oxygens (BO) are 
distributed randomly throughout the glass (Zachariasen, 1932). The number 
of bridging oxygens per network former determines the Qn structure of the 
glass, using Zachariasen’s model means that the Qn is dependent upon the 
relative concentrations of network former and modifier. Phillips and Thorpe 
have proposed the percolation theory which predicts that the glass network 
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will become rigid if the average number of bridging oxygens is greater than 
2.4 (Phillips and Thorpe, 1985). This theory is supported up by experimental 
work reviewed by Brauer and Hill where the ability to form apatite was 
minimal when the average BO was 2.4 (Brauer, 2011). 
When designing a bioactive glass the general consensus in the literature 
suggests a NC between 2.0 and 2.4 is optimal for apatite formation. Hill 
recommends a network connectivity close to 2.0, this is supported by 
experimental data with 45S5 Bioactive glass having a of NC = 2.11 (Hench, 
2009) and various experimental work showing increasing the NC from 2.0 
shows a decline in apatite formation in simulated body fluid (SBF). Edén 
suggests a broader range between 2.0 and 2.6, it is also predicted that a NC 
<1.8 and NC >2.7 would be unfavourable for apatite formation (Eden et al., 
2011, Eden, 2011). Experimentally it is difficult to produce glasses with a NC 
<2.0 due to their tendency to crystallize during quenching. 
2.5.6 Effect of Phosphate Content on Glass Structure 
Increasing phosphate content in bioactive glasses was investigated by 
O’Donnell et al (O'Donnell et al., 2008a). The authors increased the 
phosphate content in a series of bioactive glasses. Two series of glasses 
were produced, Series 1 replaced silicon with increasing amounts of 
phosphate whilst keeping the ratios of calcium and sodium constant. Series 2 
increased the phosphate content but kept the theoretical network 
connectivity constant by charge balancing the orthophosphate phase with 
calcium and sodium. The rationale behind the work was to establish how 
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phosphate existed in the glass structure. The compositions of the produced 
glasses are listed below. 
Table 7 Glass Composition Produced to Investigate Phosphate Content in Two Series of 
Glasses by O’Donnell et al.  
Name Mol %   
 SiO2 Na2O CaO P2O5 NC NC’ 
Series 1 
ICIE1 49.46 26.38 23.08 1.07 2.04 2.13 
ICSW2 47.84 26.67 23.33 2.16 2.00 2.18 
ICSW3 44.47 27.26 23.85 4.42 1.92 2.30 
ICSW4 37.28 28.52 24.95 9.25 1.75 2.62 
ICSW5 40.96 27.87 24.39 6.78 1.83 2.44 
 
Series 2 
ICSW1 51.06 26.10 22.84 0.00 2.08 2.08 
ICSW6 48.98 26.67 23.33 1.02 2.00 2.08 
ICSW7 47.07 27.19 23.78 1.95 1.92 2.08 
ICSW8 43.66 28.12 24.60 3.62 1.79 2.08 
ICSW10 40.71 28.91 25.31 5.07 1.67 2.08 
ICSW9 38.14 29.62 25.91 6.33 1.56 2.08 
Na/Ca = 0.87. NC assuming phosphate enters glass structure. NC’ assuming two phase system. 
The glass structure was investigated using 29Si and 31P MAS-NMR. The 29Si 
MAS-NMR performed on series 1 show an increase in peak asymmetry with 
increasing phosphate content. This fits with the hypothesis that phosphate 
exists as orthophosphate as when the phosphate content increases then 
more Na and Ca ions are required to charge balance the orthophosphate 
PO4
3- which increases the polymerisation in the silicate network causing 
more Q3 distribution agreeing with the results seen by 29Si MAS-NMR. 31P 
MAS-NMR drew the same conclusions, in series 1 the phosphate existed as 
an orthophosphate species. This peak shifted as NC’ increased for series 1 
but, the peak position in series 2 did not change. The results here show that 
the P2O5 introduced into the glass exists as a separate orthophosphate 
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phase within the final glass composition. The results here also show that 
when designing a glass which incorporates P2O5 this should be assumed to 
exist as orthophosphate and therefore should be charge-balanced. If the 
phosphate is not charge-balanced then this will cause the silicate phase to 
be more cross-linked which will have a highly negative impact on the glass 
bioactivity. 
The same authors also investigated the physical properties of the glasses 
produced (O'Donnell et al., 2008b). This included measuring the density, 
glass transition temperature (Tg), crystallisation temperature (Tc), and 
thermal expansion coefficients. 
Table 8 Glass Transition Temperature, Glass Crystallization Temperature, Thermal Expansion 
Coefficient and Densities of two Series Investigating Phosphate Content by O'Donnell et al. 
Name Tg/°C  Tp1,c/°C  Tp2,c/°C  α/x10-6/°C
-1
  ρ/g cm
-3
  
Series 1  
ICIE1  513  629  676  -  2.715  
ICSW2  511  636  679  15.70  2.719  
ICSW3  491  655  674  16.18  2.719  
ICSW5  485  605  625  -  2.696  
ICSW4  482  543  617  18.88  2.788  
      
Series 2  
ICSW1  519  614  642  -  -  
ICSW6  515  620  653  -  2.721  
ICSW7  513  642  692  -  -  
ICSW8  509  652  669  16.37  2.727  
ICSW10  496  619  -  16.54  2.748  
ICSW9  491  580  613  -  2.787  
 
The theoretical density of the glasses was calculated using the Doweidar 
model and these were compared with the experimental values, a modified 
Doweidar model (Doweidar, 2009) was also used to compensate for the 
existence of the orthophosphate phase. A decrease in density was seen in 
series 1 with increasing phosphate content. The experimental values showed 
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a much better fit to the theoretical density values which used the modified 
Doweidar model which took into account the orthophosphate phase. An 
anomalous result was seen with glass ICSW4, which showed an out of 
sequence dramatic decrease in density. This was attributed to crystallisation 
in the glass during quenching which was detected using XRD. 
Tg and Tc was measured using differential thermal analysis, the working 
range was also calculated which is the temperature range between Tg and Tc 
(Working Range = Tc - Tg). For Tg in both the series the Tg decreased with 
increasing phosphate content, this is somewhat unexpected in both cases. 
For series 1 it may be expected that the Tg would increase because of the 
results shown by NMR which demonstrated a more cross-linked silicate 
network formed as the phosphate content increased. In series 2 it would be 
assumed that the Tg would be kept constant regardless of the phosphate 
content because the phosphate was charged balanced meaning no effect 
was seen on the cross-linking in the silicate phase. The explanation for the 
decrease in the Tg was attributed to increase in the orthophosphate phase as 
the P2O5 content increased. This meant the glass had more pockets of 
orthophosphate droplets leading to a more open and more disrupted glass 
network. The Tc seems independent of phosphate content, though inclusion 
of phosphate does allow crystallisation at lower temperatures. 
The thermal expansion coefficients of the glasses were measured by 
comparing theoretical values calculated form the Appen model with 
experimental values from dilatometry experiments. For both series of glasses 
the thermal expansion coefficient increased with increasing phosphate 
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content, with the experimental values fitting well with the experimental 
values. This was explained by the increasing orthophosphate phase 
interdispersed through the silicate phase causing a higher glass expansion 
as the phosphate content increases. The thermal expansion coefficient is 
important for bioactive glass compositions which are used as implant coating 
materials. 
XRD studies on the glass series showed all except glass ISCW4 were 
amorphous. This glass had the highest P2O5 content of all glasses at 9.24 
mol %. This suggests that there is a maximum P2O5 content that can be 
incorporated without the glass crystallising. The nearest P2O5 content was 
6.78 mol % indicating the maximum P2O5 content lies in between 6.78 and 
9.24 mol %. 
Recently another publication has focussed on the relationship between 
phosphate content and bioactivity (Mathew et al., 2014). The authors 
produced a number of glass compositions altering the network connectivity 
(2.11, 2.15, 2.50, 2.74 and 2.93) and producing two series at different 
network connectivity’s (2.50 and 2.93) with increasing    phosphate content 
from 0 – 6 mol%, the sodium to calcium ratio was maintained at 1.54. The 
aim of the study was to study P and Si Q speciation’s in bioactive glasses 
and how these relate to bioactivity by performing NMR and molecular 
dynamic (MD) simulations of a range of glass compositions.  From 31P MAS-
NMR measurements and subsequent deconvolution the authors discovered 
the presence of phosphate species within the glass structure of both QP
0 and 
QP
1, with the being QP
0 the vast majority in all compositions. The authors did 
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discover a trend of increasing QP
1 relative speciation as the network 
connectivity was increased from 4.1% (NC = 2.1) to 20.5% (NC = 2.9). When 
P2O5 content was increased in the glass composition the authors did not 
measure a difference between QP
0 and QP
1 ratios. With relation to phosphate 
content in the glass the authors concluded that bioactivity is maximised by 
altering two factors (1) lowering the silicate network connectivity to between 
2.0 and 2.61, preferably lower as this reduces the potential fraction QP
1 
species which does not precipitate to apatite. (2) Increasing P2O5 content in 
the glass, preferably above 6.0 mol%. One should be careful though as other 
work has concluded that P2O5 contents above 8 mol% induce crystallization 
in the glass during quenching (O'Donnell et al., 2008b). 
2.5.7 Effect of Fluoride on Glass Structure 
The structural role of fluoride was investigated by Brauer et al (Brauer et al., 
2010c). The authors produced a series of bioactive glasses with fluorine 
incorporated. The series of glasses produced had increasing amounts of 
CaF2 incorporated. The ratio of network formers and network modifiers was 
kept constant this maintained the NC of the glasses so any changes seen in 
the glass were due to fluoride inclusion rather than changes in glass Qn 
structure. Table 9 below shows the glass compositions that were produced. 
Table 9 Glass Compositions Produced by Brauer et al. to Investigate Fluoride Effect on Glass 
Structure. Amounts mol%. 
Glass SiO2 P2O5 CaO Na2O CaF2 NC NC' 
A 49.47 1.07 23.08 26.38 - 2.13 2.13 
B 47.12 1.02 21.98 25.13 4.75 2.13 1.82 
C 44.88 0.87 20.94 23.93 9.28 2.13 1.49 
                                            
1
 A result partially confirmed by the conclusions of previous work conducted by a different 
author. 
106 
 
 
D 42.73 0.92 19.94 22.79 13.62 2.13 1.15 
E 40.68 0.88 19.98 21.69 17.76 2.13 0.78 
F 36.83 0.80 17.18 19.64 25.54 2.13 -0.01 
G 33.29 0.72 15.53 17.75 32.71 2.13 -0.9 
H 44.88 0.97 44.87 - 9.28 2.13 1.49 
 
The design of the glass was based on the hypothesis that in the glass 
structure the fluorine exists as a fluorine-calcium complex rather than fluorine 
forming non-bridging fluorine attached to the Silicon in the glass. How the 
fluorine exists would have a direct influence on the structure of the glass. 
The calculated network connectivity is listed as NC and assumes the fluorine 
is in a complex with calcium. The hypothetical network connectivity (NC’) is 
also listed if the glass formed non-bridging fluorine in the glass structure. 
The glasses produced were characterized using differential scanning 
calorimetry that measured glass transition (Tg) and crystallization 
temperatures (Tc). XRD was performed to conform that the glasses were 
amorphous after quenching. 19F, 31P and 29Si MAS-NMR was also performed 
on the glass samples to determine the various fluorine, silicon and 
phosphorus environments within the glass. 
No Si-F bonds were detected using 29Si MAS-NMR, a large peak at -80 ppm 
corresponded to Q2 in the glass structure, a relatively small shoulder was 
detected at -92 ppm which shows the presence of Q3Si. The presence of a 
majority of Q2Si with a lesser amount of Q
3
Si  and absence of Si-F bonds 
agrees with the hypothesis that the fluorine exists bound to the calcium, most 
likely as CaF+. This then also agrees with the hypothesis used to design the 
glasses so the actual NC is likely to be close to the intended NC of 2.13. This 
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result concurs with the findings of Lusvardi et al. who performed MD 
simulations of fluorine containing bioactive glasses and also did not find the 
presence of any Si-F bonds. 
The 19F MAS-NMR performed on this glass series found that the fluoride is 
present as complexes with either sodium, calcium or mixtures of both 
(Brauer et al., 2010b). The sodium-free glass in the series showed the 
formation of a F-Ca(n) species with a peak at -89 ppm. Hexa-coordinated 
species of F-Na(6) were found at -220 ppm and peaks at -115 and -165 ppm 
indicated the presence if mixed calcium-sodium fluoride species. As well as 
the 29Si MAS-NMR data the 19F MAS-NMR agrees with the idea that Si-F 
bonds do not form in the glass structure and rather forms calcium and/or 
sodium fluoride complexes. Brauer explains the result seen by suggesting 
that due to silicon having a higher affinity for oxygen than fluorine and the 
fact that in these glass non-bridging oxygens are abundant then the 
formation of Si-F bonds is unfavourable. 
The Tg of the series produced by Brauer et al. showed a decrease in Tg with 
increasing CaF2 content. Furthermore the onset of crystallization (measured 
using DSC) decreased with increasing fluoride content. This was explained 
due to the formation of the calcium-fluoride complexes (CaF+) which reduce 
the charge from Ca2+ in a glass without fluoride to CaF+ with fluoride. This 
reduction from a 2+ to 1+ charge in calcium reduces the potential for calcium 
ions cross-linking silicate chains leading to a more disrupted structure. 
In summary, fluoride is readily incorporated into a bioactive glass structure. 
When incorporated it has been conclusively proven that the fluoride forms 
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complexes with sodium and calcium ions and does not form Si-F bonds. 
Incorporation of fluoride in the glass leads to a more disrupted glass 
structure indicated by a decreasing Tg with increasing amounts of fluoride in 
the glass composition. Given that Si-F bonds do not form in the glass 
network when designing bioactive glass with fluoride the fluorine should be 
added but the ratios of all other components (network former and modifiers) 
should be kept constant. This will mean the NC is not affected by fluorine 
addition. 
Lusvardi et al. (Lusvardi et al., 2008) performed MD simulations of fluorine 
containing bioactive glasses and did not find the presence of Si-F bonds. The 
authors introduced CaF2 into the glass by replacing network modifiers, this 
caused an increase in  the NC’ of the final glass caused by the reduction in 
network modifier content. When introducing fluoride into the glass 
composition then the ratios of the other components must be adjusted to 
account for the addition so that the glass NC is not adjusted. As this means 
that any changes in structure or bioactivity may be due to changes in glass 
network rather than the addition of fluoride. 
A recent paper has also studied the incorporation of fluorine in bioactive 
glasses (Pedone et al., 2012). The authors compared 23Na, 31P and 19F NMR 
results and MD simulations of a bioactive glass composition containing 
fluoride from (Christie et al., 2011). The authors looked at the local 
environments of the fluoride ions and confirmed that the F ions were 
associated with the Ca2+ and Na+ ions within the glass structure and did not 
form Si-F bonds. 
109 
 
 
2.5.8 Mechanism of Bioactivity 
The dissolution of bioactive glasses is important to understand their 
bioactivity. The bioactivity of these glasses is defined as their time to form 
apatite in solution. The bond-bonding ability of bioactive glass implants 
depends on the surface reactions taking place on the bioactive glass. It is 
generally presumed that for a composition to be bioactive a layer of 
hydroxycabonated apatite must precipitate on the implant surface before it 
bonds to tissues. The ability of the glass to release ions for forming apatite 
will determine their bioactivity. 
 
Figure 15 Mechanism of bioactivity of bioactive glass proposed by Hench et al. 
Figure 15 shows the widely accepted mechanism proposed by Hench 
(Hench, 2006) to explain the bioactivity of bioactive glasses. The first step is 
the ion exchange of Na+ ions from the glass for protons in the form of H+ or 
H3O
+ in the surrounding solution.  This then induces an increase in the local 
pH due to the build-up of OH- hydroxyl ions. This causes the breakage of the 
Si-O-Si bonds in the glass network by the hydroxyl ion, forming SiOH silanol 
groups at the interface between glass and surrounding solution. Breakage of 
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the silicate network opens the glass network which allows Ca2+ and PO4
3- 
ions to migrate to the surface of the glass. An amorphous CaO-P2O5 film 
forms at the surface of the glass. This film then grows drawing Ca2+ and 
PO4
3- ions from the surrounding solution. The layer then crystallizes and 
incorporates ions from the surrounding solution, namely OH- and CO3
2- ions. 
A mixed hydroxy-carbonated apatite layer then forms which allows the 
incorporation of collagen fibres and ultimate formation of new bone. 
This mechanism gives no indication on how glass composition influences 
apatite formation. Numerous studies show that there is a large difference in 
the rates of apatite formation when the composition is altered. Hill suggests 
(Hill, 2012) that for apatite formation the surrounding solution must become 
super-saturated with PO4
3- and Ca2+ ions, therefore altering the glass 
composition to maximize this (increasing CaO relative to Na2O and 
increasing P2O5 content) would give a more rapid formation of apatite. 
Previous published work where the authors produced series of glasses with 
these modifications have increased the apatite forming ability of bioactive 
glasses (O'Donnell et al., 2008b). The Hench mechanism indirectly suggests 
that increasing the solubility of the glass would increase the rate of formation. 
From this mechanism, it would be expected that glasses with little or no 
sodium would not be bioactive or would exhibit limited bioactivity. It has been 
recently discovered that new sodium-free or low sodium-containing silicate 
glasses are exceedingly bioactive and form apatite in less than 4 hours. 
Since Hench proposed his mechanism of bioactivity of bioactive glasses the 
split network model has been proposed. The orthophosphate existing in the 
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glass structure as droplets affects this mechanism. It is known the Ca and Na 
are distributed evenly between the silicate and phosphate phases within the 
glass network. A CaNaPO4 in its amorphous form would be very soluble; 
therefore it is possible that the actual dissolution mechanism could be slightly 
different from what Hench suggests. It may be the case that when the glass 
particles enter solution the orthophosphate phase is released rapidly from 
the glass network this would also release the associated calcium and sodium 
ions. Insufficient calcium ion concentration would then limit apatite formation 
meaning the rate limiting step for apatite formation and thus bioactivity is 
release of calcium ions from the silicate network. Explaining why glasses 
with high Ca/Na ratios have seen rapid apatite formation. 
Chapter 3: Techniques 
3.1 X-ray Diffraction 
The process of X-ray diffraction involves shooting a beam of X-rays at a 
sample and when these X-rays interact with the sample secondary diffracted 
beams of X-rays are created which are related to interplanar spacing in the 
crystalline powder, which can then be interpreted to produce a pattern 
identifying the crystalline components of the sample. It is based on 
constructive interference of monochromatic X-rays and a crystalline sample 
(Zolotoyabko, 2014). These X-rays are generated by a cathode ray tube, 
filtered to produce monochromatic radiation and focussed toward the 
sample. The interaction of the incident rays with the sample produces 
constructive interference (and a diffracted ray) when conditions satisfy 
Bragg's Law: 
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(13) 
            
 
 
 
Bragg’s Law relates the wavelength of electromagnetic radiation to the 
diffraction angle and the lattice spacing in a crystalline sample. These X-rays 
once diffracted, are then detected, processed and counted (Zolotoyabko, 
2014). By scanning the sample through a range of 2θangles, all possible 
diffraction directions of the lattice should be attained due to the random 
orientation of the powdered material. Conversion of the diffraction peaks to 
d-spacing’s allows identification of the mineral because each mineral has a 
set of unique d-spacing’s. With the aid of reference patterns, X-ray diffraction 
will be used to identify which crystalline products have formed in the cement 
reactions; and also used to ensure that the glasses are amorphous as when 
X-ray diffraction is performed on amorphous materials no sharp lines are 
present on the pattern, only broad amorphous halos are present. 
 
Figure 16 Representation of diffraction of X-rays from a crystal in X-ray diffraction analysis. 
Applications and Use 
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In this project X-ray diffraction will be used to analyse both the cements and 
glasses produced. It will be used to determine the phases formed in the 
cement setting reaction, X-ray diffraction will be able to distinguish between 
the various potential phases formed in the setting reaction. X-ray diffraction 
patterns provide peaks which define the phases formed in the sample; each 
different phase present has its own specific finger print allowing its 
identification. Glasses are defined by their amorphous nature which when 
analysed using X-ray diffraction does not give diffraction lines. Ensuring the 
glasses are amorphous is important. Firstly if a glass-ceramic forms then it 
may be less reactive than its amorphous counterpart. Secondly small 
amounts of crystalline phases in glasses are hard to reproduce between 
different batch productions, therefore two batches of the same glass 
composition may give very different types and amounts of crystallisation 
which would not give reproducible glass properties. 
A particular advantage X-ray diffraction gives for this project is its ability to 
distinguish between octacalcium phosphate and hydroxyapatite. Octacalcium 
phosphate has an almost identical X-ray diffraction pattern to hydroxyapatite 
except octacalcium phosphate has a prominent peak at 4.7 degrees 2 theta 
which is absent in hydroxyapatite patterns. A disadvantage in relation to this 
project is its inability to distinguish between fluorapatite and hydroxyapatite. 
On X-ray diffraction pattern both hydroxyapatite and fluorapatite share 
identical peaks, this is a particular disadvantage for this project that aims in 
part in to produce both hydroxyapatite and fluorapatite forming cements. 
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3.2 Magic Angle Spinning Nuclear Magnetic Resonance 
Nuclear magnetic resonance relies on the phenomenon that nuclei in a 
magnetic field absorb and then re-emit electromagnetic radiation. Atomic 
isotopes with a magnetic moment can be studied for NMR spectroscopy. 
When placed into a magnetic field these isotopes exist in two spin states 
which either align with or against the magnetic field. If the nuclei are then 
irradiated with energy corresponding to the exact spin state of the specific 
nuclei causes those aligned against the magnetic field to ‘flip’ to align with 
the magnetic field. The energy difference (ΔE) between the two states is the 
energy released during this ‘flipping’ and is detected within the NMR probe. 
For ½ spin nuclei the energy difference between the two spin states at a 
given magnetic field strength is proportional to their magnetic moment 
(Keeler, 2010). However the individual environments of each isotope affect 
this energy difference slightly, causing chemical shifts. These chemical shifts 
can be used to identify nuclei within a specific molecule and also nuclei 
within different environments in the same compound (Keeler, 2010). 
 
Figure 17 Representation of MAS-NMR rotor at magic angle (θm) 
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Magic-angle spinning (MAS) is a technique used in nuclear magnetic 
resonance to perform experiments in solid-state NMR spectroscopy. In a 
condensed phase there are main three interactions (dipolar, chemical shift 
anisotropy, quadrupolar) which often lead to very broad lines. Spinning the 
sample at the magic angle (ca. 54.74°, where cos2θm 1/3) with respect to 
the direction of the magnetic field, causes these broad lines to narrow, 
increasing the resolution allowing identification and analysis of the spectrum 
produced from the sample. In liquids (for instance compounds in solution) the 
interactions outlined above are averaged out due to the fast, time-averaged 
motion of the molecules in solution, on the contrary in solids this does not 
occur. This magic angle spinning of a solid mimics the orientation averaging 
in solution. Magic angle spinning causes the signal to become much 
narrower, giving rise to the isotropic value and spinning sidebands which 
occur at multiples of the spinning speed. At the magic angle the nuclear 
dipole-dipole interaction, between magnetic moments of nuclei averages to 
zero. The chemical shift anisotropy is a nuclear-electron interaction and 
averages to a non-zero value during magic angle spinning. The quadrupolar 
interaction is only partially averaged by spinning at the magic angle leaving a 
residual secondary quadrupolar interaction (Keeler, 2010).  
Applications and Use 
In this project MAS-NMR will be used to characterize the products of the 
cements developed, it will also be used to assess the setting mechanism of 
the cements developed in this study with the potential to work with other 
(conventional) CaP cements in order to assess them using NMR. 
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Identification of the formation of apatite in the cements will be important as 
this is the desirable product of the cement formation, to identify apatite 31P 
MAS-NMR will be used, apatite appears on the spectra at 2.8 ppm (Kaflak-
Hachulska et al., 2003) and should produce a narrow peak which is 
indicative of a crystalline product. 19F NMR will be useful to firstly to ensure 
that glasses produced which include fluoride in their composition actually 
have it once they have be produced, also 19F NMR is one of the only 
techniques which allow the confirmation of the formation of fluorapatite as 
the production of fluorapatite in a cement composition will not only be novel 
but will also increase the applications of current calcium phosphate cements. 
Advantages and Disadvantages 
Advantages of MAS-NMR are that it can detect very sensitive and depending 
upon abundance of the nuclei and number of scans it can be used for 
analysis of small amounts of sample, so if a sample is multi component and 
a probed species is present is very small quantities then NMR is likely to 
detect it where other techniques may not show it presence. Also NMR can be 
used to quantitatively analyse a sample and with deconvolution can be used 
to determine relative of fractions of components in a sample. Disadvantages 
of NMR are firstly that it can be hard to interpret the spectra and successful 
interpretation requires references from literature sources and analysis using 
other techniques. Secondly detection depends upon an atom having a 
detectable isotope that is in detectable amounts. For instance, 19F is a spin ½ 
nucleus and at 100% natural abundance, all F atoms in a sample can be 
detected with no difficulty even at very low levels (White et al., 1988). 
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Table 10 Range of calcium phosphate compounds with their formulas and 
31
P MAS-NMR 
chemical shifts relative to 85% H3PO4. 
Compound Abbrevi
ation 
Formula 
31
P 
Chemical 
Shift 
Ref 
 
Fluorapatite FAP Ca10(PO4)6F2 2.8 (±0.2) (Rothwell et 
al., 1980) 
Hydroxyapatite HAP Ca10(PO4)6(OH)2 2.8 (±0.2)  
Octacalcium Phosphate OCP Ca8(HPO4)2(PO4
)4.5H2O 
-0.2, 2.0, 3.3, 
3.7 
(Tseng et al., 
2004) 
Na2HPO4 - Na2HPO4 6.6  
Dicalcium phosphate 
dihydrate/Brushite 
DCPD CaHPO4.2H2O 1.7 (±0.3) (Rothwell et 
al., 1980) 
Dicalcium phosphate 
anhydrous/Monetite 
DCPA CaHPO4 -1.5 (±0.4)  
0.0 (±0.4) 
(Rothwell et 
al., 1980) 
Monocalcium phosphate 
anhydrous 
MCPA Ca(H2PO4)2 -0.1 (±0.3)  
-4.6 (±0.3) 
(Rothwell et 
al., 1980) 
Monocalcium phosphate 
monohydrate 
MCPM Ca(H2PO4)2.H2O 0.5 (±0.4) 
-0.5 (±0.4) 
(Rothwell et 
al., 1980) 
 
3.3 Fourier Transform Infrared Spectroscopy 
Infrared spectroscopy is an important technique in chemistry.  It is an easy 
way to identify the presence of certain functional groups in a molecule.  Also, 
it can use the unique collection of absorption bands to confirm the identity of 
a pure compound or to detect the presence of specific impurities. It is a 
technique which is used to obtain an infrared spectrum of absorption and 
emission scattering of a solid, liquid or gas. 
An FTIR spectrometer scans a sample, rapidly, at all infrared frequencies 
done using an interferometer. The interferometer produces a unique type of 
signal which has all of the infrared frequencies “encoded” into it. Most 
interferometers employ a beamsplitter which takes the incoming infrared 
beam and divides it into two optical beams. One beam reflects off of a flat 
mirror which is fixed in place. The other beam reflects off of a flat mirror 
which is on a mechanism which allows this mirror to move a very short 
distance from the beamsplitter. The two beams reflect off of their respective 
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mirrors and are recombined when they meet back at the beamsplitter. 
Because the path that one beam travels is a fixed length and the other is 
constantly changing as its mirror moves, the signal which exits the 
interferometer is the result of these two beams “interfering” with each other. 
The resulting signal is called an interferogram which has the unique property 
that every data point which makes up the signal has information about every 
infrared frequency which comes from the source. Once detected the 
interferogram must be converted into a frequency spectrum which is done 
using Fourier mathematics which allows interpretation of the bands present 
within a sample. 
FTIR works by the bonds in a molecule absorbing infrared light at a certain 
wavelength which is specific for that chemical bond. The electrons within a 
chemical bond absorb the light at a specific frequency (its resonant 
frequency) and are elevated into an excited state, which causes the bond to 
vibrate. A bond can vibrate in many different ways; typically these are 
symmetrical stretching, antisymmetrical stretching, scissoring, rocking, 
wagging and twisting. Infrared light which is absorbed by the molecule is not 
detected by the detector and compared with the reference beam the sample 
is lacking energy at certain wavelengths. The bonds in a molecule that are IR 
active all contribute to make a specific ‘fingerprint’ spectrum for each specific 
molecule, allowing for its identification. 
Applications 
In this project FTIR will be used for cement characterisation. FTIR is 
advantageous because it rapidly allows the analysis of samples, with typical 
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spectrum taking less than 2 minutes to obtain. FTIR allows the 
characterisation of the phosphate groups within the apatite structure (Elliott, 
1994) as well as the water molecules and OH groups in apatite, octacalcium 
phosphate and DCPD (Elliott, 1994). It will be especially useful in this project 
for looking for any carbonate substitution within the apatite and is the only 
technique used in this project that can accomplish this (Kolmas et al., 2011). 
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Chapter 4: Aims and Objectives 
4.1 Aims 
The aim of the project is to develop a novel method of forming calcium 
phosphate cements using bioactive glasses as a reactive precursor. It is also 
an aim to develop glasses that can be used as ion delivery vehicles for the 
formation of novel cements. Fluoride and strontium will be added to glass 
compositions with the aim of producing both fluorapatite and strontium-
substituted calcium phosphate cements. 31P and 19F MAS-NMR as well as X-
ray diffraction will be used primarily to assess the viability of the glasses for 
forming calcium phosphate cement phases. Production of fluorapatite will be 
assessed by 19F and 31P MAS-NMR and XRD. 
4.2 Objectives 
Produce novel calcium phosphate cements where at least one major 
component of the setting reaction is a bioactive glass. 
Confirm that the bioactive glass is providing Ca2+ and PO4
3- for the cement 
phase to form and that the presence of the bioactive glass is essential for 
formation of the cement phase. This then confirms that the glass is taking 
part in the reaction rather than acting as a filler in the cement phase. This 
can be achieved using 31P MAS-NMR to confirm dissolution of the 
orthophosphate phase with in the glass.  
Establish optimal glass compositions for producing novel calcium phosphate 
cements. Optimal properties are defined as compressive strength (4-15 
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MPa), setting times (Gilmore needle test) (between 5 and 30 minutes), 
rheology (injectable through a needle) and porosity (high interconnectivity of 
pores). Glasses that vary calcium to sodium ratio and P2O5 content will be 
produced to measure effect on cement properties. 
Introduce fluoride in the form of CaF2 into the glass composition with the aim 
of producing a calcium phosphate cement which the main cement phase2 is 
fluorapatite. A series of glasses will be produced to establish optimal fluoride 
contents for maximum fluorapatite formation in the cement phase. 
Compare setting times, compressive strengths and phases formed against 
those of the commercially available calcium phosphate cement, HydroSet. 
  
                                            
2
 Main cement phase is defined as the major phase present in the resulting cement after 
reaction. It is also the phase that primarily contributes to the compressive strength and 
setting times of the resulting cement. In this project the main cement phases may be 
octacalcium phosphate (Ca8(HPO4)2(PO4)4.5H2O), hydroxyapatite (Ca10(PO4)6(OH)2, 
carbonated-hydroxyapatite (type A or B), Brushite (CaHPO4.2H2O), Monetite (CaHPO4), 
fluorapatite (Ca10(PO4)6F2), or a biphasic system consisting of a mixture of any of the above. 
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Chapter 5: Materials and Methods 
5.1 Cement Starting Material Production 
5.1.1 Glass Compositions 
The following glass compositions were designed to assess the influence of 
P2O5 content, CaF2 content and calcium to sodium ratio on cement formation 
and properties. The network connectivity of the glasses was maintained 
constant for all series of cement compositions in order to not change the 
degree of connectivity within the silicate glass phase. 
Series 1 (QMNWKPaG01-05), investigating P2O5 content, increased P2O5 
content in 2.00 mol% increments from 0.00-8.00. As a major component of 
hydroxyapatite, the effect of phosphorus content within the glass was studied 
to observe what effects it would have upon cement properties and chemistry. 
These amounts were selected because they range from zero phosphorus 
oxide to 8.00 mol% which is probably near the limit of incorporating ions into 
a glass according to previous work (O'Donnell et al., 2009).  
Series 2 (QMNWKPaG06-11) investigated fluoride content from 2.00-4.50 
mol% in 0.50 increments. It was unknown how fluoride content in the glass 
would affect cement properties and the ability to form fluorapatite. These 
amounts were chosen because they would give a range of potential fluoride 
substitutions in any apatite they may potentially form. 
Series 3 altered the calcium to sodium ratio within the glass. It was believed 
that additional sodium may increase the rate of glass dissolution (based on 
the Hench glass dissolution mechanism (Hench, 2006)) which would then, in 
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turn, decrease setting times of the cement compositions produced from 
these glasses. 
Table 11 Glass compositions produced to make cements. Amounts in mol%. NC’, Network 
Connectivity 
Name SiO2 P2O5 CaO Na2O CaF2 NC' 
QMNWKPaG01 50.00 0.00 45.00 5.00 0.00 2.00 
QMNWKPaG02 46.00 2.00 46.80 5.20 0.00 2.00 
QMNWKPaG03 42.00 4.00 48.60 5.40 0.00 2.00 
QMNWKPaG04 38.00 6.00 50.40 5.60 0.00 2.00 
QMNWKPaG05 34.00 8.00 52.20 5.80 0.00 2.00 
QMNWKPaG06 37.00 6.00 49.50 5.50 2.00 2.00 
QMNWKPaG07 36.00 6.00 48.60 5.40 4.00 2.00 
QMNWKPaG08 36.80 6.00 49.23 5.47 2.50 2.00 
QMNWKPaG09 36.50 6.00 49.05 5.45 3.00 2.00 
QMNWKPaG10 36.30 6.00 48.78 5.42 3.50 2.00 
QMNWKPaG11 35.80 6.00 48.33 5.37 4.50 2.00 
QMNWKPaG13 42.00 4.00 49.00 5.00 0.00 2.00 
QMNWKPaG14 42.00 4.00 44.00 10.00 0.00 2.00 
QMNWKPaG15 42.00 4.00 39.00 15.00 0.00 2.00 
QMNWKPaG16 42.00 4.00 34.00 20.00 0.00 2.00 
 
5.1.2 Glass Production 
Glasses in the system SiO2-P2O5-CaO-Na2O-(CaF2) were prepared in the 
melt-quench route (table 11). SiO2 (Prince Materials Ltd., UK), P2O5, CaCO3, 
Na2CO3 and CaF2 (all Sigma-Aldrich) were melted in a platinum-rhodium 
(90% Pt, 10% Rh) crucible at a melt temperature of 1480 ˚C for 1 hour in an 
electric furnace (Lenton EHF 17/3). Batches of 150 g were produced and 
each glass batch was quenched rapidly in water after the melting period. 
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5.1.3 Glass Milling 
100g of each glass was ground using a vibratory mill (Gy-Ro mill, Glen 
Creston) for 2 x 7 minutes and sieved (Endecotts, UK) to a particle size below 
38 μm. 
5.1.4 Ca(H2PO4)2 Milling 
The Ca(H2PO4)2 (Sigma-Aldrich) was prepared by grinding 27 g using a 
vibratory mill (Gy-Ro mill, Glen Creston) for 4 minutes. 
5.1.5 Differential Scanning Calorimetry 
Differential scanning calorimetry (DSC) was carried out using a Stanton 
Redcroft DSC 1500 (Rheometric Scientific, Epsom, UK) to study the glass 
transition temperature of the glass powders. 50 mg of each glass powder 
sample was weighed in a platinum crucible and placed onto the DSC stage 
adjacent the matched platinum crucible with to 50 mg of alumina powder. 
Samples were ramped from 20-1000  C at 10ºC/min. 
5.2 Cement Powder/Paste 
The cement mixture was prepared by mixing the sieved glass powder with 
the milled Ca(H2PO4)2  powder in a ratio to give an overall calcium to 
phosphorus ratio (Ca/P) of 1.67 (the stoichiometry of apatite). The powders 
were mixed by hand on a glass slab. In order to produce the cement paste 
and initiate the cement setting reaction the cement powder was mixed with 
2.5% Na2HPO4 solution in a liquid to powder ratio (L/P, ml/g) of 0.70. The 
paste was then mixed by hand with a metal spatula for 30 seconds. 
5.2.1 HydroSet 
HydroSet was mixed according to the manufacturer’s instructions. 
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5.2.2 Cement Cylinders 
The cement paste was filled in cylindrical steel moulds with a height of 6 mm 
and diameter of 4 mm. The cylinders were ‘over –filled’ and sandwiched 
between two steel plates. The moulds and plates were then clamped 
together using a G clamp. The clamp was then placed into a 37C oven 
(Borolabs incubator, Borolabs Basingstoke, UK) for 120 minutes. The clamp 
and plates were then removed and the cements whilst in the moulds were 
brushed with silicon-carbide paper to ensure a flat surface at each end of the 
cylinder. 
5.2.3 Immersion of Cements 
The set cement cylinders were then weighed and height and diameter was 
measured using a micrometer (Mitutoyo Ltd, Andover, UK)  for each cylinder. 
Each cylinder was then immersed in 10 ml of Tris buffer solution (in 15 ml 
plastic centrifuge tubes) for either 1 hour, 1 day, 7 days or 28 days. 8 cement 
cylinders were immersed at each time point for each cement composition for 
compressive strength measurements. The samples were stored in a 37C 
oven for their respective time-points. After being stored for its respective time 
each cylinder was removed and patted dry, the weight, height and diameter 
were then measured again. 
5.3 Cement Property Characterisation 
5.3.1 Setting Time Measurement 
The setting time of each cement sample was measured using the Gilmore 
needle test according to the ISO standard ISO (9917-1:2007(E)). Cement 
pastes were prepared according to the method outlined, the cement paste 
was filled into cylindrical moulds (Height 4 mm, Diameter 8 mm) using a 
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spatula. To measure the initial setting times the ‘lesser’ Gilmore needle (2.12 
mm 113.4 g Wt.) was lowered onto the cement surface and left for 5 seconds, 
the setting time was taken until the needle tip no longer makes an indentation 
on the cement surface. To measure the final setting time the larger Gilmore 
needle (1.06 mm dia. 453.6 g Wt.) was used and again the needle is lowered 
onto the surface of the cement paste and left for 5 seconds, the final setting 
time was taken when the needle no longer makes an indentation on the 
cement surface. 
5.3.2 Compressive Strength Measurements 
Compressive strength was measured using an Instron 5567 mechanical 
property testing machine (Instron, High Wycome, UK) using a 1kN load cell. 
Cylindrical specimen after their respective immersion times were placed 
between two steel plates without drying with a 1 cm square damp filter paper 
above and below the specimen. Force was applied at a movement rate of 1 
mm/min. The test was stopped either automatically by the machine when 
fracture was detected or when it was evident by eye that fracture had 
occurred. Eight specimens were tested for each cement composition, for 
each immersion time. 
5.3.3 Inductively Coupled Plasma-Optical Emission Spectrometry 
ICP-OES measurements were performed using a Varian Vista-PRO CCD. 
Samples were diluted by 10 with Tris buffer solution and 69% nitric acid 
(VWR, Radnor, PA, USA) was added in 5% w/w. Ion concentrations were 
measured against a range of prepared multi-element standard solutions (Si, 
Ca, Na, P; VWR, Radnor, PA, USA) of 0.1, 1, 10, 20, 50 and 100 ppm, 
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prepared with Tris buffer solution to account for ionic strength. A total of four 
measurements were performed on each cement immersion time point. 
5.3.4 Fluoride Measurements 
Fluoride-release into Tris buffer was measured using a fluoride-selective 
electrode (Orion 9609BNWP with Orion pH/ISE meter 710, both Thermo 
Scientific, Waltham, MA, USA). Calibration was performed using standard 
solutions of 0.01, 0.1, 1, 10, 100 ppm; prepared using Tris buffer to account 
for ionic strength from a 1000 ppm F stock solution (VWR, Radnor, PA, 
USA). 
5.4 Cement Phase Analysis 
5.4.1 X-ray Powder Diffraction 
Powder XRD experiments for the cements were done on Bruker D8-A25-
Advance diffractometer operating with the CuK radiation at 40kV and 
40mA. The XRD pattern for the Ca(H2PO4)2H2O was run on X'Pert Pro 
PANalytical diffraction system with Cu anode operating at 45kV and 40mA. 
5.4.2 Fourier Transform Infrared 
Samples were analysed using Fourier-transform infrared spectroscopy 
(FTIR; Spectrum GX, Perkin Elmer, Waltham, MA, USA; data collected from 
4000 to 500 cm−1)  
5.4.3 Magic Angle Spinning Nuclear Magnetic Resonance 
The 31P MAS-NMR experiments were run on Bruker 600MHz spectrometer 
at the 242.9MHz resonance frequency. The powder samples were packed 
into 4mm rotor and spun at 11-12kHz. The measurements were done using 
60s recycle delay and 85% H3PO4 was used to reference the chemical shift 
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scale. The 19F MAS-NMR experiments were run at the 564.7MHz using a 
fluorine-free probe in a 2.5 mm rotor spun at 20kHz with 60s delay for the 
cements and 10s delay for the glass. The 19F chemical shift scale was 
referenced using 1M NaF solution giving a signal at -120 ppm against CF3Cl. 
5.4.4 Scanning Electron Microscopy 
The fracture surface of the cement cylinders were studied under SEM. 
Specimen stubs were gold coated using an automatic sputter coater. 
Photomicrographs were taken using a Hitachi S-3400 machine, with the 
accelerating voltage 20kV, emission current 54mA.  
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Chapter 6: Glass and Ca(H2PO4)2 Characterisation 
Results and Discussion 
6.1 Results 
6.1.1 Glass Characterisation 
 
Figure 18 X-ray diffraction patterns of glasses with increasing phosphate content. i) 
QMNWKPaG01, ii) QMNWKPaG02, iii) QMNWKPaG03, iv) QMNWKPaG04, v) QMNWKPaG05. 
Figure 18 shows X-ray diffraction patterns of glasses QMNWKPaG01-05. 
The X-ray diffraction was performed to confirm the amorphous nature of the 
glasses. Glass QMNWKPaG01-04 show no clear diffraction lines indicative 
of crystallisation. Glass QMNWKPaG05 showed indicative lines of 
crystallisation within the sample. 
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Figure 19 X-ray diffraction patterns of fluoride containing bioactive glass 
compositions. i) QMNWKPaG06, ii) QMNWKPaG07, iii) QMNWKPaG08, iv) 
QMNWKPaG09, v) QMNWKPaG10, vi) QMNWKPaG11. 
 
Figure 19 displays X-ray diffraction patterns of glasses produced with 
increasing fluoride contents. All patterns showed no diffraction lines, 
confirming the amorphous nature of the glasses produced. 
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Figure 20 X-ray diffraction patterns of bioactive glass compositions with increasing sodium 
contents. i) QMNWKPaG13, ii) QMNWKPaG14, iii) QMNWKPaG15, iv) QMNWKPaG16. 
Figure 20 displays X-ray diffraction patterns of glasses produced with 
increasing sodium contents. All patterns showed no diffraction lines, 
confirming the amorphous nature of the glasses produced. 
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Figure 21 
31
P MAS-NMR spectra of glasses with increasing phosphate content. i) 
QMNWKPaG01, ii) QMNWKPaG02, iii) QMNWKPaG03, iv) QMNWKPaG04, v) QMNWKPaG05. 
The 31P MAS-NMR spectra of the glasses with increasing phosphate content 
showed anticipated results for glasses QMNWKPaG01-04. Glasses 
QMNWKPaG02-04 show almost identical spectra with one broad chemical 
shift all at 3.8 ppm indicative of amorphous orthophosphate (Brauer et al., 
2009) and without any additional chemical shift which would indicate the 
presence of crystalline phases. The spectrum of glass QMNWKPaG01 
showed no signal as there is no phosphate within the glass composition. 
QMNWKPaG05 showed expected results, based on the X-ray diffraction 
pattern, with two peaks at 3.2 and 5.0 ppm indicating possible presence of a 
phosphate containing crystalline phase. 
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Figure 22 
31
P MAS-NMR spectra of bioactive glass compositions with increasing sodium 
content. i) QMNWKPaG13, ii) QMNWKPaG14, iii) QMNWKPaG15, iv) QMNWKPaG16. 
Figure 22 shows 31P MAS-NMR spectra of bioactive glass compositions with 
increasing sodium content. Each spectrum shows one broad peak, indicative 
of amorphous orthophosphate. The position shifts to a higher ppm with 
increasing sodium content, with QMNWKPaG13 a centre at 3.6 ppm; 
QMNWKPaG14 at 5.0 ppm; QMNWKPaG15 at 5.7 ppm and QMNWKPaG16 
at 7.3 ppm. 
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Figure 23 
31
P MAS-NMR spectra of fluoride containing bioactive glass compositions. i) 
QMNWKPaG06, ii) QMNWKPaG07, iii) QMNWKPaG08, iv) QMNWKPaG09, v) QMNWKPaG10, vi) 
QMNWKPaG11. 
Figure 23 shows 31P MAS-NMR spectra of all glasses for the series 
produced with increasing fluoride contents. All spectra show broad peak at 
identical positions, 3.8 ppm. 
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Figure 24 FTIR spectra of glasses with increasing phosphate content. i) QMNWKPaG01, ii) 
QMNWKPaG02, iii) QMNWKPaG03, iv) QMNWKPaG04, v) QMNWKPaG05. 
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Figure 25 FTIR spectra of fluoride containing bioactive glass compositions. i) QMNWKPaG06, 
ii) QMNWKPaG07, iii) QMNWKPaG08, iv) QMNWKPaG09, v) QMNWKPaG10, vi) QMNWKPaG11. 
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Figure 26 FTIR spectra of bioactive glass compositions with increasing sodium contents. i) 
QMNWKPaG13, ii) QMNWKPaG14, iii) QMNWKPaG15, iv) QMNWKPaG16. 
The FTIR of the bioactive glasses produced in this study show almost 
identical spectra which are consistent with typical spectra of bioactive 
glasses. A broad band at ~600 cm-1 (on all spectra except QMNWKPaG01) is 
attributed to amorphous PO4 groups. Then all spectra also possess bands at 
850, 900, 1010 cm-1; which are attributed to being Si-O- Na+, Si-O- Ca2+ and 
Si-O-Si bonds respectively (Cerruti et al., 2005). 
Table 12 Glass transition temperatures of all glass compositions 
used to make cements 
Glass 
Composition  
Glass Transition 
Temperature (Tg) ºC 
QMNWKPaG01 689 
QMNWKPaG02 697 
QMNWKPaG03 695 
QMNWKPaG04 698 
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QMNWKPaG06 664 
QMNWKPaG07 635 
QMNWKPaG08 658 
QMNWKPaG09 662 
QMNWKPaG10 654 
QMNWKPaG11 625 
QMNWKPaG13 687 
QMNWKPaG14 633 
QMNWKPaG15 589 
QMNWKPaG16 544 
 
 
Figure 27 Glass transition temperature of glass compositions QMNWKPaG01-04 plotted against 
P2O5 content. Plotted with line of best fit with correlation coefficient (R
2
) and graph equation. 
Figure 27 shows the Glass transition temperature of glass compositions 
QMNWKPaG01-04 plotted against P2O5 content. With 0 mol% P2O5 content 
in the glass the Tg is at its lowest (689 ºC), after this there is a general trend 
of increasing Tg as the phosphate content is increased, with the 4 and 6 
mol% compositions being at 695 and 698 ºC respectively. The 2 mol% 
composition is perhaps slightly higher than it should be at 697 ºC as it sits 
slightly above the trend. 
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Figure 28 Glass transition temperature of glass compositions QMNWKPaG06-11 plotted against 
CaF2 content. Plotted with line of best fit with correlation coefficient (R
2
) and graph equation. 
Figure 28 shows Glass transition temperature of glass compositions 
QMNWKPaG06-11 plotted against CaF2 content. There is a general trend of 
decreasing Tg as the fluoride content was increased. With 2 mol% CaF2 the 
Tg is 698 ºC which decreases to 625 ºC with 4.5 mol%. The 2.5 mol% 
composition deviates from the general trend being at 658 ºC. 
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Figure 29 Glass transition temperature of glass compositions QMNWKPaG13-16 plotted against 
calcium to sodium ratio within the glass composition. Plotted with line of best fit with 
correlation coefficient (R
2
) and graph equation. 
Figure 29 shows Glass transition temperature of glass compositions 
QMNWKPaG13-16 plotted against calcium to sodium ratio within the glass 
composition. The Tg of each glass rises from 544 to 589 then 633 and finally 
687 ºC as the calcium to sodium ratio increases in the glass compositions. 
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6.1.2 Ca(H2PO4)2 Powder Characterisation 
 
 
Figure 30 X-ray diffraction pattern of Ca(H2PO4)2 powder. 
 
Figure 31 
31
P MAS-NMR Ca(H2PO4)2  purchased from Sigma-Aldrich. * indicate spinning 
sidebands. 
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Figure 32 FTIR spectrum of Ca(H2PO4)2 powder as purchased from Sigma Aldrich. 
The 31P MAS-NMR spectrum (Figure 31) of the Ca(H2PO4)2 from Sigma-
Aldrich shows the presence of three chemical shifts at -4.6, -1.4 and  -0.2 
ppm. The diffraction pattern (Figure 30) for the Ca(H2PO4)2 powder shows 
the presence of Ca(H2PO4)2.H2O only, referenced from ICDD reference 
code: 00-009-0347. Figure 32 shows FTIR results from the Ca(H2PO4)2 
starting powder. Bands are present at 1657, 1211, 1168, 1095, 950, 862, 
686, 559 and 551 cm-1. 
6.2 Discussion 
6.2.1 Glass Design & Synthesis 
Three series of glasses were designed to investigate the change in glass 
composition upon the cement properties. The three series investigated 
addition of P2O5, CaF2 and calcium to sodium ratio. In all glass compositions 
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the network connectivity was maintained at 2.00 in order to maintain the 
same Q structure within the glass network. The P2O5 series 
(QMNWKPaG01-05) ranged from 0.00 mol% to 8.00 mol% of P2O5 content 
increasing in 2.00 increments. The analysis of the glasses showed these 
glasses were amorphous upon production except the 8.00 mol% glass which 
had crystallinity present, this can be explained as increasing the phosphate 
content beyond 6.00 mol% has been shown to induce crystallisation 
(O'Donnell et al., 2009, O'Donnell et al., 2008a). 
Table 13 Potential maximum % fluoride substitution of apatite produced through setting 
reaction of fluoride containing cement compositions. Calculated using total calcium and 
fluoride amounts in each cement powder mixture. 
Cement Composition % Potential F Substitution 
QMNWKPaG06 48 
QMNWKPaG07 95 
QMNWKPaG08 60 
QMNWKPaG09 72 
QMNWKPaG10 84 
QMNWKPaG11 107 
 
The second series is a series investigating CaF2 addition into the glass. The 
‘base’ glass was the QMNWKPaG04 composition to which various amounts 
of CaF2 was added between 2.5 and 4.5 mol%. The analysis of the glasses 
showed crystallinity was not present in any of the glass compositions. The 
amount of fluoride incorporated into each glass was designed so the 
resultant apatite phase formed in the cement forming reaction had varying 
levels of fluoride substitution. As Table 13 shows maximum potential fluoride 
substitution in any apatite produced during the cement forming reaction 
ranges from just below 50% to just above 100%, provided all fluoride is 
available for substitution. 
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The last series was investigated to analyse the effect of calcium to sodium 
ratio on the cement properties and phases formed during the setting 
reaction. The initial glasses were all designed with a low sodium content as 
sodium is not required to form the apatite. It was added in a small fraction 
however to reduce the melting temperature of the glass. This series was then 
produced to show if the hypothesis of it not being required was true and also 
to investigate its effect in general as it could influence the dissolution of the 
bioactive glass. The QMNWKPaG13 glass was designed and the sodium 
was substituted for calcium by 5.00 mol% through the series. 
After X-ray diffraction analysis of the produced glasses, the glass with the 
code QMNWKPaG05 was not used to form cements and further study. This 
decision was taken due to the presence of a number of crystalline diffraction 
lines on the X-ray diffraction pattern (Figure 19). The presence of a 
crystalline phase in the produced glass is problematic because crystallinity is 
uncontrollable as the amount of crystallinity and distribution of crystals could 
potentially be different between batches giving unpredictability of final glass 
properties. Following this glass properties may be altered as crystallisation 
may remove certain components disproportionally. Consequentially this 
could affect the Qn structure within the glass, which would in turn influence 
glass properties like glass dissolution behaviour. Ultimately any change in 
cement properties from samples produced from this glass may be due to the 
presence of crystallinity rather than the systematic change through the 
series. 
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Whilst making cement pastes and setting them within the moulds all glass 
compositions successfully set to form a cement block. However cements 
produced through the reaction of glasses QMNWKPaG01 and 
QMNWKPaG02 broke apart upon immersion in Tris buffer solution. 
Consequently these compositions were not studied in immersion. 
 
 
Figure 33 
31
P chemical shift position of all glass compositions produced in this study plotted 
against CaO/(CaO+Na2O) of the respective glass compositon. Also included are the same 
values for an ICIE series from (Elgayar et al., 2005). Plotted with line of best fit with correlation 
coefficient (R
2
). 
Figure 33 is a plot of the 31P chemical shift of the glasses produced for this 
project plotted against CaO/(CaO+Na2O) value. It is known that due to the 
equal partitioning of sodium and calcium in bioactive glasses an alteration in 
the ratio of these two components alters the chemical environment of the 
phosphorus atoms which in turn affects the chemical shift proportionally 
(Elgayar et al., 2005). The results of this study were compared against 
another series of similar bioactive glasses and showed an almost identical 
trend (Elgayar et al., 2005). The reason for this analysis was to provide 
partial validation that the correct glass composition was produced as it allows 
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the assessment of the levels of calcium and sodium within the glasses and 
would identify any glass compositions which did not have their designed 
amounts. 
The glasses with identical CaO:Na2O showed almost identical positions on 
the plot. This indicates the correct CaO:Na2O is present in the glasses made 
as to what was designed. This is also validated by the close correlation to the 
comparative ICIE glass series which was a range of bioactive glasses of 
altering CaO:Na2O in the glass. Whilst the majority of glasses produced in 
the project had a fixed CaO:Na2O, three glasses were made with increasing 
sodium contents which are also plotted on the graph. These results also 
match the trend seen in the comparative ICIE glass series and have an R2 of 
0.985 giving high confidence that the correct glass compositions were 
produced. 
From previous studies of the phosphate environment in bioactive glasses it is 
known that the phosphate within the glass exists as an orthophosphate 
(Brauer et al., 2008). These bioactive glasses are considered to be phase 
separated between the silicate and phosphate phases and the associated 
cations that charge balance the phosphate ions are calcium and sodium ions 
(Elgayar et al., 2005). It is also known that the distribution of calcium and 
sodium ions is not favoured in either phase. The distribution then matches 
that which is put in the glass during making. It has also been shown that a 
change in the ratio of calcium to sodium affects the shielding on the 
phosphorus atom which in turn affects the chemical shift in the 31P MAS-
NMR. The change in chemical shift is proportional to the ratio of calcium and 
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sodium in the glass (Elgayar et al., 2005). This allows a method of partial 
validation that the glass compositions have been correctly produced. 
6.2.2 Ca(H2PO4)2 
The analysis of the Ca(H2PO4)2 starting powder shows 
different phases between the two techniques used to analyse 
the samples. The X-ray diffraction pattern shows only the 
presence of Ca(H2PO4)2.H2O, whereas the 
31P MAS-NMR 
spectra shows the presence of Ca(H2PO4)2 and a small 
fraction of DCPA (CaHPO4). The discrepancy between these 
two results may be due to reaction with moisture in the air 
whilst in storage. The presence of the hydrated form of the 
calcium phosphate salt (Ca(H2PO4)2.H2O) would affect the 
expected calcium to phosphorus ratio Ca/P as the reagents 
were weighed on assumption the reagent was pure 
Ca(H2PO4)2 causing an increase in the overall Ca/P of the 
cement powder mixture with the presence of either 
(Ca(H2PO4)2.H2O) or DCPD.6.3 Experimental Cement 
Compositions 
Based on the results from the glass analysis not all compositions were 
analysed as cement compositions for various reasons previously alluded to. 
The following section compares all the analysis performed on the cement 
samples from all glass compositions studied. The cements were split into two 
distinct series based upon there glass compositions that were studied. These 
two series being the fluoride containing cement series and the calcium 
sodium cement series. The fluoride containing cement series contains all 
glasses that contain fluoride QMNWKPaG06-11 and also glass 
QMNWKPaG04 which does not contain fluoride but has the ratios of all the 
other components the same as the fluoride containing compositions thus 
acting as a fluoride-free ‘base’ glass. The calcium sodium cement series 
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contains the rest of the cement compositions and have all components the 
same (silica and phosphate) and only alter the various calcium and sodium 
contents through the series. 
6.4 Glass Structure 
6.4.1 Calcium/Sodium Series Glasses 
As the calcium content increases within this glass series the glass transition 
temperature (Tg) was shown to decrease. This would influence the free 
volume within the glass structure leading to an increase in free volume as the 
Tg decreases. One would then anticipate this to equate to an alteration of the 
dissolution behaviour of the glasses upon immersion in solution, With 
increasing free volume within the glass it would be expected to degrade 
faster and release Ca2+, Na+ and PO4
3- faster than a preceding glass in the 
series with a lower free volume.  
The 31P MAS NMR results show that like results seen previously (Brauer, 
2011) the phosphate element in the glass exists as orthophosphate, with 
calcium and sodium ions acting to charge balance these ions. 
6.4.2 Fluoride Containing Glass Series 
Similarly to the calcium/sodium glass series there is a change in Tg through 
the fluoride containing series; as fluoride is increased the Tg decreases. 
Similarly to the previous series this allows the prediction of the degradation 
behaviour and ion release of the glasses in question. With the increase in 
fluoride causing the decrease in Tg, the free volume increases in the 
compositions as fluoride concentration is increased. From this it would be 
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predicited that those glasses with increasing fluoride contents will derade 
faster, releasing their associated ions. 
  
150 
 
 
 
Chapter 7: Calcium/Sodium Glass Cement Series 
Results & Discussion  
7.1 Results 
7.1.1 X-ray Diffraction 
 
 
Figure 34 X-ray diffraction patterns of cement composition produced from glass 
QMNWKPaG03 after immersion in Tris buffer solution for (i) 1 hour, (ii) 1 day, (iii) 7 days 
and (iv) 28 days. ▲ – DCPD; ▼ – DCPA; ● – Octacalcium Phosphate. 
Figure 34 shows the XRD results for cements made from the reaction 
between Ca(H2PO4)2 and QMNWKPaG03 glass powder and immersed in 
Tris buffer for 1 hour, 1 day, 7 days and 28 days. The one hour pattern has 
no lines for the Ca(H2PO4)2 starting powder, demonstrating it is no longer 
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present, indicating full dissolution of the salt before one hour3. At one hour 
two phases identifiable on the XRD are DCPD (CaHPO4.2H2O) and DCPA 
(CaHPO4).  At one day the only phases present are DCPD and DCPA. At 7 
days DCPD and DCPA are still present but octacalcium phosphate 
(Ca8(HPO4)2(PO4)4.5H2O, OCP) has also formed. The diffraction peak at 4.7 
˚2 is indicative of OCP and is the primary difference between the diffraction 
patterns of apatite and OCP due to having pseudomorphic crystal structures. 
At 28 days the DCPD and DCPA are still present on the XRD pattern along 
with OCP, though the relative intensities of their respective diffraction lines 
have decreased relative to OCP. 
                                            
3
 For the starting salt Ca(H2PO4)2 is used to describe this as this was purchased from Sigma-
Aldrich. However the results from both X-ray diffraction and 
31
P MAS-NMR disagree with the 
phase present as either Ca(H2PO4)2 or Ca(H2PO4)2.H2O was identified. The term Ca(H2PO4)2 
was used though it should be noted that it could be either Ca(H2PO4)2 or Ca(H2PO4)2.H2O. 
Additionally the result written here for the dissolution of the starting salt was the same for all 
X-ray diffraction salts at one hour. 
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Figure 35 X-ray diffraction patterns of cement composition produced from glass 
QMNWKPaG13 after immersion in Tris buffer solution for (i) 1 hour, (ii) 1 day, (iii) 7 days 
and (iv) 28 days. ▲ – DCPD; ▼ – DCPA; ● – Octacalcium Phosphate. 
Figure 35 shows the XRD results for QMNWKPaG13 cements at 1 hour, 1 
day, 7 days and 28 days. DCPD is the only crystalline phase at one hour 
immersion. After one day the only crystalline phase present is still DCPD. 
OCP is formed after 7 days immersion indicated by the peak at 4.7 ˚2; 
DCPD is still present in the cement phase. After 28 days DCPD is no longer 
present and the crystalline phase is now totally OCP. 
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Figure 36 X-ray diffraction patterns of cement composition produced from glass QMNWKPaG14 
after immersion in Tris buffer solution for (i) 1 hour, (ii) 1 day, (iii) 7 days and (iv) 28 days. ▲ – 
DCPD; ▼ – DCPA; ● – Octacalcium Phosphate; □ indistinguishable OCP/Hydroxyapatite. 
Figure 36 shows the XRD results for QMNWKPaG14 cements at 1 hour, 1 
day, 7 days and 28 days. DCPD is present at one hour as is a phase 
identified as OCP due to the low intensity broad peak at 4.7 ˚2. At one day 
the OCP peak is slightly more intense potentially indicating an increase in the 
fraction of the OCP phase; DCPD is again present at this time point. After 
seven days the DCPD peaks are no longer present indicating it has reacted 
to OCP, which is also identified. At 28 days the 4.7 ˚2 diffraction line is 
absent, indicating the OCP phase is no longer present and that in the cement 
crystalline phase is apatitic. 
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Figure 37 X-ray diffraction patterns of cement composition produced from glass 
QMNWKPaG15 after immersion in Tris buffer solution for (i) 1 hour, (ii) 1 day, (iii) 7 days 
and (iv) 28 days. ▲ – DCPD; ▼ – DCPA; ● – Octacalcium Phosphate; □ indistinguishable 
OCP/Hydroxyapatite; ♦ Apatite. 
Figure 37 shows the XRD results for QMNWKPaG15 cements at 1 hour, 1 
day, 7 days and 28 days. At one hour DCPD phase is seen as is a phase 
identified as OCP due to the low intensity peak at 4.7 ˚2. At one day the 
major cement phase is OCP. After seven days the OCP is no longer present, 
indicated by absence of the the diffraction peak at 4.7 ˚2; the cement phase 
is apatite here. After 28 days in Tris buffer solution the cement phase is 
apatite. 
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Figure 38 X-ray diffraction patterns of cement composition produced from glass 
QMNWKPaG16 after immersion in Tris buffer solution for (i) 1 hour, (ii) 1 day, (iii) 7 days 
and (iv) 28 days. ● – Octacalcium Phosphate; □ indistinguishable OCP/Hydroxyapatite; ♦ 
Apatite. 
Figure 38 shows the XRD results for QMNWKPaG16 cements at 1 hour, 1 
day, 7 days and 28 days. At one hour the cement phase is OCP indicated by 
the peak at 4.7 ˚2. At one day this peak is less intense indicating that OCP 
is transforming to apatite; meaning the cement phase is most likely an OCP 
and apatite mixture. At both seven days and 28 days the crystalline phase 
within the cement is apatite. 
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7.1.2 31P Magic Angle Spinning Nuclear Magnetic Resonance 
 
Figure 39 
31
P MAS-NMR spectra of the starting glass powder and Tris immersed cement 
samples in the cement system produced from glass QMNWKPaG03. Showing (i) QMNWKPaG03 
initial glass powder; (ii) 1 hour; (iii) 1 day; (iv) 7 days; (v) 28 days. 
Figure 39 shows the 31P MAS-NMR results for QMNWKPaG03 glass and 
QMNWKPaG03 cements at 1 hour, 1 day, 7 days and 28 days. At 1 hour the 
dominant peak at 1.4 ppm indicates that DCPD is the primary phase. A small 
fraction of the signal at -1.4 and -0.2 ppm indicates that DCPA is also 
present, but in a small fraction. At 1 day both DCPD and DCPA are still the 
only phases in the sample. At 7 days chemical shifts at -0.2, 2.0, 3.2 and 3.6 
are present indicative of the formation of OCP as well as resonances 
indicating DCPD 1.4 ppm and DCPA -1.4 and -0.2 ppm. At 28 days peaks at 
-0.2, 2.0, 3.2 and 3.6 are present showing the formation of OCP. 
Resonances indicating DCPD and DCPA are not present, indicating 
conversion of these phases to OCP. 
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Figure 40 
31
P MAS-NMR spectra of the starting glass powder and Tris immersed cement 
samples in the cement system produced from glass QMNWKPaG13. Showing (i) QMNWKPaG13 
initial glass powder; (ii) 1 hour; (iii) 1 day; (iv) 7 days; (v) 28 days. 
Figure 40 shows the 31P MAS-NMR results for QMNWKPaG13 glass and 
QMNWKPaG13 cements at 1 hour, 1 day, 7 days and 28 days. At 1 hour 
DCPD is the primary phase present at 1.4 ppm, DCPA is also present -1.4 
and -0.2 ppm but in a small fraction. At 1 day both DCPD and DCPA are still 
present. At 7 days chemical shift at -0.2, 2.0, 3.2 and 3.6 are present 
indicative of the formation of OCP as well as peaks indicating DCPD 1.4 ppm 
and DCPA -1.4 ppm. At 28 days peaks at -0.2, 2.0, 3.2 and 3.6 are present 
showing the formation of OCP. Peaks indicating DCPD and DCPA are not 
present, indicating conversion of these phases to OCP. 
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Figure 41 
31
P MAS-NMR spectra of the starting glass powder and Tris immersed cement 
samples in the cement system produced from glass QMNWKPaG14. Showing (i) QMNWKPaG14 
initial glass powder; (ii) 1 hour; (iii) 1 day; (iv) 7 days; (v) 28 days. 
Figure 41 shows the 31P MAS-NMR results for QMNWKPaG14 glass and 
QMNWKPaG14 cements at 1 hour, 1 day, 7 days and 28 days. At 1 hour 
there is a sharp resonance at 1.4 ppm that shows the presence of DCPD; 
there is a clear resonance at 3.6 ppm and low intensity chemical shift at 3.2 
ppm which suggests the presence of OCP but this is not certain as the four 
OCP peaks, at -0.2, 2.0, 3.2 and 3.6 ppm (Tseng et al., 2004), cannot each 
easily be distinguished. Also at 1 hour is a shoulder on the left of the broad 
peaks at -1.4 and -0.2 ppm which suggests the formation of DCPA, 
consistent with other cement compositions. After 1 day there are four 
chemical shift at -1.4, -0.2, 1.4 and 3.3 ppm. After 7 days there are chemical 
shift of OCP at 3.6, 3.2, 2.0, and -0.2 and also a chemical shift at 1.4 of 
DCPD along with resonances at -1.4 and -0.2 for DCPA. Finally after 28 days 
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immersion the cement sample there are two chemical shift at 2.9 and -0.2 
ppm. 
 
Figure 42 
31
P MAS-NMR spectra of the starting glass powder and Tris immersed cement 
samples in the cement system produced from glass QMNWKPaG15. Showing (i) QMNWKPaG15 
initial glass powder; (ii) 1 hour; (iii) 1 day; (iv) 7 days; (v) 28 days. 
Figure 42 shows the 31P MAS-NMR results for QMNWKPaG15 glass and 
QMNWKPaG15 cements at 1 hour, 1 day, 7 days and 28 days. The 1 hour 
sample has chemical shift at -1.4, -0.2, 2.0 and 3.6 assigned to DCPA (-1.4 
and -0.2 ppm), DCPD (2.0 ppm) and apatite (3.6 ppm). The 1 day sample 
has chemical shift at -0.2, 1.9, and 3.4 ppm of OCP. The 7 and 28 day 
samples have one resonance at 2.9 ppm assigned to apatite. 
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Figure 43 
31
P MAS-NMR spectra of the starting glass powder and Tris immersed cement 
samples in the cement system produced from glass QMNWKPaG16. Showing (i) QMNWKPaG16 
initial glass powder; (ii) 1 hour; (iii) 1 day; (iv) 7 days; (v) 28 days. 
Figure 43 shows the 31P MAS-NMR results for QMNWKPaG16 glass and 
QMNWKPaG16 cements at 1 hour, 1 day, 7 days and 28 days. The 1 hour 
sample has one chemical shift at 4.0 ppm assigned to apatite based on X-ray 
diffraction results. Similarly the 1 day sample only has one chemical shift at 
3.2 ppm assigned to apatite. The 7 and 28 day samples each have one 
chemical shift at 3.0 ppm assigned, as the 1 day sample, to apatite. 
7.1.3 Fourier Transform Infrared Spectroscopy 
The following FTIR spectra show the FTIR results of all cement compositions 
studied. The full spectrum of each sample has been separated so that the 
scan regions from 500-2000 cm-1 for each immersion time are together and 
the scan regions from 2500-4000 cm-1 are together. This was done to make 
viewing the bands on each spectrum easier. The assignments for each 
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phase were done using the references identified in the literature review for 
DCPD (Elliott, 1994), octacalcium phosphate (Fowler et al., 1993) and 
hydroxyapatite (Elliott, 1994). 
 
Figure 44 Fourier transform infrared spectra of cement composition QMNWKPaG03 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 500 to 2000 wavenumber cm
-1
. 
 
 
Figure 45 Fourier transform infrared spectra of cement composition QMNWKPaG03 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 2500 to 4000 wavenumber cm
-1
. 
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Table 14 FTIR bands and their respective assignments of cement samples produced from glass 
QMNWKPaG03 after immersion in Tris buffer solution for 1 hour, 1 day, 7 days and 28 days. 
Wavenumber 
(cm
-1
) 
Assignment 1 Hour 1 Day  7 Day  28 Day 
519 HPO4 Bending - - √ √ 
521 PO Bending √ √ - - 
558 PO4 Bending - - √ √ 
574 PO Bending √ √ √ √ 
598 PO4 Bending - - √ √ 
617 PO4 Bending - - √ √ 
649 PO Bending √ √ - - 
778 H2O Liberation √ √ - - 
868 P-O(H) Stretching √ √ - - 
905 HPO4(6) [P-(OH)] 
Stretching 
- - √ √ 
956 PO4 Stretching - - √ √ 
982 P-O Stretching √ √ - - 
997 P-O(H) Stretching √ √ - - 
1048 PO Stretching √ √ - - 
1123  √ √ - - 
1181 HPO4 Stretching - - √ √ 
1207 O-H In-plane 
Bending 
√ √ - - 
1645 H2O Bending √ √ √ √ 
1713 Overtone of 868 
band - 2 x 868 = 
1736 
√ √ - - 
3146 OH Stretching of 
Water 
√ √ - - 
3276 OH Stretching of 
Water 
√ √ - - 
3477 OH Stretching of 
Water 
√ √ - - 
3533 OH Stretching of 
Water 
√ - - - 
 
Figures 44 and 45 show the FTIR spectra of cement composition 
QMNWKPaG03 at 1 hour, 1 day, 7 days and 28 days. At 1 hour and 1 day 
there are PO bending and stretching bands at 558, 573, 599, 650, and 1050 
cm-1. For these two spectra there are also identical bands at 868 and 997 
cm-1 of P-O(H) Stretching groups. Finally these two spectra have bands 
denoting the presence of structural water molecules at 1207, 1645, 3146, 
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3276, 3477 and 3533 cm-1. At 7 days and 28 days the spectra are virtually 
identical and much reduced compared to the two previous time points. There 
are PO bending and stretching groups at 558, 587, 598, 617 and 956 cm-1. 
Additionally there are HPO4 bending and stretching groups at 518, 848, 910 
and 1181 cm-1 respectively as well as a H2O bending band at 1630 cm
-1. 
 
 
Figure 46 Fourier transform infrared spectra of cement composition QMNWKPaG13 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 500 to 2000 wavenumber cm
-1
. 
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Figure 47 Fourier transform infrared spectra of cement composition QMNWKPaG13 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 2500 to 4000 wavenumber cm
-1
. 
Table 15 FTIR bands and their respective assignments of cement samples produced from glass 
QMNWKPaG13 after immersion in Tris buffer solution for 1 hour, 1 day, 7 days and 28 days. 
Wavenumber (cm
-1
) Assignment 1 Hour 1 Day  7 Day  28 Day 
522 PO Bending √ √ √ - 
558 PO Bending - - √ √ 
574 PO Bending √ √ - - 
598 PO Bending - - √ √ 
615 PO Bending - - √ √ 
648 PO Bending √ √ - - 
781 H2O Liberation √ √ - √ 
851 HPO4 Stretching - - - √ 
868 P-O(H) Stretching √ √ - - 
905 HPO4(6) [P-(OH)] 
Stretching 
- - √ √ 
956 PO Stretch - - √ - 
983 P-O(H) Stretching √ √ - - 
994 Unassigned - √ - - 
1053 PO Stretching √ - - - 
1124 Unassigned √ - - - 
1175 HPO4 Stretch - - √ √ 
1205 O-H In-plane Bending √ √ - - 
1283 HPO4 (OH in-plane 
bending) 
- - - √ 
1630 H2O Bending - - √ √ 
1644 H2O Bending √ √ - - 
1714 Overtone of 868 band 
- 2 x 868 = 1736 
√ √ - - 
165 
 
 
3150 OH Stretching of 
Water 
√ √ - - 
3274 OH Stretching of 
Water 
√ √ - - 
3479 OH Stretching of 
Water 
√ √ - - 
3531 OH Stretching of 
Water 
√ √ - - 
 
Figures 46 and 47 show the FTIR spectra of cement composition 
QMNWKPaG13 at 1 hour, 1 day, 7 days and 28 days. The 1 hour and 1 day 
spectra have very similar bands present, with PO bending and stretching 
bands at 520, 574, 648 and 1053 cm-1. These two spectrum also have a P-
O(H) stretching band at 868 cm-1. In addition to this there are bands from 
water molecules at 780, 1205, 1644, 3150, 3274, 3479 and 3531 cm-1. The 7 
day and 28 day samples also share similar spectra, with PO bending and 
stretching bands at 518 (7 day only), 558, 598, 615 and 956 (7 day only) cm-
1. There are also bands donating HPO4 groups in the samples at 850 (28 day 
only) 905, 1175 and 1283 (28 day only) cm-1. Lastly each spectra has a band 
at 1630 cm-1 from bending in water molecules. 
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Figure 48 Fourier transform infrared spectra of cement composition QMNWKPaG14 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 500 to 2000 wavenumber cm
-1
. 
 
Figure 49 Fourier transform infrared spectra of cement composition QMNWKPaG14 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 2500 to 4000 wavenumber cm
-1
. 
Table 16 FTIR bands and their respective assignments of cement samples produced from glass 
QMNWKPaG14 after immersion in Tris buffer solution for 1 hour, 1 day, 7 days and 28 days. 
Wavenumber 
(cm
-1
) 
Assignment 1 Hour 1 Day  7 Day  28 Day 
523 PO Bending √ √ - - 
553 PO Bending √ √ √ √ 
564 PO Bending √ - - - 
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588 PO Bending √ - - - 
595 PO Bending - √ √ √ 
780 H2O Liberation √ √ √ √ 
851 P-O(H) Stretching - - √ √ 
864 P-O(H) Stretching √ √ - - 
900 HPO4(6) [P-(OH)] 
Stretching 
- - √ - 
953 PO Stretch - √ √ √ 
982 PO Stretch √ - - - 
1203 HPO4(5) [P-(OH)] 
Stretching 
- - - √ 
1211 O-H In-plane Bending √ √ - - 
1464 Carbonate - √ √ √ 
1627 H2O Bending - - √ √ 
1644 H2O Bending √ √ - - 
2844 HPO4 (OH Stretch) √ √ √ √ 
2911 HPO4 (OH Stretch) √ √ √ √ 
2943 HPO4 (OH Stretch) √ - √ √ 
3148 OH Stretching of Water √ √ - - 
3477 OH Stretching of Water √ √ - - 
3530 OH Stretching of Water √ √ - - 
3556 H-bonded H2O - - - √ 
 
Figures 48 and 49 show the FTIR spectra of cement composition 
QMNWKPaG14 at 1 hour, 1 day, 7 days and 28 days. The 1 hour and 1 day 
spectra have very similar bands present. There are PO bending and 
stretching bands at 523, 553, 564, 588 and 982 cm-1. In addition to this there 
are stretching bands from HPO4 groups at 864, 2844, 2911 and 2943 cm
-1. 
Lastly both spectra contain bands donating the presence of structural water 
molecules with bands at 780, 1211, 3148, 3477, and 3530 cm-1. The 
difference between these two spectra is the presence of an additional band 
at 1464 cm-1 on the 1 day spectra which was assigned to being carbonate 
substitution within an apatite structure. Like the 1 hour and 1 day spectra 
there are also similarities between the 7 day and 28 days samples. There are 
PO bending and stretching bands at 557, 597 and 955 cm-1. This is in 
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addition to stretching bands from HPO4 groups at 851, 900, 2847, 2915 and 
2943 cm-1. Similarly to the 1 day sample there are bands at 1464 cm-1 of 
carbonate groups within the apatite structure. Lastly the 28 day sample has a 
H-bonded H2O group at 3556 cm
-1, which indicates the presence of the 
hydroxy group within the hydroxyapatite structure. 
  
 
Figure 50 Fourier transform infrared spectra of cement composition QMNWKPaG15 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 500 to 2000 wavenumber cm
-1
. 
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Figure 51 Fourier transform infrared spectra of cement composition QMNWKPaG15 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 2500 to 4000 wavenumber cm
-1
. 
Table 17 FTIR bands and their respective assignments of cement samples produced from glass 
QMNWKPaG15 after immersion in Tris buffer solution for 1 hour, 1 day, 7 days and 28 days. 
Wavenumber 
(cm
-1
) 
Assignment 1 Hour 1 Day  7 Day  28 Day 
555 PO Bending √ √ √ √ 
594 PO Bending √ √ √ √ 
781 H2O Liberation √ √ √ √ 
849 P-O(H) 
Stretching 
- - √ √ 
863 P-O(H) 
Stretching 
√ - - - 
950 PO Stretch √ √ √ √ 
1627 H2O Bending - √ √ √ 
1638 H2O Bending √ - - - 
3552 H-bonded H2O - - √ √ 
 
Figures 50 and 51 show the FTIR spectra of cement composition 
QMNWKPaG15 at 1 hour, 1 day, 7 days and 28 days. There are relatively 
few bands present on these spectra compared to the previous samples. All 
samples contain PO bending and stretching bands at 555, 594 and 950 cm-
1. There are also P-O(H) Stretching bands at 863 cm-1 on all spectra, except 
the 1 day sample. All spectra also have bands from structural water 
170 
 
 
molecules at 781 and 1638 cm-1. The 7 day and 28 day samples have a H-
bonded H2O band at 3552, which like the QMNWKPaG14 sample is from the 
hydroxyl groups within the hydroxyapatite structure. 
 
Figure 52 Fourier transform infrared spectra of cement composition QMNWKPaG16 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 500 to 2000 wavenumber cm
-1
. 
 
Figure 53 Fourier transform infrared spectra of cement composition QMNWKPaG16 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 2500 to 4000 wavenumber cm
-1
. 
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Table 18 FTIR bands and their respective assignments of cement samples produced from glass 
QMNWKPaG16 after immersion in Tris buffer solution for 1 hour, 1 day, 7 days and 28 days. 
Wavenumber 
(cm
-1
) 
Assignment 1 Hour 1 Day  7 Day  28 Day 
554 PO Bending √ √ √ √ 
595 PO Bending √ √ √ √ 
780 H2O Liberation √ √ √ √ 
944 PO Stretch √ √ √ √ 
1634 H2O Bending - - - √ 
3554 H-bonded H2O - - √ √ 
 
Figures 52 and 53 show the FTIR spectra of cement composition 
QMNWKPaG16 at 1 hour, 1 day, 7 days and 28 days. The bands present are 
almost identical in all spectra. There are PO stretching and bending bands at 
554, 595 and 944 cm-1. There are water molecule bands at 780 and 1634 
cm-1. The 28 day spectrum also has a H-bonded H2O bands at 3552 cm
-1. 
7.1.4 Scanning Electron Microscopy 
 
Figure 54 Scanning electron micrographs of QMNWKPaG03 cements at 1 hour (top left), 1 day 
(top right), 7 days (bottom left) and 28 days (bottom right). 
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Figure 54 shows the scanning electron micrographs of QMNWKPaG03 
cements at 1 hour (top left), 1 day (top right), 7 days (bottom left) and 28 
days (bottom right). At 1 hour and 1 day the crystals are small plates that 
correspond to the morphology of DCPD seen in the literature (Kumar et al., 
1999). After 7 days the morphology of the cement is dramatically different 
with thin ribbon shaped crystals consistent with the morphology of OCP seen 
elsewhere (Legeros, 1985). The morphology is ribbon like after 28 days 
again suggesting the persistent presence of OCP (Lai et al., 2010). 
 
Figure 55 Scanning electron micrographs of QMNWKPaG13 cements at 1 hour (top left), 1 day 
(top right), 7 days (bottom left) and 28 days (bottom right). 
Figure 55 shows the SEM images for QMNWKPaG13 cements at 1 hour, 1 
day, 7 days and 28 days. There are two very distinct crystal morphologies 
existing within this cement. The 1 hour and 1 day samples have plate shaped 
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crystals, which are indicative of DCPD. The 7 day and 28 day samples seem 
to have similar microstructures, with distinctive very thin crystals. 
 
Figure 56 Scanning electron micrographs of QMNWKPaG14 cements at 1 hour (top left), 1 day 
(top right), 7 days (bottom left) and 28 days (bottom right). 
Figure 56 shows the SEM images for QMNWKPaG14 cements at 1 hour, 1 
day, 7 days and 28 days. The microstructure in all cements seem to be 
composed of very similar small plate/ribbon shaped crystals. 
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Figure 57 Scanning electron micrographs of QMNWKPaG15 cements at 1 hour (top left), 1 day 
(top right), 7 days (bottom left) and 28 days (bottom right). 
Figure 57 shows the SEM images for QMNWKPaG15 cements at 1 hour, 1 
day, 7 days and 28 days. All four time points appear to have similarly shaped 
crystals, as all are typically very thin. The 1 hour, 7 day and 28 day samples 
seem to have irregular shaped petal like crystals, whereas the 7 day sample 
has more ordered ribbon crystals with a few petal shaped crystals 
interspersed. 
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Figure 58 Scanning electron micrographs of QMNWKPaG16 cements at 1 hour (top left), 1 day 
(top right), 7 days (bottom left) and 28 days (bottom right). 
Figure 58 shows the SEM images for QMNWKPaG16 cements at 1 hour, 1 
day, 7 days and 28 days. All crystal morphologies at each time point are very 
similar small thin plate shaped crystals. In the 28 day immersed cement 
there is a residual glass particle with a reacted core. 
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7.1.5 Compressive Strength 
 
Figure 59 Compressive strength against time of calcium-sodium series cement compositions. 
plotted in oreder of sodium increase. 
Glass 
Composition 
Compressive Strength (MPa) 
1 Hour 1 Day 7 Days 28 Days 
QMNWKPaG03 n/a n/a n/a n/a 
QMNWKPaG04 9.65 (±0.55) 
12.90 
(±1.16) 
10.30 (±1.33) 5.67 (±0.94) 
QMNWKPaG13 0.47 (±0.09) 0.19 (±0.04) 1.40 (±0.53) 2.44 (±0.40) 
QMNWKPaG14 2.94 (±0.42) 4.58 (±0.33) 5.14 (±0.49) 2.86 (±0.67) 
QMNWKPaG15 6.29 (±0.38) 9.94 (±0.81) 4.67 (±0.18) 3.02 (±0.45) 
QMNWKPaG16 6.72 (±1.00) 3.68 (±0.18) 2.43 (±0.48) 1.63 (±0.21) 
 
The fluorine free samples the QMNWKPaG13 cement samples were unable 
to give a measurement for compressive strength due to cracking of the 
cement cylinders during immersion. Compressive strength of the samples 
ranged from 0.19 to 12.90 MPa. 
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7.1.6 Setting Time 
 
Figure 60 Setting times of Calcium/Sodium cement series of sodium content plotted against 
time 
Table 19 Setting times as measured using Gilmore needle test of cement compositions, 
showing both initial and final setting times in minutes. 
Cement 
Composition 
Initial Setting 
Time (min) 
Final Setting 
Time (min) 
QMNWKPaG03 35.5 89.0 
QMNWKPaG13 37.0 92.0 
QMNWKPaG14 35.0 62.5 
QMNWKPaG15 21.5 32.5 
QMNWKPaG16 8.0 16.5 
 
The glass series produced where the calcium to sodium ratio was altered in 
the base glass showed a clear trend in the setting time with a change in the 
glass composition. Both the initial and final setting times decreased as the 
sodium content in the glass powder was increased. In the lowest sodium 
glasses (QMNWKPaG03 & 13) the initial setting times are 35.5 and 37 
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minutes and the final setting times are 89 and 92 minutes respectively. The 
QMNWKPaG14 composition has a similar initial setting time as the two 
glasses with lower sodium contents of 35 minutes, but has a decreased final 
setting time of 62.5 minutes. As the sodium is increased in the last two 
compositions (QMNWKPaG15 & 16) both the initial and final setting times 
decreased. 
7.1.7 Ion Release 
 
Figure 61 Calcium release (millimole per litre, mmol/L) from immersed cement cylinders (n=4) 
plotted against square root of immersion time (hours) for all calcium/sodium cement 
compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Error Bars = Standard 
Deviation). 
Table 20 Calcium release (millimole per litre, mmol/L) from immersed cement cylinders (n=4) for 
all cement compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Standard 
Deviation). 
Cement 
Composition 
Calcium Release (mmol/L) 
1 Hour 1 Day 7 Days 28 Days 
QMNWKPaG03 0.22 (±0.00) 0.15 (±0.00) 0.18 (±0.00) 0.11 (±0.00) 
QMNWKPaG13 0.23 (±0.03) 0.04 (±0.00) 0.19 (±0.01) 0.17 (±0.01) 
QMNWKPaG14 0.13 (±0.00) 0.10 (±0.00) 0.10 (±0.00) 0.06 (±0.00) 
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QMNWKPaG15 0.02 (±0.00) 0.07 (±0.01) 0.06 (±0.00) 0.04 (±0.00) 
QMNWKPaG16 0.05 (±0.00) 0.08 (±0.00) 0.05 (±0.00) 0.04 (±0.00) 
 
The calcium release shows very similar levels of calcium release from the 
cement for most of the different cement compositions. At 1 hour the majority 
of the compositions have between 0.02 and 0.23 mmol/L calcium release. At 
1 day the majority of calcium release for the cement compositions is between 
0.04 and 0.15 mmol/L. At 7 days the majority of the calcium release is 
between 0.05 and 0.19 mmol/L. After 28 days calcium release is relatively 
low, ranging between 0.02 and 0.06 mmol/L for all compositions except 
compositions QNMWKPaG03 and 13 which have releases of 0.11 and 0.17 
mmol/L. 
 
Figure 62 Phosphorus release (millimole per litre, mmol/L) from immersed cement cylinders 
(n=4) plotted against square root of immersion time (hours) for all calcium/sodium cement 
compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Error Bars = Standard 
Deviation). 
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Table 21 Phosphorus release (millimole per litre, mmol/L) from immersed cement cylinders 
(n=4) for all cement compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Standard 
Deviation). 
Cement 
Composition 
Phosphorus Release (mmol/L) 
1 Hour 1 Day 7 Days 28 Days 
QMNWKPaG03 4.35 (±0.02) 5.48 (±0.03) 15.94 (±0.11) 17.69 (±0.05) 
QMNWKPaG13 3.55 (±0.04) 11.50 (±0.01) 12.73 (±0.04) 17.75 (±0.06) 
QMNWKPaG14 3.54 (±0.02) 6.21 (±0.03) 12.51 (±0.12) 16.21 (±0.14) 
QMNWKPaG15 2.61 (±0.11) 8.06 (±0.04) 10.63 (±0.03) 12.65 (±0.06) 
QMNWKPaG16 2.25 (±0.03) 8.82 (±0.05) 10.46 (±0.11) 11.64 (±0.05) 
 
At 1 hour the phosphorus release is between 2.25 and 4.35 mmol/L for all 
cement compositions. After 1 day the amount of phosphorus in solution for 
all compositions has risen to between 5.48 and 11.50 mmol/L. After 7 days 
the phosphorus in solution has increased a smaller amount to be between 
10.46 and 15.94 mmol/L for all cement compositions. At 28 days there is a 
fairly high distribution of the various phosphorus release rates. The release 
distribution is high with all compositions being between 11.64 and 17.69 
mmol/L. 
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Figure 63 Silicon release (millimole per litre, mmol/L) from immersed cement cylinders (n=4) 
plotted against square root of immersion time (hours) for all calcium/sodium cement 
compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Error Bars = Standard 
Deviation). 
Table 22 Silicon release (millimole per litre, mmol/L) from immersed cement cylinders (n=4) for 
all cement compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Standard 
Deviation). 
Cement 
Composition 
Silicon Release (mmol/L) 
1 Hour 1 Day 7 Days 28 Days 
QMNWKPaG03 0.10 (±0.00) 0.28 (±0.00) 0.81 (±0.00) 0.88 (±0.00) 
QMNWKPaG13 0.19 (±0.00) 0.51 (±0.00) 0.76 (±0.00) 0.89 (±0.00) 
QMNWKPaG14 0.05 (±0.00) 0.14 (±0.00) 0.39 (±0.00) 0.92 (±0.03) 
QMNWKPaG15 0.02 (±0.00) 0.13 (±0.00) 0.40 (±0.00) 1.01 (±0.12) 
QMNWKPaG16 0.00 (±0.00) 0.24 (±0.00) 0.58 (±0.00) 1.00 (±0.00) 
 
The silicon release shows a constant increase in silicon release for all 
cement compositions that shows no noticeable differences for the different 
series. At 1 hour there is the lowest silicon release of between 0.00 and 0.19 
mmol/L, which increases to between 0.13 and 0.51 mmol/L after 1 day. Then 
at 7 days the amount in solution is further increased to between 0.39 and 
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0.81 mmol/L. There is again another increase in silicon release after 28 days 
to between 0.88 and 1.01 mmol/L. 
 
Figure 64 Sodium release (millimole per litre, mmol/L) from immersed cement cylinders (n=4) 
plotted against square root of immersion time (hours) for all calcium/sodium cement 
compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Error Bars = Standard 
Deviation). 
Table 23 Sodium release (millimole per litre, mmol/L) from immersed cement cylinders (n=4) for 
all cement compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Standard 
Deviation). 
Cement 
Composition 
Sodium Release (mmol/L) 
1 Hour 1 Day 7 Days 28 Days 
QMNWKPaG03 3.35 (±0.00) 3.92 (±0.02) 4.31 (±0.00) 3.10 (±0.03) 
QMNWKPaG13 4.73 (±0.01) 2.97 (±0.03) 3.88 (±0.03) 3.49 (±0.00) 
QMNWKPaG14 4.12 (±0.03) 6.92 (±0.04) 5.83 (±0.02) 7.68 (±0.05) 
QMNWKPaG15 3.33 (±0.01) 9.74 (±0.02) 12.74 (±0.06) 14.02 (±0.10) 
QMNWKPaG16 3.18 (±0.02) 14.42 (±0.06) 18.95 (±0.08) 21.23 (±0.11) 
 
Cement compositions QMNWKPaG03 and 13 have very similar levels of 
sodium release at all time points studied, with release levels between 2.97 
and 4.73 mmol/L. compositions QMNWKPaG14-16 show higher levels of 
sodium release after 1 hour compared to the other cement compositions. At 
1 day the release of sodium from cements QMNWKPaG14-16 was 6.92, 
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9.74 and 14.42 mmol/L respectively. After 7 days the QMNWKPaG14 
composition has decreased slightly to 5.83 mmol/L whilst the 
QMNWKPaG15 and 16 compositions have increased to 12.74 and 18.95 
mmol/L. then at 28 days all three compositions have increased to 7.68, 14.02 
and 21.23 mmol/L respectively. 
7.2 Discussion 
7.2.1 Cement Phase Analysis 
QMNWKPaG03 and QMNWKPaG13 
Due to the high similarity of both the QMNKWPaG03 and QMNWKPaG13 
glass compositions and their analytical results, the following discussion 
refers to both glass compositions. 
1 hour 
The 31P MAS-NMR showed the cement phases as being predominantly 
DCPD with an intense chemical shift a 1.4 ppm. The peak at -1.4 ppm 
indicated the presence of DCPA within each cement phase; this was 
probably from the Ca(H2PO4)2 starting powder, which was confirmed to 
contain DCPA as an impurity, rather than the DCPA being formed in the 
cement setting reaction. The X-ray diffraction confirmed this finding, with the 
majority of the diffraction lines matching that of DCPD and three relatively 
low intensity diffraction lines matching DCPA. The FTIR is strongly indicative 
of the presence of DCPD with a PO bending peak, OH stretching in water 
peaks (3146, 3276, 3477 and 3533 cm-1), and PO stretching peaks (865, 997 
and 1123 cm-1) being especially indicative. DCPA cannot be easily 
distinguished on the FTIR spectra given its low fraction of the cement. 
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1 day 
The spectroscopy for the 1 day cement very much matches that of the 1 hour 
sample. The 31P MAS-NMR shows the intense DCPD chemical shift at 1.4 
ppm and a smaller less intense chemical shift of DCPA at -1.4 ppm. There 
were small chemical shifts at 0 ppm which has not been assigned to a 
specific phase. The X-ray diffraction pattern is similar to the 1 hour pattern 
with three DCPA diffraction lines of low intensity compared to the more 
numerous DCPD lines. The FTIR follows a similar trend to the XRD and 
NMR with the spectra similar to that of the 1 hour samples. There are 
distinguishing DCPD peaks at 520 (PO bending), 995 (P-O(H) stretching) 
and 3141, 3477 & 3531 cm-1 (all OH stretching in water). 
7 day 
There is a dramatic change in the cement phases between the 1 day and 7 
day samples. The 31P MAS-NMR spectra show four clear chemical shift at 
3.6, 3.2, 1.8, -0.2 ppm, which account for the six phosphorus atoms within 
the OCP structure; the 1.8 ppm OCP chemical shift has a shoulder at 1.4 
ppm which was assigned to DCPD. Additionally there is a small chemical 
shift at -1.4 ppm which is remaining DCPA in the sample. The NMR 
interpretation is matched on the X-ray diffraction pattern. OCP and apatite 
share very similar diffraction patterns due to their pseudomorphic crystal 
structure; the only three additional diffraction peaks (4.6, 9.4 and 9.7 ˚2) 
exist on the OCP diffraction pattern which do not exist on the apatite 
diffraction pattern. The 7 day XRD pattern has these three diffraction peaks 
indicative of OCP, showing the presence of OCP. The XRD gives 
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confirmation of the presence of both DCPD and DCPA. On the FTIR spectra 
the OH stretching in water peaks typical of DCPD are not discernible; 
indicating at least that the DCPD has become a much lower fraction of the 
cement phase compared to 1 day. 
28 day 
At 28 days the 31P MAS-NMR clearly shows the four chemical shifts at 3.6, 
3.2, 1.8, -0.2 ppm, indicative of OCP. There is also a very small shoulder at -
1.4 ppm which indicates a very small fraction of DCPA present. The X-ray 
diffraction shows the presence of OCP with indicative diffraction lines at 4.6, 
9.4 and 9.7 ˚2. There are also low intensity peaks of both DCPD and DCPA. 
DCPD was not detected on the 31P MAS-NMR whereas the DCPA was; the 
reason for this is due to its low fraction it would have a low intensity and it 
would be under the 1.8 ppm chemical shift of OCP and would not be seen as 
a shoulder due to surrounding OCP chemical shift of OCP. The FTIR 
matches that of the 7 day sample; there are clearly indicative peaks of OCP 
primarily HPO4 bending and stretching peaks. Again there are no clear OH 
water stretching bands which would clearly indicate DCPD.  
QMNWKPaG14 
1 hour 
At 1 hour there was an intense shift at 1.4 ppm showing the presence of 
DCPD. This is consistent with both the FTIR and XRD results where there 
are typical diffraction lines for DCPD at 21 ˚2 and FTIR bands at 523, 3150, 
3475, 3530 cm-1 typical of DCPD. The XRD and NMR results also clearly 
show that octacalcium phosphate is present but in a smaller fraction 
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compared to the DCPD by the relative intensities shown. DCPA is also 
present in this sample; evident on the MAS-NMR spectrum as a shoulder at -
1.4 ppm and on the XRD by a number of indicative diffraction lines. 
1 day 
The 1 day sample shows that whilst the same phases are present as in the 1 
hour samples the relative amounts of each has changed. The MAS-NMR 
spectrum shows an increase in the relative amount of octacalcium phosphate 
present which would be caused by dissolution of the DCPD phase and 
precipitation of the octacalcium phosphate phase from the ions which 
originally made up the DCPD. DCPA is still present in the cement sample at 
1 day. However it is difficult to distinguish whether there has been a change 
in its amount within the cement sample because it exists as a non-resolved 
shoulder on the NMR spectrum.  
7 days 
The 7 day cement sample has OCP, apatite and DCPA present. The X-ray 
diffraction pattern shows that DCPD in no longer present in the cement 
phase as the typical diffraction lines are not present. Octacalcium phosphate 
is distinguished on both the XRD and NMR with diffraction lines at 4.7, 9.3 
and 9.8 ˚2 and chemical shift at 3.6, 3.2, 2.0 and -0.2 ppm. Apatite is 
deemed as being evident from the NMR results as there is a chemical shift at 
2.9 ppm present. It is difficult to distinguish if apatite is present just from the 
XRD as the diffraction patterns of octacalcium phosphate and apatite are 
hard to distinguish between. The FTIR also indicates the presence of apatite 
187 
 
 
formation from bands at 1465 cm-1 which shows the presence of carbonate 
substitution in apatite. 
28 days 
The NMR of the 28 day sample has an intense chemical shift of apatite at 2.9 
ppm, there is also a shoulder present to the right of this resonance at 
approximately 0 ppm which is difficult to assign. The X-ray diffraction has 
diffraction lines only for apatite and no other crystalline phase is present in 
detectable amounts. The FTIR has bands of HPO4 groups at 2845, 2915 and 
2945 cm-1 usually found in octacalcium phosphate. This then most likely 
indicates that octacalcium phosphate is present but in quantities where the 
indicative 4.7 ˚2 line is not detectable. Again carbonate substitution in the 
apatite is detected on the FTIR. Also present on the FTIR is a band at 3555 
cm-1 that is of the OH group within the apatite structure. Concluding then the 
apatite formed after 28 day immersion of this cement composition is a 
carbonate-substituted hydroxyapatite. 
QMNWKPaG15 
1 hour 
At one hour the X-ray diffraction showed the presence of octacalcium 
phosphate, with a diffraction line at 4.7 degrees 2 theta. The 31P MAS-NMR 
results agreed with this finding as there were chemical shift at 3.6, 2.0 and -
0.2 ppm. There is also DCPA present which was shown on both the X-ray 
diffraction and 31P MAS-NMR. It is difficult to distinguish whether 
hydroxyapatite is present also; the X-ray diffraction presents a fairly low 
intensity diffraction line at 4.7 degrees 2 theta which in the reference pattern 
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for octacalcium phosphate is typically the most intense line. This result 
coupled with the more intense lines around 32 degrees 2 theta suggest the 
sample may be a mixture of both octacalcium phosphate and an apatite 
species. A typical 2.8 ppm chemical shift for apatite could not be clearly 
identified on the 31P MAS-NMR but due to the high intensity of the 3.6 ppm 
chemical shift it may just be a low intensity resonance which is masked by 
more intense chemical shift. The FTIR does not have many bands, but does 
have two at 555 and 594 cm-1 which are crystalline calcium phosphate and 
could be either apatite or octacalcium phosphate. There is also a band at 
863 cm-1 which was assigned to being a P-O(H) stretching bond on 
octacalcium phosphate.  
1 day 
The one day sample showed the continued presence of octacalcium 
phosphate, identifiable from the X-ray diffraction. The 31P MAS-NMR 
spectrum has an intense chemical shift at 3.4 ppm and a small shoulder at -
0.2 ppm. Similarly to the 1 hour sample it is difficult to easily conclude 
whether hydroxyapatite is also present. The typical 31P MAS-NMR chemical 
shift for octacalcium phosphate were not easily identifiable as there are only 
two chemical shift and without the X-ray diffraction it would be difficult to 
reliably conclude the presence of octacalcium phosphate. Another point to 
notice is the disappearance of DCPA from the 31P MAS-NMR but it was 
noticeable on the X-ray diffraction. This may be due to different cement 
samples being analysed, and this was a variation between the two. 
7 days 
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The 31P MAS-NMR and X-ray diffraction both show the presence of apatite. 
A chemical shift at 2.9 ppm on the NMR spectrum and typical apatite 
diffraction lines on the X-ray diffraction. The DCPA is not identifiable on 
either the NMR or X-ray diffraction. 
28 days 
Between the 7 day sample and the 28 day sample there is little change in the 
cement phase. The 31P MAS-NMR spectrum has one chemical shift at 2.9 
ppm of apatite and the X-ray diffraction. 
QMNWKPaG16 
1 hour 
The 1 hour sample is difficult to interpret. The X-ray diffraction pattern shows 
a mixture of octacalcium phosphate and apatite, this was interpreted from the 
low intensity 4.7 degree 2 theta diffraction line for octacalcium phosphate 
relative to the more intense hydroxyapatite/octacalcium phosphate diffraction 
lines. The 31P MAS-NMR is more difficult to interpret; there is one intense 
chemical shift at 4.0 ppm. Apatite normally gives a diffraction line at 2.9 ppm, 
it is also known that sodium will shift phosphorus signals to higher chemical 
shift so it may be the case that a sodium substituted apatite has formed as 
this glass has the highest sodium content of all the glasses used to make the 
cements. 
1 day 
The 1 day sample shows a predominantly apatite cement phase with a small 
diffraction line at 4.7 degree 2 theta on the X-ray diffraction pattern. The 31P 
MAS-NMR spectrum has one chemical shift at 3.3 ppm. If the hypothesis for 
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sodium substitution is true then this shift would indicate sodium was being 
replaced in the apatite crystal by calcium. This can be explained through the 
higher solubility of a sodium substituted apatite which under equilibrium 
would reprecipitate to a sodium free apatite. 
7 days 
The 7 days sample shows a monophasic apatite cement phase the X-ray 
diffraction has typical diffraction lines of apatite and the 31P MAS-NMR has 
one chemical shift at 3.0 ppm, which was assigned to being an apatite 
phase. 
28 days 
Similarly to the 7 day sample the cement phase only consists of apatite. The 
X-ray diffraction has only lines for apatite and the 31P MAS-NMR has only 
one chemical shift at 2.9 ppm of apatite. 
7.2.2 Effect of Glass Structure Upon Dissolution 
Characterisation and analysis of the glass structure showed a number of 
structural changes throughout the series which could potentially be impacting 
upon glass dissolution and eventual phase formation and cement evolution. 
Specifically the increase in free volume, intimated by Tg changes, as calcium 
is increased through the series. Increase in the free volume would equate to 
a more degradable glass. Within the context of the cement setting reaction it 
would be anticipated that faster depredation of these glasses would lead to 
the earlier formation of more calcium rich species. This is because the glass 
contributes a large proportion of the calcium in the overall cement setting 
reaction and releasing this faster is likely to increase the amount of calcium 
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available for reaction, changing the stoichiometry of the reaction, favouring a 
more calcium rich species to form.  
This idea is supported in the results seen here as that when you go ‘up’ the 
series the analysis of the cement phase formed shows the formation of initial 
phases at 1 hour that are more calcium rich. The QMNWKPaG13 and 03 
glasses show the initial formation of brusihte (Ca/P = 1.00) compared to 
QMNWKPaG15 which has a higher calcium content and forms primarily 
octacalcium phosphate (Ca/P = 1.33), the QMNWKPaG16 composition forms 
hydroxyapatite (Ca/P = 1.67) at 1 hour. Whilst the data does indeed support 
the idea that the changes in the free volume induce faster glass degradation 
and changes in cement phase shown here it cannot be for definite. This is 
because as well as the Tg changing though the series the cement 
formulation is also subject to change throughout this series. 
As the sodium content decreases down the series the amount of calcium 
coming from the glass part of the cement formulation decrease. To maintain 
the overall Ca/P ratio in the cements the glass:salt ration changes through 
the series. Descending the series the glass content of the overall cement 
formulation decrease and the amount of salt increases. This could potentially 
have a large effect upon the cement setting chemistry due to the probably 
change in the pH of the cement setting reaction. Whilst this may affect the 
dissolution of the glass it will also reduce the pH of the cement reaction 
solution possibly inducing the formation of the more acidic stable calcium 
phosphate phases, like brushite. 
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7.2.3 Compressive Strength 
The compressive strength for the cements with increasing sodium content at 
1 hour show a clear trend of increasing compressive strength when sodium 
is increased. This is caused by the change in phase that is exhibited in the 
early setting of the cements. In the low sodium content glasses the initial 
cement phase is DCPD and as you move up the series the propensity for the 
formation of OCP increases and mixed DCPD/OCP cement phases form as 
the sodium content is increased until the last glass in the series where the 
cement phase is a mixture of OCP and apatite. Like in the fluoride cements 
the presence of the weaker DCPD phase the compressive strengths are 
decreased when a high proportion of the cement phase is DCPD. 
Another trend exhibited in this cement series is a decrease in compressive 
strength after 1 day. Additionally there is a greater decrease in the 
compressive strength as the sodium content is increased in the glass used to 
produce the cement. The decrease is believed to be due to release of silicon, 
sodium and phosphorus into the Tris solution during immersion. This release 
causes porosity in the cement cylinder which decreases the compressive 
strength as there is a linear relationship in cements between porosity and 
compressive strength. The glasses are affected disproportionately as more 
sodium is in the glass used to make the cement the larger the drop in 
compressive strength. This is because the proportion of glass powder used 
to make theses cement compositions increases as sodium content is 
increased meaning there is a higher proportion of silicon and sodium ions 
making up the cement. When these ions are released into solution this 
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causes greater porosity as you move up the series causing a larger decrease 
in compressive strength. 
An interesting point to notice is that the initial cement reaction appears to 
have a large effect on the cement strength at later time points. The alteration 
in initial phase was attributed to being the cause of the different strength at 1 
hour and 1 day but if this is the case then why do the QMNWKPaG03 and 
QMNWKPaG13 cements not achieve higher compressive strengths when 
they convert to octacalcium phosphate at 7 days. 
With respect to clinical performance compressive strength is an important 
property to optimise. Whilst these materials are not currently used for load 
bearing applications they should be sufficiently strong to prevent deformation 
and remain coherent. Additionally bone cement which is too strong can be 
disadvantageous as it can lead to atypical force distribution (which can cause 
adjacent bone fracture) and stress shielding causing unwarranted resorption 
of bone. An ideal material will match the compressive strength of the bone 
into which it is implanted. Given trabecular bone has a compressive strength 
between 8 and 13 MPa, a compressive strength around this value would be 
sufficient for good clinical performance for most applications4. 
It should be noted that the compressive strength values should only be 
interpreted as a way of comparing the different cement compositions rather 
than values that are applicable to in-vivo performance. Many factors will 
affect the strength on the cement in-vivo including amount of cement, 
                                            
4
 Stronger cement compositions may be required for specific applications, especially when 
the cement is bridging a gap in bone (i.e. cranial defects) rather than filling a cavernous 
bone void. 
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morphology of implant site, mineralisation of cement after implantation, 
location of implant site, surrounding bone density and osseointegration as 
these factors will affect the force distribution. 
7.2.4 Setting Time 
The setting time results show clear trends between glass composition and 
the measured setting time. The fluoride free cement compositions show a 
decrease in setting time as the sodium content is increased in the glass. The 
gradual decrease is witnessed for both the initial and final setting times. A 
factor which causes this is the change in phase exhibited by the cements 
during setting as sodium content is increased in the glass. In these cement 
system the DCPD phase which forms initially transforms to octacalcium 
phosphate at different rates depending upon the sodium content, with a 
higher sodium content giving a faster transition rate. It is known that DCPD 
forming cements have lower compressive strengths than octacalcium 
phosphate/hydroxyapatite cements (Dorozhkin, 2008). Given the Gilmore 
needle test relies on the strength of the cement to determine the setting time 
then a weaker cement is likely to have a longer setting time as a more 
substantial proportion of the bulk cement phase would have had to have 
formed of a weaker (DCPD) cement phase to resist the Gilmore needle 
sufficiently compared to a stronger cement phase. Therefore as the higher 
sodium content cements form octacalcium phosphate/hydroxyapatite at 
earlier time points they are able to resist both Gilmore needles at earlier time 
points. 
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It is difficult to discern a reliable assessment of the effect of P2O5 content in 
the glass on the setting time of the cement because there are only two 
cement compositions where the only component altered is P2O5. The figure 
below shows the comparison between these two compositions with 4.00 and 
6.00 mol% P2O5. There clearly shows a dramatic change in setting time, with 
the high phosphate glass giving a much reduced setting time. This is most 
likely cement phase related as QMNWKPaG03 forms DCPD initially whereas 
the QMNKWPaG04 composition forms an OCP/hydroxyapatite cement 
phase rapidly. It cannot be predicted from these results whether phosphate 
content affects the glass dissolution which caused the alteration in phases or 
whether it is the alteration in glass powder/Ca(H2PO4)2. 
 
Figure 65 Initial and final setting times of the cement series with increasing phosphate content 
7.2.4 Ion Release 
The silicon release followed a fairly conspicuous trend, with silicon content in 
the solution increasing with immersion time. This is related to the hydrolysis 
of the residual silicate chains which are hydrolysed over a period of time, 
releasing soluble silicon species into solution. 
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The sodium release follows a glass composition trend; at 1 hour the sodium 
release from all glass compositions is approximately equal. At 1 day 
QMNWKPaG03 and 13 had very similar sodium release levels (and sodium 
contents in the glass), however, cements where glass QNMWKPaG14-16 
were used the sodium levels are proportionally higher. This trend continues 
at both 7 and 28 days.. This trend is because these glass compositions 
contain more sodium than the others; additionally more glass is used to 
make the cement powder relative to the calcium phosphate salt. The 
increase in sodium in glass compositions combined with the presence of 
more glass means there is more sodium present in the cement available for 
release.  
The calcium release does not show any obvious trends between glass 
compositions. The initial release remains fairly constant after the first 
measurement which means that no calcium is being release during the 
immersion time and none is being consumed by the cement during the 
immersion either. It should be noted also that the calcium levels in the 
solution are relatively low when compared to the phosphorus release. 
The phosphorus release data gives a clear trend for all glass compositions; 
with concentration in solution increasing over time. There does not appear 
any obvious trend between the different glass compositions in the release 
rate or amount released. This shows that phosphorus is continually released 
this may be due to the conversion of relatively phosphate rich calcium 
phosphate species that initially form and convert to species where phosphate 
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is less relative to calcium values. This transformation retains the calcium but 
the phosphate is released into solution, causing the results witnessed here. 
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Chapter 8: Fluoride Glass Cement Series Results & 
Discussion  
8.1 Results 
8.1.1 X-ray Diffraction 
 
Figure 66 X-ray diffraction patterns of cement composition produced from glass 
QMNWKPaG04 after immersion in Tris buffer solution for (i) 1 hour, (ii) 1 day, (iii) 
7 days and (iv) 28 days. ▲ – DCPD; ▼ – DCPA; ● – Octacalcium Phosphate; □ 
indistinguishable OCP/Hydroxyapatite; ♦ Apatite. 
Figure 66 shows the XRD results for Ca(H2PO4)2 and QMNWKPaG04 
cements at 1 hour, 1 day, 7 days and 28 days. At one hour and one day the 
cement is biphasic, consisting of DCPD and OCP. The 4.7 ˚2 line is small 
and broad, typically this line is the most intense on the diffraction pattern of 
OCP. Considering the low intensity of this line relative to the other OCP lines 
in this sample and that apatite shares these remaining diffraction lines with 
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OCP, it could be that there is a mixture of both OCP and apatite. After seven 
days a number of peaks are no longer present for instance the line at 11.67 
˚2, thus, DCPD is no longer present. At 28 days the peak at 4.7 ˚2 of OCP 
is very low in intensity; it is likely that apatite and OCP are present with OCP 
in small quantities though other techniques are needed to confirm this. 
 
 
Figure 67 X-ray diffraction patterns of cement composition produced from glass 
QMNWKPaG06 after immersion in Tris buffer solution for (i) 1 hour, (ii) 1 day, (iii) 
7 days and (iv) 28 days. ▲ – DCPD; ▼ – DCPA; ♦ Apatite. 
Figure 67 shows the XRD results for QMNWKPaG06 cements at 1 hour, 1 
day, 7 days and 28 days. This composition is fluoride containing and at one 
hour DCPD is present as well as an apatite5 phase but the appearance of the 
                                            
5
 The phase is deemed apatite for simplicity. The phase could be hydroxyapatite, 
fluorohydroxyapatite or fluorapatite as this composition contains fluoride. X-ray diffraction 
▼ 
▼ 
▼ 
200 
 
 
apatite phase suggests low crystallinity due to the broadness of the peaks. At 
one day the same phases are present except the intensity of the apatite 
peaks has increased compared to one hour; indicating the DCPD is 
transforming to apatite. At seven days a small line is present at 11.67 ˚2 
indicating a small fraction of DCPD present but the majority of the crystalline 
phase is apatitic. The diffraction pattern of the 28 day cement shows the 
presence of apatite; DCPD is no longer present. 
 
Figure 68 X-ray diffraction patterns of cement composition produced from glass 
QMNWKPaG07 after immersion in Tris buffer solution for (i) 1 hour, (ii) 1 day, (iii) 7 
days and (iv) 28 days. ▲ – DCPD; ▼ – DCPA; ♦ Apatite. 
Figure 68 shows the XRD results for QMNWKPaG07 cements at 1 hour, 1 
day, 7 days and 28 days. At one hour the main crystalline phase is apatite, 
DCPD is present in a small fraction of the total crystalline phase. After one 
                                                                                                                           
cannot be used to differentiate between these phases consequently the term apatite has 
been used. 
▼ 
▼ 
▼ 
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day the diffraction pattern is similar although there is a slight reduction in the 
intensity of the DCPD peaks. After seven days the DCPD is no longer 
present; only apatite is present. After 28 days the cement phase is apatite. 
 
 
Figure 69 X-ray diffraction patterns of cement composition produced from glass 
QMNWKPaG08 after immersion in Tris buffer solution for (i) 1 hour, (ii) 1 day, (iii) 7 
days and (iv) 28 days. ▲ – DCPD; ▼ – DCPA; ♦ Apatite. 
The X-ray diffraction results for cements QMNWKPaG07-10 (Figures 68, 69, 
70, 71) were identical with respect to the phases present at each time point. 
Therefore, for figure descriptions for each please see Figure 68 above. 
▼ 
▼ 
▼ 
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Figure 70 X-ray diffraction patterns of cement composition produced from glass 
QMNWKPaG09 after immersion in Tris buffer solution for (i) 1 hour, (ii) 1 day, (iii) 
7 days and (iv) 28 days. ▲ – DCPD; ▼ – DCPA; ♦ Apatite. 
The X-ray diffraction results for cements QMNWKPaG07-10 (Figures 68, 69, 
70, 71) were identical with respect to the phases present at each time point. 
Therefore, for figure descriptions for each please see Figure 68 above. 
▼ 
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Figure 71 X-ray diffraction patterns of cement composition produced from 
glass QMNWKPaG10 after immersion in Tris buffer solution for (i) 1 hour, (ii) 1 
day, (iii) 7 days and (iv) 28 days. ▲ – DCPD; ▼ – DCPA; ♦ Apatite. 
The X-ray diffraction results for cements QMNWKPaG07-10 (Figures 68, 69, 
70, 71) were identical with respect to the phases present at each time point. 
Therefore, for figure descriptions for each please see Figure 66 above. 
▼ 
▼ 
▼ 
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Figure 72 X-ray diffraction patterns of cement composition produced from glass 
QMNWKPaG11 after immersion in Tris buffer solution for (i) 1 hour, (ii) 1 day, (iii) 7 
days and (iv) 28 days. ▲ – DCPD; ▼ – DCPA; ♦ Apatite. 
Figure 72 shows the XRD results for QMNWKPaG11 cements at 1 hour, 1 
day, 7 days and 28 days. At one hour the main crystalline phase is apatite, 
DCPD is present in a small fraction of the total crystalline content. After one 
day the DCPD is not present, the crystalline phase primarily consists of 
apatite. The patterns for 7 days and 28 days show the crystalline cement 
phase is apatite. 
▼ 
▼ 
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8.1.2 Magic Angle Spinning Nuclear Magnetic Resonance 
8.1.2.1 31P MAS-NMR 
 
Figure 73 
31
P MAS-NMR spectra of the starting glass powder and Tris immersed cement 
samples in the cement system produced from glass QMNWKPaG04. Showing (i) QMNWKPaG04 
initial glass powder; (ii) 1 hour; (iii) 1 day; (iv) 7 days; (v) 28 days. 
Figure 73 shows the 31P MAS-NMR results for QMNWKPaG04 glass and 
QMNWKPaG04 cements at 1 hour, 1 day, 7 days and 28 days. At 1 hour 
there are chemical shift at -1.4, -0.2, 1.4 and 3.3 ppm. The 1 day sample has 
chemical shift at -1.4, -0.2, 1.4, and 3.1 ppm. The 1 hour and 1 day spectra 
show identical phases present with DCPA (-1.4 and -0.2 ppm), DCPD (1.4 
ppm) and apatite (3,1 ppm). The 7 day sample has chemical shift at -1.4, -
0.2, 2.0 and 3.1 ppm, this shows the same phases present at the 1 hour and 
1 day samples (DCPD, DCPA and Apatite). The 2.0 ppm peak appears as a 
shoulder on the 3.1 ppm peak, this was attributed to DCPD and appears at 
2.0 ppm rather than 1.4 ppm due to it being a shoulder on the 3.1 ppm peak 
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which makes it appear at a higher chemical shift. The 28 day sample has a 
chemical shift at 2.9 ppm, which was assigned as apatite. 
 
 
Figure 74 
31
P MAS-NMR spectra of the starting glass powder and Tris immersed cement 
samples in the cement system produced from glass QMNWKPaG06. Showing (i) QMNWKPaG06 
initial glass powder; (ii) 1 hour; (iii) 1 day; (iv) 7 days; (v) 28 days. 
Figure 74 shows the 31P MAS-NMR results for PaG06 glass and PaG06 
cements at 1 hour, 1 day, 7 days and 28 days. At 1 hour the NMR spectra 
identifies the cement phase formed in the initial reaction, showing the 
presence of an apatite phase at 2.9 ppm, DCPD at 1.4 ppm and DCPA at --
1.4 and -0.2 ppm. At one day the same phases are present except the DCPD 
has decreased its amount compared to the apatite phase. At 7 days apatite 
is the primary cement phase, with a small shoulder on the right side of this 
peak indicating a small residual amount of DCPD. The -0.2 ppm peak is still 
present as well as a peak at -1.4 ppm showing the presence of DCPA. At 28 
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days apatite 2.9 ppm is the prominent phase with a small shoulder on the 
right side indicating another phase though this is unidentifiable. 
 
 
Figure 75 
31
P MAS-NMR spectra of the starting glass powder and Tris immersed cement 
samples in the cement system produced from glass QMNWKPaG07. Showing (i) QMNWKPaG07 
initial glass powder; (ii) 1 hour; (iii) 1 day; (iv) 7 days; (v) 28 days. 
Figure 75 shows the 31P MAS-NMR results for QMNWKPaG07 glass and 
QMNWKPaG07 cements at 1 hour, 1 day, 7 days and 28 days. . At 1 hour 
the NMR spectra identifies the cement phase formed in the initial reaction, 
showing the presence of an apatite phase at 2.9 ppm, DCPD at 1.4 ppm and 
DCPA at -1.4 and -0.2 ppm. At one day the same phases are present except 
the DCPD has decreased its amount compared to the apatite phase, 
appearing as a shoulder on the right of the apatite peak. After 7 days 
immersion apatite is the predominant phase with a peak at 2.9 ppm; DCPA -
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1.4 and -0.2ppm is also present in small quantities. At 28 days the 
phosphorus in the cement phase is completely apatitic, 2.9 ppm. 
 
 
Figure 76 
31
P MAS-NMR spectra of the starting glass powder and Tris immersed cement 
samples in the cement system produced from glass QMNWKPaG08. Showing (i) QMNWKPaG08 
initial glass powder; (ii) 1 hour; (iii) 1 day; (iv) 7 days; (v) 28 days. 
Figure 76 shows the 31P MAS-NMR results for QMNWKPaG08 glass and 
QMNWKPaG08 cements at 1 hour, 1 day, 7 days and 28 days. At 1 hour the 
NMR spectra identifies the cement phase formed in the initial reaction, 
showing the presence of an apatite phase at 2.9 ppm, DCPD at 1.4 ppm and 
DCPA at -1.4 and -0.2 ppm. At one day there are peaks at -1.4, -0.2, 1.4 and 
2.9 ppm indicating the same phases are present except the DCPD has 
decreased its amount compared to the apatite phase, appearing as a 
shoulder on the right of the apatite peak. After 7 days immersion apatite is 
the predominant phase with a peak at 2.9 ppm; DCPA -1.4 and -0.2 ppm is 
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also present in small quantities. At 28 days the phosphorus in the cement 
phase is completely apatitic, 2.9 ppm. 
 
 
Figure 77 
31
P MAS-NMR spectra of the starting glass powder and Tris immersed cement 
samples in the cement system produced from glass QMNWKPaG09. Showing (i) QMNWKPaG09 
initial glass powder; (ii) 1 hour; (iii) 1 day; (iv) 7 days; (v) 28 days. 
Figure 77 shows the 31P MAS-NMR results for QMNWKPaG09 glass and 
QMNWKPaG09 cements at 1 hour, 1 day, 7 days and 28 days. At 1 hour the 
NMR spectra identifies the cement phase formed in the initial reaction, 
showing the presence of an apatite phase at 2.9 ppm, DCPD at 1.4 ppm and 
DCPA at -1.4 and -0.2 ppm. At one day the same phases are present except 
the DCPD has decreased its amount compared to the apatite phase, 
appearing as a shoulder on the right of the apatite peak. After 7 days 
immersion apatite is the predominant phase with a peak at 2.9 ppm; DCPA -
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1.4 and -0.2 ppm is also present in small quantities. At 28 days the 
phosphorus in the cement phase is completely apatitic, 2.9 ppm. 
 
Figure 78 
31
P MAS-NMR spectra of the starting glass powder and Tris immersed cement 
samples in the cement system produced from glass QMNWKPaG10. Showing (i) QMNWKPaG10 
initial glass powder; (ii) 1 hour; (iii) 1 day; (iv) 7 days; (v) 28 days. 
The 31P MAS-NMR results for cement compositions QMNWKPaG09-11 are 
identical in the presence of various peaks. For results description of Figure 
78 and Figure 79 see the description after Figure 76. 
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Figure 79 
31
P MAS-NMR spectra of the starting glass powder and Tris immersed cement 
samples in the cement system produced from glass QMNWKPaG11. Showing (i) QMNWKPaG11 
initial glass powder; (ii) 1 hour; (iii) 1 day; (iv) 7 days; (v) 28 days. 
The 31P MAS-NMR results for cement compositions QMNWKPaG09-11 are 
identical in the presence of various peaks. For results description of Figure 
78 and Figure 79 see the description after Figure 76. 
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8.1.2.2 19F MAS-NMR 
 
Figure 80 
19
F MAS-NMR of glass QMNWKPaG10 and i) 1 hour and iv) 28 days immersion in Tris 
buffer solution. 
The 19F MAS-NMR spectra for QMNWKPaG10 (CaF2 3.50 mol%) cement 
compositions at 1 hour and 28 days including the glass are shown in Figure 
78. The glass shows a very broad chemical shift with its highest point at 
approximately -104 ppm. The 1 hour and 28 day samples show at least two 
peaks very close to each other in the same positions in each spectrum at -
106 and -108 ppm. There is a slight change in the relative intensity between 
the two bands at -106 and -108 ppm, with the -108 ppm peak being slightly 
more intense at 1 hour, whereas at 28 days this is reversed. 
19F chemical shift, ppm
Glass
i
iv
*
* *
*
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8.1.3 Fourier Transform Infrared 
 
Figure 81 Fourier transform infrared spectra of cement composition QMNWKPaG04 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 500 to 2000 wavenumber cm
-1
. 
 
Figure 82 Fourier transform infrared spectra of cement composition QMNWKPaG04 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 2500 to 4000 wavenumber cm
-1
. 
Table 24 FTIR bands and their respective assignments of cement samples produced from glass 
QMNWKPaG04 after immersion in Tris buffer solution for 1 hour, 1 day, 7 days and 28 days. 
Wavenumber 
(cm
-1
) 
Assignment 1 Hour 1 Day  7 Day  28 Day 
523 PO Bending √ √ - - 
554 PO Bending √ √ √ √ 
566 PO Bending √ √ - - 
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596 PO Bending √ √ √ √ 
781 H2O Liberation √ √ √ √ 
854 HPO4(5) [P-(OH)] 
Stretching 
- - √ √ 
865 P-O(H) Stretching √ √ - - 
954 PO4 Stretching √ √ √ √ 
982 P-O Stretching √ - - - 
1213 O-H In-plane Bending √ √   
1643 H2O Bending √ √ √ √ 
3148 OH Stretching of Water √ - - - 
3473 OH Stretching of Water √ √ - - 
3528 OH Stretching of Water √ √ - - 
3554 H-bonded H2O - - - √ 
 
Figures 81 and 82 show the FTIR spectra of cement composition 
QMNWKPaG04 at 1 hour, 1 day, 7 days and 28 days. The spectra at 1 hour 
and 1 day are similar in which bands they have present with PO bond 
bending and stretching bands at  524, 554, 566, 596, 954 and 982 (1 hour 
only) cm-1. At 865 cm-1 both spectra have a band donating P-O(H) Stretching 
groups. Lastly there are bands showing water molecules at 781, 1643, 3148 
(1 hour only), 3473 and 3528 cm-1. Similarly to the 1 hour and 1 day spectra 
the 7 day and 28 day samples also have similar bands. PO bending and 
stretching bands are present at 555, 597 and 954 cm-1, with a P-O(H) 
Stretching band at 855 cm-1. Structural water molecules give bands at 785, 
784 and 1630 cm-1, with the 28 day sample having a H-bonded H2O band at 
3554 cm-1. 
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Figure 83 Fourier transform infrared spectra of cement composition QMNWKPaG06 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 500 to 2000 wavenumber cm
-1
. 
 
Figure 84 Fourier transform infrared spectra of cement composition QMNWKPaG06 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 2500 to 4000 wavenumber cm
-1
. 
Table 25 FTIR bands and their respective assignments of cement samples produced from glass 
QMNWKPaG06 after immersion in Tris buffer solution for 1 hour, 1 day, 7 days and 28 days. 
Wavenumber 
(cm
-1
) 
Assignment 1 Hour 1 Day  7 Day  28 Day 
524 PO Bending √ √ - - 
561 PO Bending √ √ √ √ 
599 PO Bending √ √ √ √ 
649 H2O Liberation √ √ - - 
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781 H2O Liberation √ √  √ 
852 P-O(H) Stretching - - √ √ 
866 P-O(H) Stretching - - √ √ 
953 PO4 Stretching - - - - 
980 P-O Stretching √ - - - 
1205 O-H In-plane Bending √ √ √ √ 
1628 H2O Bending - - √ √ 
1645 H2O Bending √ √ - - 
1714 Overtone of 866 band 
- 2 x 866 = 1732 
√ √ - - 
3150 OH Stretching of 
Water 
√ √ - - 
3476 OH Stretching of 
Water 
√ √ - - 
3531 OH Stretching of 
Water 
√ √ - - 
 
Figures 83 and 84 show the FTIR spectra of cement composition 
QMNWKPaG06 at 1 hour, 1 day, 7 days and 28 days. At 1 hour and 1 day 
there are PO bending and stretching bands at 524, 561, 599 and 980 cm-1. In 
addition there is a P-O(H) stretching band at 866 cm-1. Finally bands from 
water molecules are present at 649 (1 hour only), 781, 3150, 3476 and 3531 
cm-1. The 7 day and 28 day samples have PO bending and stretching bands 
at 561, 600, 653 and 953 cm-1, with a P-O(H) Stretching band at 852 cm-1. 
Similarly to the 1 hour and 1 day samples there are structural water 
molecules present at 1628 1209 and, in the 28 day sample, at 787 cm-1. 
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Figure 85 Fourier transform infrared spectra of cement composition QMNWKPaG07 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 500 to 2000 wavenumber cm
-1
. 
 
Figure 86 Fourier transform infrared spectra of cement composition QMNWKPaG07 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 2500 to 4000 wavenumber cm
-1
. 
Table 26 FTIR bands and their respective assignments of cement samples produced from glass 
QMNWKPaG07 after immersion in Tris buffer solution for 1 hour, 1 day, 7 days and 28 days. 
Wavenumber 
(cm
-1
) 
Assignment 1 Hour 1 Day  7 Day  28 Day 
524 PO Bending √ - - - 
559 PO Bending √ √ √ √ 
564 PO Bending √ √ √ - 
600 PO Bending √ √ √ √ 
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785 H2O Liberation √ √ √ √ 
854 P-O(H) Stretching - - √ √ 
858 P-O(H) Stretching  √ - - 
866 P-O(H) Stretching √ - - - 
955 PO4 Stretching √ √ √ √ 
983 P-O Stretching √ - - - 
1207 O-H In-plane Bending √ √ √ √ 
1630 H2O Bending - √ √ √ 
1641 H2O Bending √ - - - 
3148 OH Stretching of Water √ - - - 
3478 OH Stretching of Water √ √ - - 
3530 OH Stretching of Water √ √ - - 
 
Figures 85 and 86 show the FTIR spectra of cement composition 
QMNWKPaG07 at 1 hour, 1 day, 7 days and 28 days. At 1 hour and 1 day 
the PO bending and stretching bands are similar being at 559, 567, 601 and 
955 cm-1, the 1 hour sample has an additional band at 524 cm-1. Each 
sample also has also a P-O(H) Stretching band at 864 cm-1. Lastly there are 
structural water molecules present at 785, 1207, 1641, 3148, 3478 and 3530 
cm-1. The 7 day and 28 day samples are similar having PO bending and 
stretching bands at 559, 567 (7 day only), 600and 955 cm-1. Similarly to the 1 
hour and 1 day samples there are structural water molecules at 784, 1211 
and 1627 cm-1.  
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Figure 87 Fourier transform infrared spectra of cement composition QMNWKPaG08 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 500 to 2000 wavenumber cm
-1
. 
 
Figure 88 Fourier transform infrared spectra of cement composition QMNWKPaG08 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 2500 to 4000 wavenumber cm
-1
. 
Table 27 FTIR bands and their respective assignments of cement samples produced from glass 
QMNWKPaG08 after immersion in Tris buffer solution for 1 hour, 1 day, 7 days and 28 days. 
Wavenumber 
(cm
-1
) 
Assignment 1 Hour 1 Day  7 Day  28 Day 
523 PO Bending √ √ - - 
557 PO Bending √ √ √ √ 
600 PO Bending √ √ √ √ 
784 H2O Liberation √ √ √ √ 
866 P-O(H) Stretching √ √ √ √ 
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955 P-O Stretching √ √ √ √ 
982 P-O Stretching √ - - - 
1205 O-H In-plane Bending √ √ √ √ 
1627 H2O Bending - - √ √ 
1644 H2O Bending √ √ - - 
3144 OH Stretching of Water √ √ - - 
3280 OH Stretching of Water √ - - - 
3477 OH Stretching of Water √ √ - - 
3527 OH Stretching of Water √ √ - - 
 
Figures 87 and 88 show the FTIR spectra of cement composition 
QMNWKPaG08 at 1 hour, 1 day, 7 days and 28 days. At 1 hour and 1 day 
the samples share similar spectra, with PO bending and stretching bands at 
523, 557, 600, 955 and 982 (1 hour only) cm-1, in addition there is also a P-
O(H) Stretching band at 866 cm-1 on both spectra. Bands from water 
molecules bands exist at 784, 1205, 1644, 3144, 3280 (1 hour only), 3477 
and 3527 cm-1. At 7 days and 28 days there are less bands compared to the 
previous immersion time points and like previous samples the two spectra 
have almost identical bands present. There are PO bending and stretching 
bands in both spectra at 555, 598 and 953 cm-1. Similarly to the 1 hour and 1 
day samples there is a P-O(H) Stretching band at 856 cm-1. There are also 
three bands from water molecules at 788, 1217, 1627 cm-1. 
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Figure 89 Fourier transform infrared spectra of cement composition QMNWKPaG09 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 500 to 2000 wavenumber cm
-1
. 
 
Figure 90 Fourier transform infrared spectra of cement composition QMNWKPaG09 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 2500 to 4000 wavenumber cm
-1
. 
Table 28 FTIR bands and their respective assignments of cement samples produced from glass 
QMNWKPaG09 after immersion in Tris buffer solution for 1 hour, 1 day, 7 days and 28 days. 
Wavenumber 
(cm
-1
) 
Assignment 1 Hour 1 Day  7 Day  28 Day 
524 PO Bending √ √ - - 
559 PO Bending √ √ √ √ 
566 PO Bending √ √ - - 
599 PO Bending √ √ √ √ 
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786 H2O Liberation √ √ √ √ 
862 P-O(H) Stretching √ √ √ √ 
950 P-O Stretching √ √ √ √ 
982 P-O Stretching √ - - - 
1123 PO Stretching √ - - - 
1211 O-H In-plane Bending √ √  √ 
1638 H2O Bending √ √ √ √ 
3141 OH Stretching of Water √ - - - 
3477 OH Stretching of Water √ √ - - 
3531 OH Stretching of Water √ √ - - 
 
Figures 89 and 90 show the FTIR spectra of cement composition 
QMNWKPaG09 at 1 hour, 1 day, 7 days and 28 days. The 1 hour and 1 day 
spectra share similarities in having PO bending bands at 524, 559, 566, 599 
cm-1 and a PO stretching band at 950 cm-1. The 1 hour sample has additional 
PO stretching bands at 982 and 1123 cm-1, which the 1 day sample does not 
have. In addition to the phosphate groups both spectra also have bands of 
water molecules at 786, 1638, 3141 (1 hour only), 3477, 3531 cm-1. The 7 
day and 28 day samples have relatively few bands on the spectra. There are 
PO bending and stretching bands at 555, 592 and 953 cm-1 as well as a P-
O(H) Stretching band at 853 cm-1. There are also some water molecule 
bands at 781, 1217 (28 day only) and 1625 cm-1. 
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Figure 91 Fourier transform infrared spectra of cement composition QMNWKPaG10 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 500 to 2000 wavenumber cm
-1
. 
 
Figure 92 Fourier transform infrared spectra of cement composition QMNWKPaG10 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 2500 to 4000 wavenumber cm
-1
. 
Table 29 FTIR bands and their respective assignments of cement samples produced from glass 
QMNWKPaG10 after immersion in Tris buffer solution for 1 hour, 1 day, 7 days and 28 days. 
Wavenumber 
(cm
-1
) 
Assignment 1 Hour 1 Day  7 Day  28 Day 
519 PO Bending √ - - - 
553 PO Bending √ √ - - 
560 PO Bending - - √ √ 
595 PO Bending √ √ - - 
601 PO Bending - - √ √ 
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650 H2O Liberation √ - - - 
784 H2O Liberation √ √ √ √ 
865 P-O(H) Stretching √ √ √ √ 
955 P-O Stretching - - √ √ 
1203 O-H In-plane Bending - - √ √ 
1219 O-H In-plane Bending √ √ - - 
1627 H2O Bending - - √ √ 
1644 H2O Bending √ √   
1703 Overtone of 865 band - 
2 x 865 = 1730 
√ - - - 
3144 OH Stretching of Water √ - - - 
3285 OH Stretching of Water √ - - - 
3473 OH Stretching of Water √ - - - 
3531 OH Stretching of Water √ - - - 
 
Figures 91 and 92 show the FTIR spectra of cement composition 
QMNWKPaG10 at 1 hour, 1 day, 7 days and 28 days. The 1 hour sample 
has PO bending and stretching bands at 519, 553 and 595 cm-1, with a P-
O(H) Stretching band at 865 cm-1. The 1 day, 7 day and 28 day samples 
share all the same bands. There are PO bending and stretching bands at 
553, 598 and 953 cm-1, with a P-O(H) Stretching band at 855 cm-1. Lastly 
there are bands from water molecules at 790, 1219 and 1636 cm-1. 
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Figure 93 Fourier transform infrared spectra of cement composition QMNWKPaG11 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 500 to 2000 wavenumber cm
-1
. 
 
Figure 94 Fourier transform infrared spectra of cement composition QMNWKPaG11 at (i) 1 
hour, (ii) 1 day, (iii) 7 days, and (iv) 28 days immersion time in Tris buffer solution, plotted 
between 2500 to 4000 wavenumber cm
-1
. 
Table 30 FTIR bands and their respective assignments of cement samples produced from glass 
QMNWKPaG11 after immersion in Tris buffer solution for 1 hour, 1 day, 7 days and 28 days. 
Wavenumber 
(cm
-1
) 
Assignment 1 Hour 1 Day  7 Day  28 Day 
525 PO Bending √ - - - 
562 PO Bending √ √ √ √ 
567 PO Bending √ - - - 
601 PO Bending √ √ √ √ 
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781 H2O Liberation √ - - √ 
862 P-O(H) Stretching √ √ √ √ 
954 P-O Stretching √ √ √ √ 
983 P-O(H) Stretching √ - - - 
1199 O-H In-plane Bending √ - - - 
1211 O-H In-plane Bending - √ √ √ 
1625 H2O Bending - √ √ √ 
1638 H2O Bending √ - - - 
3144 OH Stretching of 
Water 
√ - - - 
3475 OH Stretching of 
Water 
√ - - - 
3530 OH Stretching of 
Water 
√ - - - 
 
Figures 93 and 94 show the FTIR spectra of cement composition 
QMNWKPaG11 at 1 hour, 1 day, 7 days and 28 days. At 1 hour there are PO 
bending and stretching bands at 525, 562, 567, 601 and 954 cm-1, in addition 
to P-O(H) Stretching bands at 862 and 983 cm-1. Lastly the 1 hour spectrum 
has water molecule bands at 781, 1199, 1638, 3144, 3475 and 3530 cm-1. 
The 1 day, 7 day and 28 day spectra are broadly similar in the bands they 
each possess. There are PO bending and stretching bands at 561, 601 and 
957 cm-1, with a P-O(H) Stretching band at 854 cm-1. There are also water 
molecule bands at 788 (28 day only), 1207 and 1630 cm-1. 
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8.1.4 Scanning Electron Microscopy 
 
Figure 95 Scanning electron micrographs of QMNWKPaG04 cements at 1 hour (top left), 1 day 
(top right), 7 days (bottom left) and 28 days (bottom right). 
Figure 95 shows the SEM images for QMNWKPaG04 cements at 1 hour, 1 
day, 7 days and 28 days. At 1 hour the cement shows small plate shaped 
crystals with a high degree of interlocking; these were attributed to being 
apatite or OCP which displays this morphology. The image of the cement at 
1 day shows what appear to be apatite/OCP crystals inside a bulk cement 
phase. The 7 day sample demonstrates plate like crystals. After 28 days 
immersion there are many interlocked irregular petal shaped crystals. 
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Figure 96 Scanning electron micrographs of QMNWKPaG06 cements at 1 hour (top left), 1 day 
(top right), 7 days (bottom left) and 28 days (bottom right). 
Figure 96 shows the SEM images for QMNWKPaG06 cements at 1 hour, 1 
day, 7 days and 28 days. The 1 hour sample shows clustered collections of 
small crystals. The 1 day sample shows a collection of three types of crystal 
morphology; ribbon morphology, round plates and needle crystals. The 7 day 
sample shows the majority of the crystals have a small needle morphology 
but there is also present a few ribbon shaped crystals. The centre of the 
image shows a glass particle is present. The 28 day sample has many 
needle shaped crystals on the edge of the image whereas the centre has a 
network of irregular shaped, thin crystals. 
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Figure 97 Scanning electron micrographs of QMNWKPaG07 cements at 1 hour (top left), 1 day 
(top right), 7 days (bottom left) and 28 days (bottom right). 
Figure 97 shows the SEM images for QMNWKPaG07 cements at 1 hour, 1 
day, 7 days and 28 days. The 1 hour sample shows two crystal morphologies 
relatively thick plated shaped crystals and very small needle like crystals. At 
1 day and 7 days the morphology is entirely needle like. At 28 days the 
individual crystal is difficult to distinguish and only the bulk cement phase can 
be seen. 
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Figure 98 Scanning electron micrographs of QMNWKPaG08 cements at 1 hour (top left), 1 day 
(top right), 7 days (bottom left) and 28 days (bottom right). 
Figure 98 shows the SEM images for QMNWKPaG08 cements at 1 hour, 1 
day, 7 days and 28 days. The 1 hour sample shows a mixture of relatively 
small needle crystals and larger plate shaped crystals. At 1 day individual 
crystal cannot be easily distinguished most likely due to their very small size. 
There is a dramatic change in morphology in the 7 day sample, where the 
cement morphology exists as large ribbons and rods. The 28 day sample has 
a mixture of needle and plate morphologies. 
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Figure 99 Scanning electron micrographs of QMNWKPaG09 cements at 1 hour (top left), 1 day 
(top right), 7 days (bottom left) and 28 days (bottom right). 
Figure 99 shows the SEM images for QMNWKPaG09 cements at 1 hour, 1 
day, 7 days and 28 days. At 1 hour the cement has two predominant 
morphologies, needles and small relatively thick plates. After 1 day the 
cement morphology shows a needle shape. The 7 day sample shows a 
majority of plate shaped crystals with some needles interdispersed. At 28 
days the cement phase is primarily made up of a needle morphology. 
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Figure 100 Scanning electron micrographs of QMNWKPaG10 cements at 1 hour (top left), 1 day 
(top right), 7 days (bottom left) and 28 days (bottom right). 
Figure 100 shows the SEM images for QMNWKPaG10 cements at 1 hour, 1 
day, 7 days and 28 days. At 1 hour the crystal morphology is a mixture of 
both needle and plate shaped crystals. The morphology is much the same at 
1 day. The crystal morphology in the 7 day and 28 day samples is also very 
similar; there is a monophasic crystal morphology with all crystals having a 
needle shape. 
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Figure 101 Scanning electron micrographs of QMNWKPaG11 cements at 1 hour (top left), 1 day 
(top right), 7 days (bottom left) and 28 days (bottom right). 
Figure 101 shows the SEM images for QMNWKPaG11 cements at 1 hour, 1 
day, 7 days and 28 days. The morphology in all four images is very similar as 
they all predominantly have small needle-like morphologies. Over the 
immersion time there does appear to be a growth of the crystals and in the 
one hour sample there are a very few number of plate like crystals. 
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8.1.5 Compressive Strength 
 
Figure 102 The compressive strength (MPa) of the fluoride containing cement series along with 
the equivalent fluorine-free glass composition. 
Glass 
Composition 
Compressive Strength (MPa) 
1 Hour 1 Day 7 Days 28 Days 
QMNWKPaG04 9.65 (±0.55) 
12.90 
(±1.16) 
10.30 (±1.33) 5.67 (±0.94) 
QMNWKPaG06 1.60 (±0.30) 4.98 (±0.53) 4.88 (±0.39) 4.28 (±0.61) 
     
QMNWKPaG08 2.24 (±0.76) 4.17 (±0.72) 4.44 (±1.11) 4.18 (±0.55) 
QMNWKPaG09 3.48 (±0.43) 5.48 (±0.99) 4.78 (±0.45) 4.35 (±0.64) 
QMNWKPaG10 2.87 (±0.79) 6.76 (±0.39) 4.49 (±0.64) 4.21 (±0.68) 
QMNWKPaG07 3.03 (±0.43) 3.77 (±0.69) 3.18 (±1.06) 3.18 (±0.54) 
QMNWKPaG11 3.22 (±0.45) 5.10 (±0.52) 4.51 (±1.02) 3.31 (±0.56) 
 
All of the fluorine containing cement samples showed increases in 
compressive strength compared to the 1 hour samples for each composition. 
The maximum compressive strength for cement samples containing fluoride 
was 6.76 MPa for the QMNWKPaG10 at 1 day. With the lowest being 1.60 
for the QMNWKPaG06 composition at 1 hour.  The fluorine free sample 
(QMNWKPaG04) had higher compressive strengths than those containing 
fluoride, ranging from 5.67 to 12.90 MPa. 
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8.1.6 Setting Time 
 
Figure 103 Initial and final setting times (minutes) against CaF2 content in glass 
(mol%) of fluoride containing cement compositions 
Table 31 Setting times as measured using Gilmore needle test of cement compositions, 
showing both initial and final setting times in minutes. 
Cement 
Composition 
Initial Setting 
Time (min) 
Final Setting 
Time (min) 
QMNWKPaG04 10.5 15.0 
QMNWKPaG06 10.0 33.5 
   
QMNWKPaG08 8.0 28.0 
QMNWKPaG09 7.5 21.5 
QMNWKPaG10 5.0 25.5 
QMNWKPaG07 4.5 36.0 
QMNWKPaG11 5.0 21.0 
 
The fluoride containing cement series shows a gradual decrease in initial 
setting time as the fluoride concentration is increased, decreasing from 10 
minutes (QMNWKPaG06) to 5 minutes (QMNWKPaG11). The final setting 
time from this series shows a slight trend of decreasing setting time with 
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increasing fluoride content; however the QMNWKPaG07 composition 
deviates from this trend with a final setting time of 36 minutes whilst the 
others in this series are between 21 and 33.5 minutes. The comparative 
glass composition without fluoride (QMNWKPaG04) has an initial setting 
time of 10.5 minutes and a final setting time of 15 minutes. 
8.1.7 Ion Release 
 
Figure 104 Fluoride release (millimole per litre, mmol/L) from immersed cement cylinders (n=4) 
plotted against square root of immersion time (hours) for all fluoride containing cement 
compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Error Bars = Standard 
Deviation). 
Table 32 Fluoride release (millimole per litre, mmol/L) from immersed cement cylinders (n=4) for 
fluoride containing cement compositions from immersion for 1 hour, 1 day, 7 days, 28 days. 
Cement 
Composition 
Fluoride Release (mmol/L) 
1 Hour 1 Day 7 Days 28 Days 
QMNWKPaG06 0.0030 0.0039 0.0024 0.0032 
QMNWKPaG07 0.0028 0.0044 0.0037 0.0059 
QMNWKPaG08 0.0032 0.0024 0.0019 0.0032 
QMNWKPaG09 0.0023 0.0027 0.0026 0.0025 
QMNWKPaG10 0.0023 0.0021 0.0017 0.0024 
QMNWKPaG11 0.0015 0.0018 0.0017 0.0021 
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The fluoride release measurements from the fluoride containing cement 
compositions show variable release at 1 hour, with fluoride release ranging 
from 0.0015 and 0.0030 mmol/L. At one hour the fluoride concentrations in 
the immersion solutions change with some compositions increasing and 
others decreasing, the range of fluoride release being between 0.0018 and 
0.0044 mmol/L. At 7 days there is an apparent decrease in fluoride 
concentration in solution for all compositions compared to 7 days, with 
fluoride release levels between 0.0017 and 0.0037 mmol/L. After 28 days the 
fluoride release has increased compared to the 7 day levels to between 
0.0021 and 0.0059 mmol/L. 
 
Figure 105 Calcium release (millimole per litre, mmol/L) from immersed cement cylinders (n=4) 
plotted against square root of immersion time (hours) for all fluoride containing cement 
compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Error Bars = Standard 
Deviation). 
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Table 33 Calcium release (millimole per litre, mmol/L) from immersed cement cylinders (n=4) for 
all cement compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Standard 
Deviation). 
Cement 
Composition 
Calcium Release (mmol/L) 
1 Hour 1 Day 7 Days 28 Days 
QMNWKPaG04 0.07 (±0.00) 0.07 (±0.00) 0.08 (±0.00) 0.04 (±0.00) 
QMNWKPaG06 0.09 (±0.00) 0.08 (±0.00) 0.11 (±0.00) 0.04 (±0.00) 
QMNWKPaG07 0.07 (±0.00) 0.08 (±0.00) 0.14 (±0.01) 0.02 (±0.00) 
QMNWKPaG08 0.07 (±0.00) 0.08 (±0.00) 0.11 (±0.00) 0.03 (±0.00) 
QMNWKPaG09 0.08 (±0.00) 0.08 (±0.01) 0.11 (±0.00) 0.04 (±0.00) 
QMNWKPaG10 0.08 (±0.00) 0.10 (±0.01) 0.10 (±0.00) 0.04 (±0.00) 
QMNWKPaG11 0.09 (±0.00) 0.11 (±0.00) 0.08 (±0.00) 0.08 (±0.00) 
 
The calcium release shows very similar levels of calcium release from the 
cement for most of the different cement compositions. At 1 hour the majority 
of the compositions have between 0.07 and 0.09 mmol/L calcium release. At 
1 day the majority of calcium release for the cement compositions is between 
0.07 and 0.11 mmol/L. At 7 days the majority of the calcium release is 
between 0.08 and 0.11 mmol/L. After 28 days calcium release is relatively 
low, ranging between 0.02 and 0.06 mmol/L for all compositions. 
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Figure 106 Phosphorus release (millimole per litre, mmol/L) from immersed cement cylinders 
(n=4) plotted against square root of immersion time (hours) for all fluoride containing cement 
compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Error Bars = Standard 
Deviation). 
Table 34 Phosphorus release (millimole per litre, mmol/L) from immersed cement cylinders 
(n=4) for all cement compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Standard 
Deviation). 
Cement 
Composition 
Phosphorus Release (mmol/L) 
1 Hour 1 Day 7 Days 28 Days 
QMNWKPaG04 2.03 (±0.03) 5.36 (±0.00) 9.00 (±0.04) 9.41 (±0.01) 
QMNWKPaG06 3.02 (±0.02) 6.56 (±0.03) 10.74 (±0.02) 6.47 (±0.04) 
QMNWKPaG07 2.61 (±0.01) 5.99 (±0.03) 7.54 (±0.16) 6.34 (±0.01) 
QMNWKPaG08 2.58 (±0.02) 5.96 (±0.06) 9.89 (±0.02) 13.87 (±0.07) 
QMNWKPaG09 2.92 (±0.00) 5.83 (±0.05) 9.46 (±0.06) 10.71 (±0.00) 
QMNWKPaG10 2.58 (±0.02) 5.78 (±0.05) 9.64 (±0.01) 11.33 (±0.08) 
QMNWKPaG11 3.12 (±0.01) 6.31 (±0.04) 11.17 (±0.05) 11.17 (±0.05) 
 
At 1 hour the phosphorus release is between 2.03 and 3.12 mmol/L for all 
cement compositions. After 1 day the amount of phosphorus in solution for 
all compositions has risen to between 5.36 and 6.56 mmol/L. After 7 days the 
phosphorus in solution has increased a smaller amount to be between 7.54 
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and 11.17 mmol/L for all cement compositions. At 28 days there is a fairly 
high distribution of the various phosphorus release rates. The release 
distribution is high with all compositions being between 6.34 and 11.33 
mmol/L. 
 
Figure 107 Silicon release (millimole per litre, mmol/L) from immersed cement cylinders (n=4) 
plotted against square root of immersion time (hours) for all fluoride containing cement 
compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Error Bars = Standard 
Deviation). 
Table 35 Silicon release (millimole per litre, mmol/L) from immersed cement cylinders (n=4) for 
all cement compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Standard 
Deviation). 
Cement 
Composition 
Silicon Release (mmol/L) 
1 Hour 1 Day 7 Days 28 Days 
QMNWKPaG04 0.04 (±0.00) 0.21 (±0.00) 0.54 (±0.00) 0.80 (±0.00) 
QMNWKPaG06 0.12 (±0.00) 0.31 (±0.00) 0.52 (±0.00) 0.73 (±0.00) 
QMNWKPaG07 0.05 (±0.00) 0.21 (±0.00) 0.54 (±0.01) 0.73 (±0.00) 
QMNWKPaG08 0.06 (±0.00) 0.24 (±0.00) 0.58 (±0.00) 0.98 (±0.00) 
QMNWKPaG09 0.05 (±0.00) 0.20 (±0.00) 0.46 (±0.00) 0.93 (±0.00) 
QMNWKPaG10 0.05 (±0.00) 0.16 (±0.00) 0.59 (±0.00) 0.92 (±0.00) 
QMNWKPaG11 0.06 (±0.00) 0.24 (±0.00) 0.50 (±0.00) 0.50 (±0.00) 
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The silicon release shows a constant increase in silicon release for all 
cement compositions that shows no noticeable differences for the different 
series. At 1 hour there is the lowest silicon release of between 0.04 and 0.12 
mmol/L, which increases to between 0.16 and 0.31 mmol/L after 1 day. Then 
at 7 days the amount in solution is further increased to between 0.46 and 
0.58 mmol/L. There is again another increase in silicon release after 28 days 
to between 0.73 and 0.98 mmol/L. 
 
Figure 108 Sodium release (millimole per litre, mmol/L) from immersed cement cylinders (n=4) 
plotted against square root of immersion time (hours) for all fluoride containing cement 
compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Error Bars = Standard 
Deviation). 
Table 36 Sodium release (millimole per litre, mmol/L) from immersed cement cylinders (n=4) for 
all cement compositions from immersion for 1 hour, 1 day, 7 days, 28 days. (Standard 
Deviation). 
Cement 
Composition 
Sodium Release (mmol/L) 
1 Hour 1 Day 7 Days 28 Days 
QMNWKPaG04 2.22 (±0.00) 5.05 (±0.03) 5.47 (±0.04) 4.07 (±0.04) 
QMNWKPaG06 3.21 (±0.03) 4.26 (±0.03) 4.41 (±0.04) 2.78 (±0.01) 
QMNWKPaG07 2.73 (±0.01) 4.38 (±0.03) 4.83 (±0.01) 2.74 (±0.01) 
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QMNWKPaG08 2.92 (±0.02) 4.39 (±0.01) 4.57 (±0.01) 5.30 (±0.01) 
QMNWKPaG09 3.19 (±0.00) 4.90 (±0.04) 4.67 (±0.06) 4.54 (±0.04) 
QMNWKPaG10 2.73 (±0.01) 4.38 (±0.02) 4.69 (±0.02) 4.33 (±0.03) 
QMNWKPaG11 2.90 (±0.03) 4.07 (±0.00) 4.33 (±0.03) 4.32 (±0.01) 
 
Cement compositions in the fluoride containing cement compositions all have 
very similar levels of sodium release at all time points studied, with release 
levels between 2.22 and 5.47 mmol/L. 
8.2 Discussion 
8.2.1 Cement Phase Analysis 
8.2.1.1 QMNWKPaG04 
1 hour 
What is clearly evident form the 31P MAS-NMR and X-ray diffraction is that at 
one hour both the glass and Ca(H2PO4)2 starting reagents have reacted and 
are no longer present. With respect to the cement phase the 31P MAS-NMR 
shows chemical shifts at 3.3, 1.4, -0.2, -1.4 ppm. The 1.4 and -1.4 ppm shifts 
are easily assignable to DCPD and DCPA respectively the 3.3 and -0.2 ppm 
are less easily assigned. OCP has chemical shifts at 3.6, 3.2, 1.8, and -0.2 
ppm, this spectrum is crowded with reasonably broad chemical shifts which 
causes convergence of peaks. Given the XRD has diffraction lines showing 
the presence of OCP, the -0.2 ppm shift is that from OCP and the 3.3 ppm 
shift may be the 3.6 and 3.2 ppm OCP shifts but converged into one peak. 
The XRD indicates the formation of OCP, DCPD and DCPA, with DCPA 
being only a small fraction due to the low intensity of the diffraction lines. 
Referring to the FTIR, there are clear OH stretching water bands present at 
3148, 3473 and 3528 cm-1. There are a number of PO bending and 
stretching bands present, bands at 555 and 600 cm-1 (PO bending) are 
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indicative of either OCP or apatite, due to apatite not being clearly present of 
the NMR these have been assigned to being part of the OCP structure. 
1 day 
At 1 day the 31P MAS-NMR spectrum is similar to the 1 hour sample. There 
are four distinguishable chemical shifts at 3.1, 1.4, -0.2, and -1.4 ppm. The 
1.4 and -1.4 ppm shifts are easily assigned to being DCPD and DCPA; 
similarly to the 1 hour sample the last two shifts (3.1 and -0.2 ppm) are more 
difficult to easily assign, but again due to the presence of OCP diffraction 
lines on the XRD these were assigned to showing the presence of OCP. The 
3.1 ppm shift like the 1 hour sample is most likely a mixture of the 3.6 and 
3.2 ppm shifts of OCP. Compared to the 1 hour sample the position of this 
shift has changed from 3.3 to 3.1 ppm. The reason for this is perhaps the 
formation of an apatite phase at 2.8 ppm, where all three shifts are present 
together and existing as ‘one’ shift. Given the 4.6 ˚2 diffraction line of OCP 
is so weak on the diffraction pattern for this cement this could indicate that 
both OCP and apatite are present. The XRD has diffraction lines indicative of 
both DCPD and DCPA, consistent with the NMR results. The FTIR spectra 
have PO bond bending bands at 555 and 600 cm-1, which indicates the 
presence of OCP, apatite or a mixture of the two. Bands at 3480 and 3530 
cm-1 showing OH stretching of water indicate that DCPD is present. 
7 days 
The 31P MAS-NMR spectrum has two clearly noticeable chemical shifts at -
0.2 ppm and 3.1 ppm; the 3.1 ppm shift not being symmetrical, having low 
intensity shoulders either side of the main shift at 3.1 ppm. Given the XRD 
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has an OCP diffraction line at 4.6 ˚2 it could be assumed that the 
‘shoulders’ on the shift at 3.1 ppm are the OCP shifts at 3.6 and 1.8 ppm; 
consequentially the presence of an apatite shift (2.8 ppm) cannot be 
discounted. There are numerous broad diffraction lines for OCP, apatite or a 
mixture of the two. Conspicuously there is an absence of any clear lines 
donating the presence of either DCPD or DCPA. Whilst DCPA has been 
found on the 31P MAS-NMR spectrum (a shift at -1.4 ppm) it most likely not 
detected on XRD as it is too low a fraction of the cement phase to be 
detectable. The FTIR spectra have two PO bond bending bands at 555 and 
600 cm-1 indicating either OCP or apatite. It is noticeable that there is an 
absence of a HPO4 bond bending band and 520 cm
-1 that is of OCP and 
there a few of the HPO4 bond bending and stretching bands as would be 
expected in a pure OCP sample (although one HPO4 bond stretching band is 
at 855 cm-1). The spectroscopic results then conclude to the cement phase 
as being a mixture of DCPA, OCP and apatite; the DCPD in this cement 
sample appears to have formed either an apatite/OCP phase between 1 day 
and 7 days. 
28 days 
The 31P MAS-NMR of the 28 day sample shows one main chemical shift at 
2.9 ppm and two less intense shoulder peaks at 5.5 and 0.8 ppm. The 2.9 
ppm shift was assigned to hydroxyapatite as the XRD shows a monophasic 
apatite cement phase. The 5.5 ppm shift was assigned to being 
unprotonated surface phosphates and the 0.8 ppm chemical shift protonated 
surface phosphates, confirmed by (Kolmas and Kolodziejski, 2012) to be 
245 
 
 
present in synthesised hydroxyapatite. The FTIR spectra agrees with this 
assignment, as well as having bands indicative of apatite there is also a band 
at 855 cm-1 assigned as a HPO4 stretching bond; fitting the 0.8 ppm shift 
assignment of protonated phosphate groups. 
8.2.1.2 Fluoride containing compositions 
Glasses QMNWKPaG06-11 have increasing levels of fluoride incorporation 
from 2.5-4.5 mol%. 31P and 19F MAS-NMR, X-ray diffraction, and FTIR 
spectroscopic techniques were used to identify the cement phases 
investigated in the setting reaction and phase evolution during immersion in 
Tris buffer solution. The 31P MAS-NMR was run on all samples and showed 
the presence at 1 hour in all samples of DCPD (1.4 ppm), DCPA (-0.2 & -1.4 
ppm) and an apatite (2.9 ppm) phase. This assignment is supported in X-ray 
diffraction where characteristic diffraction lines were assigned on the 1 hour 
diffraction patterns for all fluoride containing cements. The FTIR results also 
support this assignment as typical apatite bands (crystalline orthophosphate) 
were identified at approximately 560 and 600 cm-1. Additionally DCPD was 
identified through the assignment of bands at 520 (PO bending), 3150, 3475 
and 3530 cm-1 (all OH stretch in water) which all belong to DCPD. 
Between 1 hour and 28 days a phase evolution process occurs with both the 
DCPD and DCPA phase initially present undergoing dissolution then 
precipitation to apatite. The rate of this transformation occurs at a different 
rate for the different glass compositions with different fluoride amounts. With 
higher fluoride content the rate of this dissolution occurs at a faster rate. For 
instance, after 7 days in the cement QMNWKPaG11, the highest fluoride 
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content cement, has only apatite present; identified clearly on the X-ray 
diffraction and 31P MAS-NMR. Comparatively in all other samples at this time 
only DCPA is present. Similarly after one day all cement samples contain a 
mixture of DCPD, DCPA and apatite with the exception of QMNWKPaG11 
which contains only apatite and DCPA. After 28 days all of the cement 
samples show monophasic apatite cement phases. The 31P MAS-NMR 
results show one peak in all samples at 28 days immersion at 2.9 ppm, 
assigned as apatite. All of the X-ray diffraction results are in conclusion with 
this result as they also show only diffraction lines for apatite. The FTIR result 
again back this up by the presence of apatite bands at 560 and 600 cm-1. 
One observation that can be made is the apparent decrease in the relative 
intensity of the different phases through this cement series at the same time 
point. Addition of more fluoride in the glass composition causes an increase 
in the rapidity of the formation of the apatite phase and a decrease of the 
DCPD phase. Although this rate of transformation may be related to the 
amount of apatite formed before 1 hour immersion, as it is evident (from the 
31P MAS-NMR) that more apatite is present at 1 hour immersion as fluoride 
content is increased. Normally deconvolution can be used to quantify the 
relative intensities of the phases present in a sample. This was not done 
here however due to the low resolution of the respective peaks within the 
sample, which render any deconvolution highly inaccurate. 
19F MAS-NMR was only performed on the 1 hour and 28 day samples of 
cements produced through a reaction from the QMNWKPaG10 glass. The 
spectra confirmed the formation of a fluoride containing apatite phase. The 
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spectra do however suggest that the apatite formed is a fluoridated apatite 
rather than fluorapatite; meaning that the phase formed is a 
Fluorohydroxyapatite (Ca10(PO4)6(OH)2-xFx) rather than a pure stoichiometric 
fluorapatite (Ca10(PO4)6F2). This result was drawn from the position of the 
peaks indicating fluoride within the apatite structure. Braun & Jana showed 
that the position of the fluorine chemical shifts in apatite with hydroxyl 
content. Stoichiometric fluorapatite has a peak position of -101 ppm, it was 
shown that as hydroxyl content increases (and fluoride content decreases) 
the position of the chemical shift becomes more negative. The 
QMNWKPaG08 cement samples show two peaks at approximately -106 and 
-108 ppm respectively. The -106 ppm peak is attributed to being a low 
fluoride substituted fluorohydroxyapatite species and the -108 ppm peak is 
attributed to a CaF2 species given this is where crystalline CaF2 gives a 
resonance. Comparing the 1 hour sample with the 28 day sample there is a 
slight increase in the relative intensity of the fluorohydroxyapatite species 
compared to the CaF2 in the 28 day sample. The difference between the 
glass spectrum and the cement spectra show the fluoride has changed 
environment through the cement setting reaction and subsequent immersion. 
Whilst without analysing all the other samples one cannot conclude with 
certainty that all other samples follow this same trend it is highly likely given 
the similarity in properties that this series has. Given this the apatite within 
the fluoride containing cement samples will hereby be referred to as 
fluoridated apatite. 
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8.2.2 Effect of Glass Structure Upon Dissolution 
As with the calcium/sodium cement series with the glasses produced there is 
a change in the glass structure through the series. As well as the addition of 
CaF2 through the series there is also witnessed an increase in the free 
volume. As mentioned previously this would likely equate to a more soluble 
glass that would release its constituent ions at a faster rate as the free 
volume increased. This is supported in the results at a higher fraction of 
apatite is witnessed in the cements at 1 hour with increasing levels of CaF2. 
This supports the idea that free volume increases also equates to a more 
rapidly dissolving glass because the glass element of the cement produces a 
higher ratio of the overall calcium content of the cement; meaning that a 
cement phase with a higher calcium content (hydroxyapatite over brushite) 
forming preferentially indicates more calcium in solution. 
Unlike in the calcium/sodium cement series, where a similar trend could not 
be definitively concluded due to changes in cement composition through the 
series, the results here can be more reliably attributed to changes in glass 
structure. This is because unlike in the previous series the glass:salt ratio 
does not change, so the only change between the cement compositions in 
the alteration in glass composition rather than the amount there. 
8.2.3 Compressive Strength 
The fluorine-free cement (QMNWKPaG04) compared with all the fluorine 
containing cements shows a higher compressive strength, with the 
QMNWKPaG04 (see Figure 100) composition having a compressive strength 
at 1 hour of 9.65 MPa and the highest fluoride-containing composition being 
3.48 MPa. As is visible in the figure above this is a general trend at all time 
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points, except arguably the 28 day sample which is only marginally higher in 
the fluorine–free sample compared to those containing fluoride. The cause of 
this is related to the crystallite size and morphology. The cement strength is 
determined by interlocking of the cement phase crystallites. The ability to 
interlock and strength of interlocking is related to the crystallite size and 
shape. In Portland cement the length of the crystallite affects the strength of 
the sample and the strong cement has larger crystallites (provided other 
factors are constant). The SEM results show that the QMNWKPaG04 
(fluoride-free) cement composition has much larger plate-like crystallites 
(figure 109) that are considerably larger that the small needle-like crystallites 
in the fluoride containing cements. When comparing the cements with 
differing fluoride contents there does not appear to be a clear trend in 
compressive strength and fluoride content. This means that addition of 
fluoride in these levels causes a decrease in compressive strength that is not 
proportional to fluoride content. 
 
 
Figure 109 QMNWKPaG11 1 Hour (right), QMNWKPaG04 1 Hour (left) 
 
8.2.4 Setting Time 
The fluoride containing cements have a trend when the fluoride content is 
changed. As fluoride content in the glass is increase the length of the initial 
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setting time decreases (Figure 103). The final setting times also show a 
general trend for decreasing the setting time as fluoride content in the 
cement is increased. There is a probable anomalous result for the 
QMNWKPaG07 cement with 4.00 mol% CaF2. The cause of this trend is 
probably similar to that causing the difference in the fluoride free cements, 
albeit with different phases. The 1 hour immersion data shows that with 
increasing fluoride in the cement the proportion of apatitic cement phase to 
DCPD cement phase increases (Figure 113). As the stronger apatite phase 
forms the ability to resist the Gilmore needle increases leading to shorter 
setting times as the fluoride concentration is increased and apatite phase 
forms at a faster rate. It is also important to note that this change can be 
directly attributed to change in glass composition rather than change in glass 
powder/Ca(H2PO4)2  ratio because this ratio in the fluoride cement series is 
constant. Comparing the addition of fluoride with a cement composition 
which contains no fluoride but all other components are in the same ratios 
the results show that fluoride dramatically decreases the final setting time but 
has less of an effect on the initial setting time. The QMNWKPaG04 (fluoride-
free) composition has an initial setting time of 10.5 minutes and a final setting 
time of 19 minutes, whilst the initial setting times for the fluoride containing 
cements are between 10 and 5 minutes and final setting time between 22 
and 36 minutes. The cause of this difference again most likely lies in the 
rapidity at which the cement phase forms. It could be that the easier to 
nucleate fluoridated apatite phase forms rapidly (without immersion in Tris), 
meaning the cement is able to resist the Gilmore needle at a much earlier 
time point; though further experimentation would be required to confirm this. 
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8.2.5 Ion Release 
The fluoride release data showed that release was very low, with the fluoride 
release levels not surpassing 0.006 mmol/L in any cement compositions. 
This shows the majority of the fluoride remains within the cement mass. Its 
exact location (i.e. in cement phase or as precipitated CaF2) is unclear. The 
19F MAS-NMR suggested the fluorine is split between the apatite cement 
phase and a precipitated CaF2 phase. This is not unexpected as there is a 
strong thermodynamic drive for the fluoride to be incorporated into the 
apatite structure. 
The sodium shows similar levels in all compositions. This was related to the 
glass design where the sodium content in all of these glass compositions 
was kept constant; this coupled with the glass fraction of the cement powder 
is maintained at a similar level for all of these cement compositions caused 
the sodium release to be approximately constant. 
The calcium release does not show any obvious trends between glass 
compositions. The initial release remains fairly constant after the first 
measurement which means that no calcium is being release during the 
immersion time and none is being consumed by the cement during the 
immersion either. It should be noted also that the calcium levels in the 
solution are relatively low when compared to the phosphorus release. 
The silicon release followed a fairly conspicuous trend, with silicon content in 
the solution increasing with immersion time. This is related to the hydrolysis 
of the residual silicate chains which are hydrolysed over a period of time, 
releasing soluble silicon species into solution. 
252 
 
 
The phosphorus release data gives a clear trend for all glass compositions; 
with concentration in solution increasing over time. There does not appear 
any obvious trend between the different glass compositions in the release 
rate or amount released. This shows that phosphorus is continually released 
this may be due to the conversion of relatively phosphate rich calcium 
phosphate species that initially form and convert to species where phosphate 
is less relative to calcium values. This transformation retains the calcium but 
the phosphate is released into solution, causing the results witnessed here. 
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Chapter 9: HydroSet™ Results and Discussion 
9.1 Results 
9.1.1  X-ray Diffraction 
 
Figure 110 X-ray Diffraction pattern of HydroSet™ Starting powder. ▲ - DCPD; ⌂ - tetracalcium 
phosphate. 
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Figure 111 X-ray diffraction pattern of HydroSet™ cement cylinders after i) 1 
hour, ii) 1 day, iii) 7 days and iv) 28 days immersion in Tris buffer soltution. ● – 
Octacalcium Phosphate; ♦ Apatite; ⌂ - tetracalcium phosphate; ▲DCPD. 
 
Figure 110 and Figure 111 show the X-ray diffraction patterns of the 
HydroSet™ starting powder and the immersed HydroSet™ specimen after 1 
hour, 1 day, 7 days and 28 days. The pattern of the starting materials shows 
both DCPD and tetracalcium phosphate (Ca4(PO4)2O) within the sample. In 
the one hour pattern tetracalcium phosphate, DCPD and a small fraction of 
octacalcium phosphate were all identified within the sample. For all other 
immersion time points the octacalcium phosphate and DCPD phases were 
not identified and instead hydroxyapatite and tetracalcium phosphate were 
the cement phases, with the fraction of tetracalcium phosphate decreasing in 
relative intensity within the sample. 
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The identification of octacalcium phosphate is not as clear as in some of the 
synthesised experimental cements and one could argue that it is perhaps not 
present. The propensity of OCP to hydrolyse to hydroxyapatite has been 
discussed extensively previously. Why OCP is given as being present in 
these samples is due to the higher intensity broad line below 5 °2θ at 1 hour 
compared to the longer immersion times; which is in addition to the low 
intensity line at 9.56 °2θ at 1 hour which switch to approximately 10.8 
degrees two theta for the subsequent samples. This switch from an OCP 
diffraction line 9.5 °2θ to an apatite one at 10.8 °2θ is noticeable and taken 
as evidence supporting OCP formation. 
9.1.2 31P MAS-NMR 
 
Figure 112 
31
P MAS-NMR spectra of HydroSet™ showing i) starting powder, ii) 1 hour 
immersion, iii) 1 day immersion, iv) 7 days immersion and v) 28 days immersion. 
                                            
6
 The broad diffraction line at 9.5 °2θ is believed to be a combination of two lines in OCP 
which are found at 9.3 and 9.7 °2θ. 
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Figure 112 shows the 31P MAS-NMR for the HydroSet™ cement after 
immersion in Tris buffer solution. The starting powder sample has six peaks 
at -1.4, -0.1, 1.4, 2.8, 3.7 and 4.9 ppm. The 1 hour sample has chemical 
shifts at -1.4, -0.2, 0.2, 1.4, 2.0, 2.7, 3.7, 4.0 and 4.9 ppm. The 1 day sample 
has chemical shift at 0.0, 1.4, 2.0, 2.7, 3.7, 4.0 and 4.9 ppm. The 7 day 
sample has chemical shift at 3.1 and 3.6 ppm. The 28 day sample has 
chemical shift at 3.1 and 3.6 ppm. 
The spectral results of HydroSet™ show that this cement system is an 
OCP/HAP forming calcium phosphate cement. The 31P MAS-NMR and X-ray 
diffraction of the starting materials show that the phases present are DCPD, 
tetracalcium phosphate and DCPA. The DCPA was identified only on the 31P 
MAS-NMR and not on the X-ray diffraction by chemical shift at -1.4 and -0.2 
ppm. 
After 1 hour in Tris buffer solution the X-ray diffraction shows the presence of 
DCPD, tetracalcium phosphate and octacalcium phosphate. The 31P MAS-
NMR (Figure 112) for this sample is more complicated and difficult to 
interpret. The tetra calcium phosphate is clearly still present, as can be 
identified by the peaks at 3.8 and 4.8 ppm. This is true also for DCPD where 
a peak at 1.4 ppm is present. The peaks at -1.4 and -0.2 ppm show a small 
fraction of DCPA is still present in the cement phase from the starting 
materials. At one hour there is also octacalcium phosphate present. This was 
identified on the X-ray diffraction from low intensity lines at 4.7 and 9.8 
degrees 2 theta. The 31P MAS-NMR is slightly more difficult to identify OCP 
due to the large number of peaks at similar chemical shifts. Strong evidence 
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of OCP on the 31P MAS-NMR spectra is a peak at 3.6 ppm which would be 
expected if OCP was present. The other chemical shift for OCP at 3.3, 2.0 
and -0.2 ppm are more difficult to identify due to the higher number of signals 
between -1.4 and 5.0 ppm from a number of calcium phosphate phases. 
The X-ray diffraction shows that on the 1 day, 7 day and 28 day samples the 
same two phases are present, tetracalcium phosphate and hydroxyapatite. 
The only apparent change is the relative intensities of the two phases appear 
to change; the tetracalcium phosphate decreases in relative intensity 
whereas the hydroxyapatite increases in its relative intensity. The 31P MAS-
NMR results show that at 1 hour tetracalcium phosphate is present with 
peaks at 3.8 and 5.0 ppm. There is a fairly broad shoulder at 2.8 ppm 
suggesting hydroxyapatite is present, as well as a peak at 1.4 ppm 
suggesting a small fraction of DCPD is present. There are also several peaks 
at 3.6, 2.0 and -0.2 ppm showing that OCP is present. The 7 day 31P MAS-
NMR spectrum has a peak at 3.0 ppm of hydroxyapatite and two additional 
peaks at 3.7 and 4.9 ppm of tetra calcium phosphate. The 28 day sample 
has a main peak at 2.9 ppm (hydroxyapatite), a shoulder at 3.7 ppm and a 
very small shoulder at 4.9 ppm (tetracalcium phosphate).  
9.1.3 Compressive Strength 
Glass 
Composition 
Compressive Strength (MPa) 
1 Hour 1 Day 7 Days 28 Days 
HydroSet™ 14.24 25.43 13.58 25.12 
 
HydroSet™ has higher values compared to the experimental compositions, 
the values ranged from 13.58 to 25.43 MPa. 
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9.1.4 Setting Time 
Cement 
Composition 
Initial Setting 
Time (min) 
Final Setting 
Time (min) 
HydroSet™ 6 30 
 
The initial setting time of the HydroSet sample was 6 min and the final setting 
time was 30 min. 
9.2 Discussion 
9.2.1 Cement Phase Analysis 
The spectral results of HydroSet™ show that this cement system is an 
OCP/HAP forming calcium phosphate cement. The 31P MAS-NMR and X-ray 
diffraction of the starting materials show that the phases present are DCPD, 
tetracalcium phosphate and DCPA. The DCPA was identified only on the 31P 
MAS-NMR and not on the X-ray diffraction by chemical shift at -1.4 and -0.2 
ppm. 
After 1 hour in Tris buffer solution the XRD shows the presence of DCPD, 
tetracalcium phosphate and octacalcium phosphate. The 31P MAS-NMR 
(Figure 112) for this sample is more complicated and difficult to interpret. The 
tetracalcium phosphate is clearly still present, as can be identified by the 
peaks at 3.8 and 4.8 ppm. This is true also for DCPD where a peak at 1.4 
ppm is present. The peaks at -1.4 and -0.2 ppm show a small fraction of 
DCPA is still present in the cement phase from the starting materials. At one 
hour there is also OCP present. This was identified on the X-ray diffraction 
from low intensity lines at 4.7 and 9.8 degrees 2 theta. The 31P MAS-NMR is 
slightly more difficult to identify OCP due to the large number of peaks at 
similar chemical shifts. Strong evidence of OCP on the 31P MAS-NMR 
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spectra is a peak at 3.6 ppm which would be expected if OCP was present. 
The other chemical shift for OCP at 3.3, 2.0 and -0.2 ppm are more difficult 
to identify due to the higher number of signals between -1.4 and 5.0 ppm 
from a number of calcium phosphate phases. 
The X-ray diffraction shows that on the 1 day, 7 day and 28 day samples the 
same two phases are present, tetracalcium phosphate and hydroxyapatite. 
The only apparent change is the relative intensities of the two phases appear 
to change; the tetracalcium phosphate decreases in relative intensity 
whereas the hydroxyapatite increases in its relative intensity. The 31P MAS-
NMR results show that at 1 hour tetracalcium phosphate is present with 
peaks at 3.8 and 5.0 ppm. There is a fairly broad shoulder at 2.8 ppm 
suggesting hydroxyapatite is present, as well as a peak at 1.4 ppm 
suggesting a small fraction of DCPD is present. There are also several peaks 
at 3.6, 2.0 and -0.2 ppm showing that OCP is present. The 7 day 31P MAS-
NMR spectrum has a peak at 3.0 ppm of hydroxyapatite and two additional 
peaks at 3.7 and 4.9 ppm of tetra calcium phosphate. The 28 day sample 
has a main peak at 2.9 ppm (hydroxyapatite), a shoulder at 3.7 ppm and a 
very small shoulder at 4.9 ppm (tetracalcium phosphate). 
9.2.2 Compressive Strength 
9.2.3 Setting Time 
Stryker, the manufacturers of HydroSet™ state that HydroSet™ has an initial 
setting time of 4.5 minutes and a final setting time of 8.5 minutes (Co, 2010) 
whereas the results using the Gilmore needle test give an initial setting time 
of 6 minutes and final setting time of 30 minutes. Thus difference is because 
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the manufacturers use a different method to measure the initial and final 
setting times when developing HydroSet™. This highlights that setting time is 
a difficult thing to assess and measure and especially apply this to a clinically 
meaningful context. There is no figure of acceptable and not acceptable 
setting times rather the assessment should be does this set well enough in-
vivo to allow the clinician to easily implant it and to not cause any negative 
effects in-vivo such as washout or disfigurement. 
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Chapter 10: Overall Discussion 
10.1 General Comments and Trends of Experimental 
Cements 
Table 37 Summary of major cement phases formed in each cement formulation at each 
immersion time point. DCPD = dicalcium phosphate dihydrate (Red), OCP = octacalcium 
phosphate (Green), HAP = hydroxyapatite (Purple), AP = apatite
7
 (Blue), FAP = fluoridated 
apatite (Black). 
 
The results presented here demonstrate the use and value gained from 
using multiple techniques to characterise not only the setting reaction of 
calcium phosphate cements, but also in the characterisation of calcium 
phosphates in general. The value was most obvious when characterising the 
octacalcium phosphate, due to the similarity in the crystal structure of apatite 
and octacalcium phosphate it can be very difficult to differentiate between 
these two phases via X-ray diffraction. As mentioned previously this is due to 
                                            
7
 HAP and AP were used respectively for hydroxyapatite and apatite in order to specify 
when the prensence of hydroxyl ions in the apatite structure. Usually confirmed using FTIR. 
Cement 
Composition 
Immersion Time 
1 Hour 1 Day 7 Days 28 Days 
Calcium/Sodium Series 
HydroSet™ DCPD/OCP DCPD/OCP/ HAP HAP HAP 
QMNWKPaG13 DCPD DCPD DCPD /OCP OCP 
QMNWKPaG03 DCPD DCPD DCPD /OCP OCP 
QMNWKPaG14 DCPD /OCP DCPD /OCP OCP OCP/HAP 
QMNWKPaG15 OCP OCP AP AP 
QMNWKPaG16 OCP/AP OCP/AP AP AP 
 CaF2 Series 
QMNWKPaG04 DCPD /OCP DCPD /OCP OCP/AP AP 
QMNWKPaG06 DCPD /AP DCPD /AP DCPD /AP AP 
QMNWKPaG08 DCPD/FAP DCPD /AP AP FAP 
QMNWKPaG09 DCPD /AP DCPD /AP AP AP 
QMNWKPaG10 DCPD /AP DCPD /AP AP AP 
QMNWKPaG07 DCPD /AP DCPD /AP AP AP 
QMNWKPaG11 DCPD /AP AP AP AP 
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these two phases possessing indistinguishable diffraction patterns above 10 
˚2. When performing X-ray diffraction on calcium phosphate systems it is 
advisable to run from at least 3 ˚2 in order to be able to detect the 4.7 ˚2 
diffraction line which is a diffraction line present in octacalcium phosphate but 
not in apatite. However, whilst this procedure was performed on these 
cement systems it still could have led to mischaracterisation of the exact 
cement phase. This is because whilst the presence of the 4.7 ˚2 diffraction 
line does show that octacalcium phosphate is present it does not tell you 
whether apatite is not present as there could be present a mixture of the two 
phases. It could be partially deciphered by looking at the relative intensities 
of the diffraction lines because the 4.7 ˚2 diffraction line is the most intense 
line on octacalcium phosphate, one could argue that a relatively intense 4.7 
˚2 line would indicate that the cement phase is in the vast majority 
octacalcium phosphate with only maybe a small fraction of apatite. The 
results here demonstrate that this cannot be assumed; for instance, in the X-
ray diffraction pattern of the 28 day QMNWKPaG03 cement the diffraction 
lines around 31˚2 are much more intense than the diffraction line at 4.7 ˚2 
which could lead one to assume the octacalcium phosphate is present but as 
a small fraction of the cement phase. However the 31P MAS-NMR showed 
that the cement phase was virtually completely octacalcium phosphate and 
that there was not apatite detectable. 
Further to this the multiple technique characterisation of calcium phosphates 
proved valuable in fully characterising the cement phases, especially when 
the cement phase is primarily apatite. The 28 day QMNWKPaG14 cement 
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sample demonstrates this aptly. The X-ray diffraction shows that apatite is 
present which is in agreement with the 31P MAS-NMR results. The FTIR was 
able to demonstrate the presence of the hydroxyl group in the apatite 
structure and the presence of carbonate substitution, enabling the 
characterisation of this cement phase as being carbonate substituted 
hydroxyapatite. 
All of the spectral results show that both the starting reagents have dissolved 
within 1 hour for all cement compositions. The 31P MAS-NMR spectra show 
that the Ca(H2PO4)2 and the phosphate content of the glass has degraded 
before one hour to form the cement phase. This is due to the high solubility 
of both the Ca(H2PO4)2 salt phase and the bioactive glass. This differs from 
the HydroSet™ setting reaction where the starting reagents of undergo 
complete dissolution between 7 days and 28 days. 
The 19F MAS-NMR could only be run on one cement sample, the 
QMNWKPaG08. It confirmed the presence of a CaF2 species and a 
fluoridated apatite species. Stoichiometric fluorapatite (Ca10(PO4)6F2) gives a 
chemical shift at -101 ppm. It has been shown previously that non-
stoichiometric fluorapatite causes a shift in the position of the chemical shift 
on the 19F MAS-NMR spectra proportionally to fluoride content.  
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10.2 Calcium-sodium Cement Compositions (QMNWKPaG03 
& 13-16 
10.2.1 Summary 
In all the cement compositions there is a clear reaction pathway; in the 
fluoride-free cement compositions this being DCPD > octacalcium phosphate 
> hydroxyapatite and the fluoride containing series being DCPD > apatite.  
The change in glass composition clearly causes the rate at which this 
reaction pathway progresses to change. The slowest rate of this transition 
occurs in the QMNWKPaG03 and QMNWKPaG13 cement compositions 
where the DCPD to octacalcium phosphate transition occurs between 1 day 
and 7 days and the octacalcium phosphate to hydroxyapatite transition is not 
witnessed within 28 days. Whereas the fastest transition occurs in 
QMNWKPaG16 cement composition, at 1 hour the cement phase is a 
mixture of apatite and octacalcium phosphate, with hydroxyapatite being the 
major phase. The cement has already passed though the DCPD step within 
an hour. There is also a noticeable shift as the sodium content of the glass is 
increased, as more sodium is in the glass composition the rate of phase 
evolution increases.  
The cause of this can be speculated upon and may be due to the 
combination of a number of factors. (1) The increase in sodium content has 
been shown to cause an increase in pH (Wallace et al., 1999). This affect 
could be translated into the cement system causing those cements to more 
rapidly increase pH after the initial acidity created by the dissolution of the 
Ca(H2PO4)2, causing a faster transition to a pH outside that of the stability 
range of DCPD thus causing a faster transition to octacalcium 
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phosphate/apatite. (2) As the sodium is increased in the glass composition 
the amount of Ca(H2PO4)2 salt added to maintain the overall calcium to 
phosphorus ratio in the cement powder is decreased. A decrease in salt 
quantity would reduce the acidity of the reaction environment when the salt 
dissolves, the cement would then reach a pH outside the stability range of 
DCPD.  
10.2.2 Proposed Setting Reaction 
(1) Ca(H2PO4)2 + 2H2O → CaHPO4.2H2O + H3PO4 
(2) H3PO4 → 3H
+ + PO4
3- 
(3a) 2(Si-O)Ca + 2H+ → 2SiOH + Ca2+ 
(3b) R-(Si-O)Na + H+ → R-SiOH + Na+ 
(4) 10CaHPO4.2H2O → Ca8(HPO4)2(PO4)4.5H2O + 2Ca
2+ + 4H2PO4
- + 
15H2O 
(5) Ca8(HPO4)2(PO4)4.5H2O + 2(OH)
- + 2Ca2+ → Ca10(PO4)6(OH)2 + 5H2O 
+ 2H+ 
(1) All the spectroscopic techniques show that within 1 hour the Ca(H2PO4)2 
starting reagent has completely dissolved and the primary cement phase is 
DCPD (CaHPO4.2H2O). This is particularly evident on in the QMNWKPaG03 
1 hour cement composition where the FTIR, MAS-NMR and XRD all show an 
almost pure DCPD cement phase. This is due to the high solubility of 
Ca(H2PO4)2, which once the 2.5% Na2HPO4 solution is added immediately 
dissolves, creating an acidic reaction environment. The H+, Ca2+ and PO4
3- 
ions released after the dissolution then precipitate the DCPD phase, which 
according to calcium phosphate solubility diagrams is favoured due to the 
high acidity of the reaction solution (Elliott, 1994). 
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(2-3) Steps 2-3 are related stages and step three is induced by step two. 
Step two is partially simplified as the H3PO4 species would most likely exist 
as a number of protonated phosphate species of varying degrees between 
completely deprotonated to completely protonated with any deprotonated 
hydrogen ions being in the reaction solution. Steps 3a and 3b refer to 
degradation of the glass which is induced by the acidity of the solution. Ion 
exchange occurs between the calcium and sodium ions and the protons in 
solution. This causes the release of calcium and sodium ions into the 
reaction solution and creation of silanol groups (Si-OH) on the silicate chains 
(Hench, 1993). Another likely consequence of the ion exchange process is 
an increase in pH due to the consumption of protons in solution. This idea is 
applied from the original and widely accepted Hench mechanism of glass 
dissolution (Hench, 1993). 
(4) Once the pH of the reaction environment begins to increase caused by 
the ion exchange process and after the immersion in Tris buffer, a phase 
transition process is initiated. The DCPD undergoes a 
dissolution/precipitation process after which octacalcium phosphate 
precipitates. It is most likely a contribution of two processes which induce this 
transformation. (1) Change in pH causes DCPD to leave its pH stability 
range and (2) there is a thermodynamic drive to form a more 
thermodynamically stable phase (Elliott, 1994). The point at which this 
process begins to occur and the rate at which it happens is shown to alter 
between cement compositions. 
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(5) The octacalcium phosphate phase over time is transformed to a 
hydroxyapatite phase. This is a thermodynamically driven process as 
hydroxyapatite is more thermodynamically stable than octacalcium 
phosphate (Fernandez et al., 1999a). It is strongly believed that the 
transformation of octacalcium to hydroxyapatite proceeds via a solid state 
phase transition rather than dissolution/precipitation as in DCPD to 
octacalcium phosphate transition (Tseng et al., 2006, Aue et al., 1984). 
10.3 Fluoride Containing Cement Compositions 
10.3.1 Summary 
The fluoride containing glasses produced cements followed the same 
reaction pathway as each other. The presence of DCPA was most likely 
introduced as an impurity from the Ca(H2PO4)2, which was shown to be 
present in the NMR. In all cement compositions with fluorine the reaction 
follows the same pathway (evolution of phase); in the initial cement reaction 
(0-60 min) DCPD and fluoridated-apatite are formed. Subsequently the 
DCPD phase undergoes a hydrolysis reaction to form apatite; this is evident 
on the NMR where the intensity of the DCPD chemical shift decreases 
relative to the apatite shift (Figure 111). The DCPA generally persists until 
after the DCPD has been hydrolysed and like DCPD it will be hydrolysed 
also to an apatite phase. 
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Figure 113 
31
P MAS-NMR spectra of series of fluoride containing cement compositions 
plotted in order of increasing CaF2 (mol%) in the glass used to produce the cement, 
ranging from 2.5-4.5 mol% CaF2 and 0 mol% CaF2. 
An evident trend in the fluoride containing series is the effect on the cement 
setting reaction of the fluoride content, whilst the amount of DCPA appears 
unaffected (due to it being an impurity in the starting material) the ratio of 
DCPD and apatite phase alters depending upon fluoride concentration. As is 
visible in Figure 113, as the concentration of fluoride increases the fraction of 
DCPD decreases.  
10.3.2 Proposed Setting Reaction 
(1) Ca(H2PO4)2 + 2H2O → CaHPO4.2H2O + H3PO4 
(2) H3PO4 → 3H
+ + PO4
3- 
(3a) 2(Si-O)Ca + 2H+ → 2SiOH + Ca2+ 
(3b) (Si-O)Na + H+ → SiOH + Na+ 
(4) Ca2+ + (PO4)
3- + (OH)- + F- → Ca10(PO4)6(OH)2-xFx  
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(5) 6CaHPO4.2H2O  + 2-x(OH)
-  + xF- + 4Ca2+ → Ca10(PO4)6(OH)2-xFx + 
5H2O + 6H
+ 
(1-3) The initial cement setting mechanism in the fluoride containing cements 
is believed to follow the same initial steps as in the fluoride-free cements 
(and is explained in detail there). Essentially this details the dissolution of the 
Ca(H2PO4)2 and glass starting reagents to release the calcium phosphate 
phase forming ions. Additionally the formation of DCPD occurs during these 
stages. 
(4) In step four the reaction pathway deviates from that of the fluoride-free 
cements. The cements show the direct precipitation of a fluoridated apatite, 
rather than an octacalcium phosphate phase. Indeed, whilst octacalcium 
phosphate is identified in at least one time point for every cement 
composition not containing fluoride in cement compositions containing 
fluoride octacalcium phosphate was not identified at any time point 
(5) The DCPD formed in the initial dissolution of the Ca(H2PO4)2 dissolves 
and precipitates to a fluoridated apatite. For most of the compositions this 
occurred between 1 day and 7 days apart from the cement with the lowest 
fluoride concentration, which transformed completely between 7 days and 28 
days. 
10.4 HydroSet™ 
10.4.1 Summary 
Both the X-ray diffraction and 31P MAS-NMR for the studied HydroSet™ are 
somewhat difficult to interpret given the complexity of the results caused by 
the presence of many phases. The X-ray diffraction and 31P MAS-NMR 
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results agree the cements form octacalcium phosphate and hydroxyapatite 
during the cement setting reaction, with the octacalcium phosphate 
transforming to hydroxyapatite with 28 days in Tris buffer solution. The 
starting materials remain unreacted inside the cement cylinder for a 
considerably longer period than the cement developed in this project. Whilst 
the DCPD fully dissolves between 1 day and 7 days the tetracalcium 
phosphate is still present at 28 days.  
One interesting result is the amount of time the tetracalcium phosphate takes 
to fully react to form the cement phase. The two starting reagents are added 
together in an overall calcium to phosphorus ratio of 1.67 to favour apatite 
formation (Clarkin et al., 2009). This could be due to the relative particle 
sizes of the two starting reagents or lack of water penetrating the cement 
cylinder causing the dissolution of the tetracalcium phosphate and 
precipitation of the cement phase, as it has been shown particle size can 
have a large influence on the reactivity of starting components in calcium 
phosphate cements (Ishikawa et al., 1995). 
Traditionally it was believed that during the setting of HydroSet™ the cement 
phase formed was hydroxyapatite (Clarkin et al., 2009). The results show 
here that the cement setting reaction additionally forms octacalcium 
phosphate. It is not known from these results if the octacalcium phosphate 
forms as a precursor to the hydroxyapatite formation, as it does in the novel 
cement compositions developed, or if it only forms as well as the 
hydroxyapatite. 
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10.4.2 Setting Reaction 
1. 2CaHPO4.2H2O + 2Ca4(PO4)2O + H2O → Ca8(HPO4)2(PO4)4.5H2O + 
2Ca2+ + 2(OH)- 
2. Ca8(HPO4)2(PO4)4.5H2O + 2Ca
2+ + 2(OH)- → Ca10(PO4)6(OH)2 + 2H
+ 
+5H2O 
10.5 Crystal Morphology 
The results from the scanning electron microscopy showed a range of crystal 
morphologies which appeared to follow a number of trends that correlated 
with the spectral analysis of the cement samples. There were generally four 
crystal morphologies visible in the cement phases; although there was some 
slight differences in the exact dimensions of each of the morphologies. The 
four morphologies identified were needles, ribbons, plates and irregular 
petals. 
1. Needles – The needle morphology was only seen in the cements 
where fluoride was added and the cement phase was apatitic. Figure 
114 shows a representative image of this morphology. As can be seen 
the crystals are very small but relatively long in one direction. It is 
thought that the phase of these crystallites is a fluoridate-apatite. 
Fluorapatite or fluoride containing apatite is known to take this needle 
morphology and its occurrence here agrees with this interpretation. 
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Figure 114 Typical needle morphology witnessed on the SEM images of the calcium phosphate 
cements. 
2. Ribbons – ribbon morphology was observed in cement compositions 
where octacalcium phosphate was present or had been previously 
formed. The ribbons were generally large >30 µm in their longest 
direction. The ribbons are displayed in Figure 115. The cause of this 
morphology is outlined in the following section. 
 
Figure 115 Typical ribbon morphology witnessed on the SEM images of the calcium phosphate 
cements. 
3. Plates – Figure 116 shows the plate morphology seen in some of the 
cements. This morphology is attributed to being DCPD crystallites 
because it is only witnessed in the cements where DCPD is identified 
using the spectroscopy, this is emphasised in the QMNWKPaG03 
cement composition at 1 hour and 1 day. 
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Figure 116 Typical plate morphology witnessed on the SEM images of the calcium phosphate 
cements. 
4. Irregular Petals – there was a distinctive irregular petal morphology 
seen in some of the cement compositions at generally longer time 
points of immersion. As seen in Figure 117 the crystals have irregular 
shaped boarders but are very thin. It is believed that these crystals are 
predominantly apatite that has undergone phase transition from 
octacalcium phosphate crystals. This would account for the thin nature 
of the crystal that is driven by the structure of the octacalcium 
phosphate. Continual growth during the immersion period causes the 
irregular shape observed as the crystals. 
 
Figure 117 Typical irregular plate morphology witnessed on the SEM images of the calcium 
phosphate cements. 
10.5.1 Octacalcium Phosphate 
In the SEM images it is evident that the OCP crystallites take a ribbon-like 
morphology. This ‘ribbon’ or ‘plate’ morphology is not unique in this study 
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and is in fact a common trend for OCP. It is believed this is caused by the 
octacalcium phosphate structure having the lowest overall interfacial energy 
compared to any other potential morphology. In 1878 Gibbs theorised that a 
crystal (or droplet) will arrange itself in an orientation of low surface (or 
interfacial) energy that minimises Gibbs free energy (Gibbs, 1957). This was 
defined as:  
(13) 
    ∑   
 
   
 
 
 
Where γj represents the surface energy per unit area of the jth face and Oj is 
the area of said face. ∆Gi represents the difference in energy between a real 
crystal composed of i molecules with a surface, and a similar configuration of 
i molecules located inside an infinitely large crystal. This quantity is therefore 
the energy associated with the surface. The conclusion can then be drawn 
that the equilibrium shape of the crystallite will be that which minimises the 
value of ∆Gi. Succinctly put, where possible thermodynamics will induce a 
crystallite morphology that maximises the surface area of low interfacial 
energy surfaces and minimises the surface area of high interfacial energy 
ones. Further to this the Gibbs-Wulff theorem proposes that the length of a 
vector drawn from the centre of a crystal to the crystal face hj will be 
proportional to its surface energy γj (Strickland-Constable, 1968). 
(14)           
 
The vector ‘hj’ is the height of the jth face, and is drawn from the centre of the 
crystal to the chosen face. 
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Figure 118 Representative images of atom 
arrangement in octacalcium phosphate crystal 
structure (right) and layer ordering and 
morphology of octacalcium phosphate crystallites. 
If this idea is applied to the morphology of the octacalcium phosphate 
crystals seen on the SEM then it explains the morphology witnessed. The 
octacalcium phosphate crystal consists of two layers; an apatite-layer and a 
water-layer. The ‘a’ axis of an octacalcium phosphate crystallite is made of 
alternating apatite-layer and water-layers.  Comparing the composition of the 
apatite and hydrated layers in the OCP crystal structure the apatite layer is 
made of six Ca2+ ions, two phosphate ions and one water molecule; the 
water layer consists of two Ca2+ ions, one phosphate ion and four water 
molecules, with the remaining three phosphates are located in the junction 
between the two layers (Brown, 1962). Due to the difference in the 
composition of these two layers it is thought that they will have different 
interfacial energies. Due to the high water content of the hydrated layer, the 
H2O molecules would induce hydrogen bonding between the crystal and 
surrounding aqueous solution and there would have a slightly higher affinity 
between the hydrated layer and the solution compared to the apatite layer 
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and the same solution. This would equate to a lower interfacial energy on the 
water layer compared to the apatite layer. Thermodynamics would then 
favour the increase in the proportion of lower interfacial energy surface in 
order to reduce free energy. In this instance the face of the b-c axis on the 
OCP crystal would be increased causing the ribbon (or sometimes plate) 
morphology. 
 
 
Figure 119 Scanning eletron micrographs of cement compositions 
showing typical octacalcium phosphate morphology 
10.5.2 Fluoridated Apatite 
The SEM images show a clear morphology difference between different 
cement phases. A particularly noticeable difference is between the 
hydroxyapatite/octacalcium phosphate and fluoridated-apatite cement 
phases. The hydroxyapatite/octacalcium phosphate crystallite morphology in 
the fluorine-free cement compositions has a ribbon or plate morphology 
(Figure 119) whilst the fluoridated-apatite shows a small needle morphology. 
The potential causes of the needle morphology is that the fluoridate-apatite 
has not passed through the OCP precursor phase like the hydroxyapatite 
has, so the thermodynamic drive to increase the face area corresponding to 
the octacalcium phosphate water layer has not occurred.  
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10.6 Phase Transition in Cement Evolution 
10.6.1 Dicalcium Phosphate Dihydrate-Octacalcium Phosphate-
Hydroxyapatite 
According to thermodynamic theory one would expect for hydroxyapatite to 
form preferentially to octacalcium phosphate due to it having a lower 
solubility because of its higher stability and being more thermodynamically 
stable than octacalcium phosphate. However, in the incidence of the fluorine-
free cement compositions it is clear that octacalcium phosphate forms as an 
intermediary to hydroxyapatite formation. It is known that octacalcium 
phosphate both nucleates and grows easier than hydroxyapatite (Elliott, 
1994). This indicates that the reaction is a kinetically determined process as 
opposed to a thermodynamically determined one. According to the Ostwald-
Lussac law of stages, in a system where a number of crystalline phases can 
potentially form, the phase with the most kinetically favourable phase will 
form preferentially over any phase with a higher nucleation energy barrier 
(De Yoreo and Vekilov, 2003). Then the phase will pass through any 
potential metastable intermediary phases until the most stable phase is 
formed. 
A contributor to the high energy of formation of hydroxyapatite is the relative 
lack of hydroxyl ions in the solution given the reaction occurs in an acidic 
environment meaning the available concentration of hydroxyl ions is very 
low. Given hydroxyl ions make up part of the hydroxyapatite structure the 
chance of them being readily available for nucleation is relatively low. 
Octacalcium phosphate on the other hand does not have hydroxyl ions within 
its structure and actually possesses protonated phosphate groups. Another 
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factor contributing to the favourable formation of octacalcium phosphate is 
the structural water molecules in the crystal structure which would contribute 
to lowering the interfacial energy of the octacalcium phosphate crystallites. 
The Ostwald-Lussac law of stages also applies to understanding why DCPD 
forms preferentially to DCPA; as DCPA is a more stable and less soluble, as 
such, thermodynamically one would expect DCPA to form preferentially 
(Elliott, 1994, Gibbs, 1957). As with the octacalcium phosphate the cause of 
this is most likely due to the kinetics of the nucleation of the DCPD phase. 
The formula of DCPD (CaHPO4.2H2O) and DCPA (CaHPO4) show that the 
only difference is two structural water molecules in the DCPD structure. 
These water molecules are likely to lower the interfacial energy in DCPD 
nuclei which is likely to be reflected in a lower nucleation energy barrier. 
There is a slight deviation in the reaction pathway from the Ostwald-Lussac 
law of stages as after the DCPD forms one would expect DCPA to form 
except in the fluorine free composition the reaction goes from DCPD to OCP 
and in the fluorine containing compositions the reaction goes from DCPD to 
apatite. The cause of this is perhaps pH related as during the initial setting 
when the DCPD is initially formed the reactions conditions are highly acidic in 
the region of the stability of DCPD and DCPA.  
10.6.2 Dicalcium Phosphate Dihydrate -Fluoridated Apatite 
These results show that in an acidic environment the nucleation of 
fluorapatite is more kinetically favourable than the formation of octacalcium 
phosphate. This conclusion was drawn from a number of the results gained 
from the studies performed. Firstly the 31P MAS-NMR and XRD confirmed 
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that in all of the fluoride containing cement compositions a fluoridated apatite 
was formed in all instances, whereas in the fluoride free cement 
compositions octacalcium phosphate was identified in at least one time point 
in all compositions. Secondly in the SEM images show a difference in the 
size and number of crystallites between the fluoride containing and fluoride-
free samples. In general the fluorine containing cement compositions had 
small (<10 µm length) crystallites that were more numerous than the 
generally larger crystallites (>20 µm) in the fluorine free cement 
compositions. 
Explaining the reaction mechanism requires applying both kinetics and 
thermodynamics the process. There are three potential reasons for the 
formation of apatite preferentially to OCP in the fluoride containing cements. 
(1) Fluorapatite has a lower energy barrier to nucleation than octacalcium 
phosphate, this idea is supported by the large number of small 
crystallites witnessed on the SEM. Fluorapatite is a more 
thermodynamically stable phase than OCP but the reaction pathway is 
a kinetically driven process, following the Ostwald-Lussac law (De 
Yoreo and Vekilov, 2003). OCP is less thermodynamically stable than 
hydroxyapatite but the nucleation of it is more kinetically favourable it 
does not mean than less thermodynamically stable phases are always 
more kinetically favourable in formation. It is believed that a more 
soluble (and less stable) phase is likely to have a lower nucleation 
energy than a less soluble phase. The SEM support this idea in that 
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the apatite cement phase is a high number of small needle-like 
crystals. 
(2) Apatites (including hydroxyl, fluoro and any mixtures of the two) have 
lower nucleation energies than OCP and the reason apatite does not 
form directly in the fluorine free cement compositions is the lack of 
hydroxyl ions in the acidic cement forming reaction environment. This 
is in contrast to the first idea which suggests that only fluorapatite has 
a lower nucleation energy. 
(3) OCP may in actual fact form in the fluoride containing cements though 
the transition from OCP to fluorapatite occurs before the first time 
point studied. There is evidence showing that addition of fluoride to a 
OCP containing solution does increase the rate of OCP to apatite 
formation but this theory is slightly affected by the fact there is a clear 
difference in both the number and size of crystallites. If OCP was still 
an intermediary phase then you would expect the nuclei to form at the 
same rate and grow to the same size as those crystallites without 
fluoride because the nucleation barrier for OCP formation should not 
change through fluoride presence. This is not the case however as the 
crystallites in the fluoride containing cements are smaller and more 
numerous than the fluoride free OCP crystallites. Another point 
against this idea is that in OCP to apatite transition the resultant 
crystallite morphology of the apatite is the same as the morphology 
(plate-like) of the initial OCP formed. This is because the transition 
between these two species is via solid state phase transition rather 
than dissolution and precipitation (Tseng et al., 2006). However, in the 
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SEM images for the fluoride containing cements the morphology of 
the apatite cement phase is small needle-like crystals. 
At least all three explanations are possible, however of these ideas theory 
one is probably the most likely as it fits with the results and nothing obviously 
contradicts it. Further experimentation should be conducted to confirm this is 
the case. 
10.7 Comparisons and Differences with Existing Calcium 
Phosphate Cements 
Comparing the novel cements developed through this project, with 
conventional CPCs, shows a series of similarities and differences in their 
properties and behaviour. These novel cements are related in that they are 
calcium phosphate forming cement phases. 
A difference from traditional calcium phosphates is the use of glass as a 
reactive precursor which releases ions for the cement setting reaction. Whist 
previously bioactive glasses have been added to calcium phosphate 
cements, there role was only as a bioactive filler designed to improve 
biocompatibility of the cement (Renno et al., 2013). This is a similar 
approach to other biomaterials which have had bioactive glass added to 
them as a filling agent (Li et al., 2013). The use of glass gives contrasting 
properties to traditional CPC’s; these results demonstrate the potential to 
control various properties of the cements produced. Traditional calcium 
phosphate cements can only be manipulated through changes in particle 
size, ratios of components or through the addition of accelerants or retarders. 
The reason for this is that salts are fixed in their stoichiometry and solubility 
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whereas glasses can have these properties altered through composition 
changes. It was shown here that the setting time, compressive strength, and 
cement phase could all be altered through changes in the glass composition. 
This is due to the high variability in potential glass composition which 
enables the alteration of  
A difference witnessed with these cements is the extension in setting times 
of DCPD forming cement compositions without the use of retardants. 
Unworkable setting times (1-3 mins) initially hampered the clinical use of 
DCPD forming calcium phosphate cements (Tamimi et al., 2012). The short 
setting times did not allow adequate time for the cement to be mixed the 
injected into the implanted site and moulded to the desirable shape. 
Consequently efforts were taken to extend these times to those more 
acceptable and various retardants were added to delay the setting reactions. 
Magnesium and pyrophosphate have both been added as retardants to 
DCPD cements8. With the addition of additives one must consider the 
potential negative in-vivo consequences of their addition. Pyrophosphates 
are known to have biological effects, specifically have been known to cause 
bisphosphonate related osteonecrosis of the jaw (BRONJ), when used to 
treat osteoporosis; and both magnesium and pyrophosphates have been 
shown to influence apatite mineralisation in vitro. Therefore it is 
advantageous to limit the number of potential additional components in any 
cement formulation. 
                                            
8
 Additionally the use of these components has also been used to inhibit the transformation 
of Brushite to apatite in-vivo, with the aim of increasing resorption rates. 
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Compressive strengths are difficult to judge and compare as porosity affects 
strength proportionally (Guo et al., 2009). Whilst the compressive strengths 
presented here are perhaps lower than those previously reported for calcium 
phosphate cements (which have maximum values of approximately 25-30 
MPa), it should be mentioned of the effect liquid to powder ratio (L/P) has 
upon cement strength. The L/P in the initial reaction has a high effect upon 
the porosity of the resultant cement. Typically apatite forming calcium 
phosphate cements have L/P of 0.3 – 0.4, however due to the high solubility 
of the two starting reagents causes the need for the high L/P (0f 0.7) to 
produce a cement with sufficient rheology for the cement to be injectable. 
Silicon incorporation (and release) in the cement composition also has a 
number of benefits. Aqueous Si has been shown to enhance osteoblast 
proliferation, differentiation and collagen production and to have dose 
dependent effects on osteoclast cells under in vitro conditions (Reffitt et al., 
2003). Whilst there are developed calcium phosphate bone substitute 
materials incorporating silicon into their formulation, currently there are no 
known examples of silicon incorporation into calcium phosphate cements.  
Octacalcium phosphate forming calcium phosphate cements have been 
reported previously (Honda et al., 2009) but not as extensively as if 
octacalcium phosphate is a precursor species to hydroxyapatite as has 
previously been suggested. Although this may have just been due to difficulty 
in identification as it has been shown here that the previously believed 
directly hydroxyapatite forming HydroSet™ actually forms octacalcium 
phosphate during early time points. In addition, as the HydroSet™ starting 
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reagents are identical to those originally formulated in CPCs (and is 
commonly used in commercial examples) it is likely that many other CPC 
formulations also form OCP but it has not been identified. Octacalcium 
phosphate has been shown to enhance bone formation in-vivo (Suzuki et al., 
2006, Anada et al., 2008) and also have a positive impact on cell proliferation 
(Morimoto et al., 2012). 
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Chapter 11: Conclusions 
 It was shown that it is possible to form a calcium phosphate cement 
where one of the starting reagents is a silicate based bioactive glass. 
 
 Bioactive glass plays a crucial role in the formation of the cement 
phase through the release of calcium and phosphate ions. It was 
possible to form a cement which had both clinically acceptable setting 
times and compressive strengths. 
 
 It was shown through investigation of numerous glass compositions 
that glass composition has an effect upon cement properties, 
specifically the setting time and compressive strength. Alterations in 
setting times was mainly due to alteration in the cement phase 
induced by either change in glass composition or alteration in 
glass/Ca(H2PO4)2 ratio. 
 
 The sodium and calcium ratio within the glass composition had a large 
effect upon cement properties. As the sodium content was increased 
the setting time decreased which was attributed to the change in 
cement phase the alteration in glass composition induced.  
 
 It was hypothesised that fluorapatite cements would be stronger due 
to much longer crystallites in the C-axis (known to occur in 
fluorapatite) (Elliott, 1994) leading to a higher degree of interlocking of 
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the fluorapatite cement phase than conventional hydroxyapatite 
cements, however, this was not the result found. 
 
 The addition of fluoride caused a higher degree of nucleation leading 
to small but more numerous crystallites than the fluoride-free cement 
compositions. It was confirmed in one composition that fluorapatite 
had been formed and it is likely to be present in the other 
compositions (but should be confirmed). However the large increase 
in the number of crystallites in the fluoride samples coupled with their 
small size is likely to cause an increase in solubility due to an increase 
in surface area. 
 
 The presence of fluoride inhibited the formation of octacalcium 
phosphate. In all cement compositions where fluoride was not present 
octacalcium phosphate was always identified in at least one time point 
whereas when fluoride was present in the cement compositions 
octacalcium phosphate was not identified in any cement compositions 
at any time points. This was attributed to the fluoride offering a 
different reaction route and the cement setting reaction forming a 
fluoridated apatite rather than octacalcium phosphate. 
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Chapter 12: Future Work 
There are a number of potential routes which could be explored following the 
completion of this project to further progress this project. Essentially the 
future work could be categorised as either (1) further understanding the 
chemistry of the cements outlined in the above piece of work or (2) improved 
the cement properties and tailor compositions for particular in-vivo 
applications. 
An immediate task to be conducted would be to perform 19F MAS-NMR 
analysis on all fluoride containing cement compositions in order to confirm 
the strongly suspected formation of a fluoridated apatite cement phase. 
Studying the dissolution profile of the glasses in solution would also provide 
much information that would help interpret the results seen here. These 
studies would involve immersion of each glass in a buffered solution like Tris 
buffer, in a similar fashion to what has been performed previously (Brauer 
2011). Ion release measurements can then be conducted to measure rate of 
release of the respective ions.  
Porosity measurements would be an important property to measure. The 
scale and size of the porosity is an important factor in the performance of 
these materials in-vivo. High porosity and large pore interconnect size allows 
cellular penetration and neovascularisation. An ideal method for measuring 
this would be to use mercury intrusion porosimetry which measures the pore 
interconnect size9.  
                                            
9
 This was attempted with 8 x 12 mm cylindrical specimen. However the instrumentation was 
unable to reach a sufficient strength vacuum to perform the measurement. 
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Another property to measure would be the particle size of the glass powders. 
Whilst care was taken to perform identical methods to produce the glass 
powders there may still be some differences induce by change in glass 
composition therefore it would be desirable to confirm this. This could be 
measured by using a particle size analyser which would give the particle size 
distributions within the glass sample. The particle size of the Ca(H2PO4)2 
powder is not known and it would also be advisable to measure this. This 
would have to be done in an ethanol solution due to the high solubility of this 
salt. 
It would also be worthwhile to produce cements with strontium; there are lots 
of examples in the literature where strontium has been incorporated into 
traditional calcium phosphate cements. Bioactive glasses have been shown 
to readily incorporate strontium and have been shown to release it in 
solution. Strontium has also been shown to have a beneficial effect on 
osteoblast and osteoclast cells (Gentleman et al., 2010). Additionally 
strontium would cause the cements to be more radiopaque than pure 
calcium cements, allowing their resorption to be tracked via X-rays. 
In this study the cement cylinders were immersed into Tris buffer solution, 
this was partly for simplicity as Tris buffer solution does not contain many 
ions which could influence the cement phase evolution. However, body fluid 
is a much more complex mixture of numerous different ions which could all 
affect the setting reaction, cement phase evolution and the cement phase 
itself. Therefore it would be interesting to study the effect upon cement 
properties of cement cylinders immersed into different solutions; possible 
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solutions could be simulated body fluid, physiological-like solution and 
phosphate buffered saline. All of these solutions have been used previously 
to immerse calcium phosphate cements. 
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